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Abstract 
 
NSAIDs, which act as COX antagonists, are widely used in veterinary practice to 
provide long-term pain relief, however a major limiting complication of their use in 
dogs is gastric ulceration. Gastric ulceration may result from either direct toxic effects 
on gastric epithelial cells or systemic action, including the inhibition of gastric epithelial 
cell migration. The role of cell migration in this effect and the specific signalling 
pathways involved are not known. COX-derived prostaglandins are known to have an 
important role in gastric defence and cytoprotection through the promotion of gastric 
mucosal blood flow and mucus secretion and the inhibition of gastric acid secretion. 
Given the importance of gastric epithelial cell migration in re-establishing gastric 
mucosal integrity following injury, the aim of this investigation was to test the 
hypothesis that paracrine PGE2 signalling modulates gastric epithelial cell migration. 
 
In order to address this hypothesis, a primary cell culture model which incorporates 
intact canine gastric glands that spread to form monolayer cell islands, was first 
characterised and then used. The effects of non-selective and COX-2 selective 
antagonism on cell spreading in this model and wound healing in immortalised cell 
monolayers was assessed. Furthermore, the involvement of subtype-specific EP receptor 
signalling in PGE2-mediated modulation of epithelial cell migration was investigated 
through treatment with specific agonists and antagonists. 
 
Both non-selective and COX-2 selective antagonism inhibited PGE2 production and 
epithelial cell migration, thus providing evidence that COX-2-derived PGE2 is 
important for the modulation of epithelial cell migration. Furthermore, non-selective 
and COX-2 selective antagonism inhibited cellular protrusive activity. The effects of 
PGE2 on epithelial cell migration were shown to be mediated through EP3 and EP4 
receptor signalling. Expression of COX-2, EP3 and EP4 was found to be readily 
induced in response to stressors. Interestingly, COX-2 expression was up-regulated in 
patients infected with spiral bacteria.  
 
These findings provide evidence that COX-2-derived PGE2 stimulates epithelial cell 
migration and the formation of cellular protrusions. Thus, reduced PGE2 production in 
the gastric mucosa may inhibit gastric epithelial migration and contribute to the 
ulcerogenic effects associated with COX antagonist therapy. 
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Chapter 1 - Introduction 
 
Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used in both 
veterinary and human practice to treat pain and inflammation. Gastric ulceration is 
a limiting complication of their use and the major mechanism through which 
NSAIDs appear to cause gastric injury is via the inhibition of COX-1 and -2, 
leading to decreased prostaglandin production. Prostaglandins have an important 
role in gastric defence and cytoprotection, via the promotion of blood flow and 
mucus secretion and the inhibition of gastric acid secretion. Small areas of 
damage in the gastric epithelium are usually rapidly repaired via a process known 
as „gastric epithelial restitution‟. During restitution, underlying epithelial cells 
migrate from the gastric pits to cover the denuded areas. The role of restitution in 
NSAID-induced gastric ulceration has not been widely studied.  
 
1.1 Canine stomach anatomy 
 
1.1.1. Structure of the canine stomach 
 
The canine stomach is located between the oesophagus and the small intestine and 
plays a vital role in the second phase of digestion through the secretion of acid 
and gastric enzymes. The functional stomach is divided into two distinct parts, the 
proximal stomach that consists of the cardia, fundus and a proportion of the body 
and the distal stomach, consisting of the antrum and the pylorus. The proximal 
stomach is involved in food storage and is capable of expanding considerably, 
while the distal section is responsible for the peristaltic contractions that mix food 
and acid together, thus aiding digestion. These contractions also encourage the 
movement of chyme, a semi-fluid material produced during the mechanical 
mixing of food in the stomach, into the duodenum. 
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The wall of the stomach is composed of four layers, the serosa, the muscularis 
layer, the submucosa and the mucosa. The serosa is the outermost layer that 
serves to reduce friction on the stomach. The inner lining of the stomach, the 
mucosa, consists of the lamina propria, the muscularis mucosae and densely 
packed gastric pits leading to the gastric glands. The lamina propria comprises 
many different cell types, including T and B lymphocytes, macrophages, plasma 
cells and myofibroblasts (Wu et al., 1999). Intraepithelial lymphocytes are also 
present in the normal gastric mucosa, with the majority being CD3
+
 T 
lymphocytes and approximately 70% expressing CD8 on the cell surface 
(Oberhuber et al., 1998). The submucosa is a layer of collagen-rich connective 
tissue that provides most of the gastric wall strength and supports the mucosa. The 
mucosa and submucosa are separated by the muscularis mucosae, a smooth 
muscle sheet consisting of an inner circular and an outer longitudinal layer. 
Separating the submucosa and the serosa is the muscularis propria, which also 
consists of longitudinal and circular fibres and serves to impede gastric ulcer 
progression (Clayburgh et al. 2004).  When the stomach is empty, elastic fibres in 
the submucosa and the muscularis mucosae push the mucosa to create 
 
 
FUNDUS 
BODY 
ANTRUM 
Oesophagus 
 
Pylorus 
 
Cardia 
Figure 1.1- Diagram illustrating the basic stomach anatomy 
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characteristic folds, known as rugae. The anatomy of the canine stomach is very 
similar to that of the human stomach, both are glandular and consist of cardiac, 
fundic and pyloric mucosal areas. These areas occupy similar proportions of both 
the canine and human stomachs (Kararli, 1995). 
 
1.1.2. Structure and function of the canine gastric mucosa 
 
There are two types of gastric gland found in the stomach, the oxyntic or fundic 
gland and the pyloric gland, named for their location. The pyloric glands consist 
of predominately mucus-secreting epithelial cells and gastrin-secreting G-cells, 
while the fundic glands are primarily composed of mucus-secreting epithelial cells 
and acid-secreting parietal cells (Schubert & Peura, 2008). Other cells present in 
the fundic glands include somatastatin-secreting D-cells, ECL cells and 
pepsinogen-secreting chief cells, while the pyloric glands also contain D cells. 
Functionally, the parietal cells are the most important cells in the fundic glands. 
They express the transmembrane enzyme H
+
/K
+
 ATPase, a proton pump that 
maintains the acidification of the stomach by catalysing the exchange of one 
hydrogen ion out of the cytoplasm for one potassium ion from the gastric lumen 
(Law et al., 2008). G-cell derived gastrin primarily stimulates acid secretion in an 
endocrine manner, via activation of the CCK2 receptor on ECL cells, causing 
release of histamine. Histamine then binds to H2 receptors on the parietal cell and 
activates adenylate cyclase, causing generation of cAMP. Gastrin can also signal 
directly to parietal cells via CCK2 receptors, activating PLC which causes a 
release of cytosolic Ca
++
 and promotes acid secretion (Schubert & Peura, 2008). 
Chief cells, located in the fundic glands, also work synergistically with parietal 
cells. They release the inactive precursor enzyme pepsinogen, which is converted 
into its active form, pepsin, by secreted acid. Pepsin is one of the primary 
proteolytic enzymes present in the digestive system (Raufman, 2004). 
 
Gastric acid is an important secretion that prevents bacterial overgrowth, thus 
helping to protect against the development of enteric infection, and also provides 
a negative feedback loop for gastrin secretion (Spencer & Metz, 2010). However, 
abnormally high levels of gastric acid have been linked to gastric ulcer formation 
in the mucosa (Schubert & Peura, 2008), thus, regulatory mechanisms to tightly 
control gastric acid secretion are important. Somatostatin, a peptide hormone 
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secreted by D cells, is involved in regulating the endocrine system via G-protein 
coupled receptors; it acts as an inhibitor of gastrin-stimulated acid secretion 
(Shamburek & Schubert, 1993). Furthermore, the surface mucous cells, located 
primarily within the top half of the gland (Figure 1.2), secrete thick, acid-resistant 
mucus that lubricates and protects the mucosal lining from any acid-induced 
damage (Laine et al., 2008). The surface mucus also contains bactericidal 
components, such as, macrophages, lysozyme and IgA (Nakagawa et al., 2000).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.1.3. Paracrine signalling in the gastric epithelium  
 
Paracrine signalling between the cells of the gastric epithelium may have an 
important regulatory role. Activation of the gastrin-CCKB receptor via paracrine 
gastrin release has been shown to induce MMP-9 expression, leading to increased 
cell invasion in a gastric epithelial cell line (Wroblewski et al., 2002) and to 
induce gastric epithelial cell migration via activation of the EGF receptor, the 
erbB-2 receptor tyrosine kinase and the MAP kinase pathway (Noble et al., 2003). 
Gastrin release also induces IL-8 production in gastric epithelial cells via 
activation of the transcription factors, NF-κB and AP-1 (Hiraoka et al., 2001). In 
addition, HGF produced by gastric fibroblasts, acts on neighbouring epithelial 
cells to promote gastric epithelial proliferation and migration (Takahashi et al., 
1995). Prostaglandins are known to strongly induce HGF release, and HGF may 
G cells 
Surface mucous cells 
Fundic gland Pyloric gland 
Parietal cells 
ECL cells 
D cells 
Chief cells 
Surface mucous 
cells 
Figure 1.2- Diagram illustrating the structure of the fundic and pyloric glands 
D cells 
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modulate the protective effects of prostaglandins in the stomach (Takahashi et al., 
1996). The HGF receptor gene, c-met is up-regulated in rat gastric mucosa during 
the healing process, indicating a role for HGF and its receptor in gastric mucosal 
healing (Tsuji et al., 1995). It is believed that HGF mediates interactions between 
mesenchymal and epithelial cells predominately during the remodelling stage of 
mucosal healing (Schmassman et al., 1997).TGF–α, released by parietal cells also 
appears to act in a paracrine manner to regulate the growth of canine oxyntic 
mucosal cells (Chen et al., 1993). 
 
1.1.4. Mechanisms of gastric protection 
 
The gastrointestinal tract is in constant contact with potentially damaging 
substances, including gastric acid and pepsin, both of which are capable of 
digesting tissue (Laine et al., 2008), thus several defence mechanisms exist to 
protect the gastric tissue from injury. The gastric mucosal barrier consists of a 
lining of columnar epithelial cells which secrete bicarbonate and mucus to 
neutralise gastric acid and also generate prostaglandins, which can act in a 
paracrine manner to inhibit acid secretion and stimulate mucus and bicarbonate 
production (Laine et al., 2008). The surface epithelial cells also exhibit tight 
junctions between them in order to maintain a physical barrier and prevent the 
back diffusion of acid (Shorrock & Rees, 1988). Microcirculation around the 
mucosa enables the delivery of cytoprotective agents, such as prostaglandins and 
EGF, and promotes acidic neutralisation via bicarbonate delivery (Abdel-Salam, 
et al., 2001). The TFF family have also been shown to play an essential role in 
gastric cytoprotection (Farrell et al., 2002; Babyatsky et al., 1996; Marchbank et 
al., 1998) via the stimulation of cellular proliferation and the inhibition of gastric 
acid secretion (Farrell et al., 2002). All three TFF‟s are expressed in the tissue of 
the stomach (Madsen et al., 2007) and exhibit gastric cytoprotective and healing 
effects (Taupin & Podolsky, 2003). Furthermore, mucosal NO protects the gastric 
mucosa against NSAID-induced damage through the maintenance of blood flow 
and the promotion of prostaglandin production (Khattab, 2001). 
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1.2.Cell migration  
 
1.2.1.Importance in embryogenesis 
 
Cell migration is a critical process in embryogenesis, for instance in giving rise to 
key embryogenic structures such as the ectoderm, the mesoderm and the 
endoderm (Strachan & Read, 2004). Perturbation of some of the important 
components involved in embryonic cell migration can lead to severe 
developmental defects (Kurosaka & Kashina, 2008), as evidenced using knockout 
mouse models, for example, knocking out E-cadherin caused a loss of 
trophectoderm epithelium formation, resulting in lethality at the time of 
implantation (Larue et al., 1994). 
 
1.2.2.Importance in wound healing 
 
Cell migration plays an important role in the repair of superficial or partial-
thickness wounds in the adult. These wounds occur when the epidermis and 
superficial layers of the dermis are injured but the basal layer of cells remains 
intact and cells migrate into the gap in order to close the wound (Enoch & Leaper, 
2005). Cell migration is an important homeostatic process involved in maintaining 
the integrity of skin, corneal, intestinal and gastric tissue. Migration appears to 
follow a similar process in all cell types and environments that have been 
investigated so far. Repair of damage within the cornea is a complex process as, 
due to the function of the eye, it is essential that the transparent properties of the 
cornea remain unaffected. During the first four to six hours following injury, 
corneal epithelial cells polarise and the actin cytoskeleton is reorganised, then 
when actively migrating, the epithelial cells flatten and spread out to cover the 
wound area, projecting both lamellipodia and filopodia from the leading edge 
(Dua et al., 1994). Glycogen metabolism provides the energy required for this 
process (Dua et al., 1994; Kuwabara et al., 1976). Cell migration within the 
gastrointestinal tract is very similar to the process involved in corneal wound 
repair. IBD is a group of conditions which cause the intestinal mucosa to become 
chronically inflamed and this inflammation can lead to repeated injury of the 
intestinal wall and thus the requirement for constant tissue repair. In the case of 
IBD, mucosal epithelial cells adjacent to the wound edge polarise, undergo 
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cytoskeletal changes and spread out in order to fill the gap (Sturm & Dignass, 
2008). Rapid repair of superficial GI mucosal injury is important to prevent the 
occurrence of more widespread damage. As this project focusses on cell migration 
in the context of gastric mucosal repair, this process will be discussed in more 
detail. Cells within the stomach are exposed to a highly acidic environment, 
constant friction from ingested food and potential contact with pathogens, thus the 
stomach is an active site for rapid cell migration into denuded areas (Wallace and 
Granger, 1996).  
 
1.2.3. Rapid epithelial restitution in the gastric mucosa 
 
Gastric epithelial cell migration in response to gastric damage is referred to as 
rapid epithelial restitution (Lacy & Ito, 1984). Lacy and Ito (1984) conducted 
research looking at the cellular mechanisms involved in the repair of epithelial 
cells in the rat gastric mucosa following injury with absolute ethanol. The process 
of restitution started within three minutes of injury and was virtually complete 
after one hour. Lacy and Ito (1984) characterised restitution into four distinct 
stages based on the microscopic appearance of the cells (Figure 1.3). At stage one, 
the necrotic epithelium was still attached to viable cells within the gastric pits and 
no cell migration had occurred. The necrotic tissue was detached at stage two, 
leaving the basal lamina denuded. Migrating squamous cells with extended 
lamellipodia covered the basal lamina at stage three and changed to columnar 
cells at stage four to complete the migration process. A reduced level of cell 
migration occurred in areas containing breaks in the basal lamina (Lacy & Ito, 
1984) thus suggesting that an intact basal lamina is important. 
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Prior to migration, cells undergo a series of characteristic changes in preparation 
for the process. Initially, migrating cells must polarise, with lamellipodia, 
microtubules and the Golgi complex locating towards the front of the cell and 
myosin II locating towards the rear (Ridley et al., 2003). Cell polarity is regulated 
by various signalling molecules, for instance, epithelial cell-cell contact, mediated 
by E-cadherin, has been shown to induce polarity (Desai et al., 2009). An intact 
actin cytoskeleton and Cdc42 signalling are also required (Desai et al., 2009) and 
Cdc42 is known to have a central role in cell polarisation (Etienne-Manneville, 
2004). 
 
Stage 1  Stage 2  
Stage 3 Stage 4 
 
Figure 1.3- Photomicrographs of gastric mucosae illustrating the various stages 
involved in restitution; * = gastric pit, L = lumen, C = capillary, the arrowheads 
indicate the denuded basal lamina and the arrow indicates a parietal cell in the gastric 
pit. 
(Figure reproduced from Lacy & Ito, 1984) 
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Following polarisation, migrating cells extend protrusions from their plasma 
membrane at the leading edge. Actin polymerisation at the leading edge is 
stimulated by the activation of Rac or Cdc42 (Horwitz & Webb, 2003) and 
functions to push the membrane forward (Figure 1.4). There are four specific 
types of cellular protrusions involved in cell migration, namely lamellipodia, 
filopodia, blebs and invadopodia (Ridley, 2011). Lamellipodia are sheet-like, 
actin cytoplasmic projections that function to “pull” the migrating cell forwards 
and these were first identified by Abercrombie in 1980. The α6 and α3β1 integrins 
have a role in the formation of lamellae (Lotz et al., 2000). Filopodia were first 
described in 1961 by Gustafson and Wolpert, who referred to them as pseudopods 
and observed them in primary mesenchymal cells of the sea urchin embryo. 
Filopodia are finger-like projections that extend beyond the leading edge of the 
lamellipodia and function to explore the local environment. Blebs are spherical 
protrusions supported by the actomyosin cortex (Charras & Paluch, 2008); 
however, blebbing migration has not been widely studied. Invadopodia are 
protrusions typically extended by invasive tumoural or transformed cells. These 
protrusions are proteolytic in nature and their function is to degrade the 
extracellular matrix (Ayala et al., 2006), allowing further invasion. The pathways 
that activate the formation of these cellular protrusions differ. Lamellipodia 
formation is activated via Rac and the downstream WAVE2 complex, while 
filopodia formation is induced via WASP, which is activated downstream of 
Cdc42 (Takenawa & Miki, 2001). Bleb protrusions are Rho/ROCK dependant 
(Charras & Paluch, 2008) and invadopodia protrusions are RhoC dependant 
(Bravo-Cordero et al., 2011). 
 
 
Figure 1.4- Illustration highlighting the processes involved in rapid epithelial restitution 
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In order for cellular protrusions to occur, areas of extension must overcome the 
resistive forces of cell membrane tension. A direct inverse relationship between 
lamellipodial extension rate and membrane tension has been described (Raucher 
& Sheetz, 2000). Once established, protrusions are stabilised via the binding of 
adhesions with the substratum (Horwitz & Webb, 2003). Adhesion formation is 
dependent on both Rac and Cdc42 (Ridley et al., 2003) and adhesions function as 
both traction sites and mechanosensors (Galbraith et al., 2002). 
 
Finally, in order to complete its forward movement, a contractive force is exerted 
onto the rear of the cell in a myosin-dependant process (Horwitz & Webb, 2003). 
Adhesions at the rear of the cell are disassembled to allow movement, this 
disassembly can occur via two mechanisms, either the strong contractive force can 
physically „tear‟ the adhesion bond or signals from regulatory pathways may 
activate the process (Lauffenburger & Horwitz, 1996). 
 
1.2.4. Signalling molecules linked to migration 
 
The cells within gastric glands may release many molecules, such as growth 
factors, cytokines and prostaglandins and several of these signalling molecules 
have been shown to be involved in the regulation of cell migration. These include 
EGF (Maldonado & Furcht, 1995), HGF (Netzer et al., 2003), TFF‟s (Taupin & 
Podolsky, 2003; Xue et al., 2010) and prostaglandins (Buchanan et al., 2003). 
Furthermore, FAK, a signalling molecule implicated in initiating many 
downstream processes, including tyrosine phosphorylation appears to have a role 
in leading edge formation during cell migration (Tilghman et al., 2005). Cell-cell 
junctions are also important in the regulation of cell migration, for instance, E-
cadherin mediates cell polarity (Desai et al., 2009) and occludin regulates 
directional migration (Du et al., 2010). As well as functioning as adhesion sites, 
junctions can act as signal carriers to limit a cell‟s growth or to communicate a 
cell‟s position (Dejana, 2004).  
 
1.2.5. Models used for studying cell migration 
 
Due to its importance in a variety of biological processes, various experimental 
models have been developed to enable the study of cell migration. The most 
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common in vitro method used is the scratch wound healing assay, which is simple 
to perform, relatively cheap and mimics the migratory behaviour of cells seen in 
vivo (Liang, Park & Guan, 2007). Crude wounds are made in confluent cell 
monolayers and migration into the wound space is measured over a period of 
time. As wounded cells migrate as a sheet, normal cell-cell interactions are 
preserved (Fotheringham et al., 2012). This technique has been successfully used 
in a variety of cell types (Herren et al., 2001; Lu et al., 2004; Huang et al., 2008), 
however as a large quantity of cells are required, this is not usually the assay of 
choice for primary cell experiments. The Boyden chamber assay provides a means 
for studying directional cell migration in response to chemoattractants. Cells are 
seeded in serum-free medium over a porous insert and chemoattractants are placed 
in the well beneath, thus migration through the pores of the insert can be recorded 
(Chen, 2005). These assays are summarised in Figure 1.5. Both assays involve the 
use of a single cell type, which does not fully recapitulate the cell to cell 
interactions that occur in vivo. From a clinical perspective, analysis of the 
interactions between all cell types within the gastric gland would be more 
valuable. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scratch wound healing assay Boyden chamber assay 
Figure 1.5- Diagram illustrating assays commonly used to study cell migration 
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1.3. Prostaglandins 
 
1.3.1. Prostaglandin structure and synthesis 
 
Prostaglandins are synthesised within the cell from the fatty acid precursor, 
arachidonic acid. The COX enzymes, COX-1 and COX-2, are involved in the 
metabolism of arachidonic acid, which is mainly stored in membrane 
phospholipids. PLA2 mediates the release of arachidonic acid from the cell‟s 
membrane, arachidonic acid is then oxidised by COX into PGG2, and reduced to 
PGH2. PGH2 acts as a substrate for the COX enzymes, leading to production of the 
five prostaglandins (Hata & Breyer, 2004) (Figure 1.6). Once synthesised, the 
prostaglandins are released from the cell and have a short half-life in vivo, thus 
they act primarily on neighbouring cells (Narumiya et al., 1999). The 
prostaglandins are rapidly inactivated by the cytosolic enzymes, 15-
ketoprostaglandin ∆13-reductase and 15-hydroxyprostaglandin dehydrogenase 
(Legler et al., 2010). Prostaglandins are produced primarily when required; they 
do not appear to be stored in either tissues or cells in any appreciable quantity 
(Gibson, 1977).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6- Schematic diagram illustrating the biosynthesis of prostaglandins 
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1.3.2. Functions of prostaglandins 
 
1.3.2.1. General 
 
Prostaglandins exert their effects via a diverse array of G-protein coupled 
receptors (Hata & Breyer, 2004), resulting in a variety of physiological effects 
within the body, including effects on reproduction and cardiovascular (Miller, 
2006), renal (Schlondorff & Ardaillou, 1986), and gastrointestinal function 
(Robert, 1984). Prostaglandins are involved in various aspects of reproduction, 
including menstrual regulation, ovulation and stimulation of uterine contractions 
during labour (Embrey, 1981). Within the cardiovascular system, prostaglandins 
inhibit platelet aggregation (Miller, 2006), resulting in an anti-coagulant effect 
and also stimulate the vasodilation of endothelial cells. Prostacyclin has a vital 
role in regulation of renal blood flow, glomerular filtration rate and renin 
secretion and PGE2 produced via the interstitial cells of the renal medulla 
regulates salt and water excretion (Miller, 2006). Furthermore, prostaglandins 
modify the inflammatory response through stimulation of vasodilation and 
vascular permeability (Goodwin & Webb, 1980). PGE2 mediates arterial dilation, 
leading to redness and swelling and acts directly on peripheral sensory neurons, 
causing pain (Ricciotti & FitzGerald, 2011). Prostaglandins have also been shown 
to exhibit anti-inflammatory effects in allergic lung disease (Gavett et al., 1999) 
and inflammatory colitis (Morteau et al., 2000). Immune responses are initiated by 
T lymphocytes and prostaglandins may modulate the development and maturation 
of T cells and influence the function of mature lymphocytes. PGE2 can inhibit 
many T and B cell functions including the inhibition of T lymphocyte activation 
and proliferation (Chouaib et al., 1985) and the inhibition of IgE production by B 
lymphocytes (Pène et al., 1988). 
 
1.3.2.2. Gastrointestinal specific 
 
Prostaglandins derived via COX activity, in particular PGE2, are believed to have 
an important role in gastric defence and cytoprotection. Prostaglandins are 
synthesised throughout the gastrointestinal tract, with PGE2 and PGF2α being the 
most abundantly produced prostaglandins in the human gastric mucosa (Eberhart 
& Dubois, 1995). PGD2 and PGI2 are also produced in the gastric mucosa but at 
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significantly lower concentrations (Eberhart & Dubois, 1995). Prostaglandins 
contribute to gastric mucosal protection by increasing the production of 
bicarbonate and mucus (Laine et al., 2008), inhibiting gastric acid secretion 
(Whittle, 1980) and decreasing epithelial cell permeability to protect against acid 
back-diffusion (Takezono et al., 2004). Additionally, prostaglandins may protect 
the gastric mucosa by down-regulating the release of certain pro-inflammatory 
molecules, for example IL-1 (Kunkel et al., 1986) and LTB4 (Ham et al., 1983) 
that can cause the development of gastric lesions. Prostaglandins may also protect 
epithelial cells from NSAID or ethanol-induced injury through a direct cellular 
effect (Tarnawski et al., 1988), although a mechanism for this was not clear. 
Furthermore, endogenous prostaglandins are potent vasodilators that can increase 
gastric mucosal blood flow. Gastric mucosal blood flow has a vital role in gastric 
cytoprotection and healing via the constant supply of oxygen and bicarbonate and 
the removal of excess acid and toxins. It is not known whether or not the 
cytoprotective effects of prostaglandins are a direct result of increased gastric 
mucosal blood flow or if prostaglandins increase blood flow to an appropriate 
level for restitution to occur (Abdel-Salam et al., 2001). 
 
1.3.3.COX enzymes 
 
1.3.3.1. Structural features of COX-1 and -2 
 
Two isoforms of the COX enzymes (also known as prostaglandin endoperoxidase 
H2 synthases) exist, namely COX-1 and COX-2. COX-1 was initially purified in 
1976 from the vesicular glands of sheep (Hemler & Lands, 1976) and the COX-1 
gene was sequenced in 1989 (Yokoyama & Tanabe, 1989), while the existence of 
a COX-2 isoform was first described in 1991 (Kujubu et al., 1991). The isoforms 
are each coded for by a different gene, although they have similar primary protein 
structures, sharing between 60 and 65% amino acid identity (Chandrasekharan & 
Simmons, 2004) and they both catalyse the conversion of arachidonic acid to 
PGG2 and the reduction of PGG2 to PGH2. The isoforms also have similar three-
dimensional structures, comprising of three structural domains, the N-terminal 
EGF domain, a membrane binding domain and a catalytic domain, containing a 
heme binding site and a COX site (Garavito & Mulichak, 2003). Despite having 
similar overall structures, the membrane binding domain sites of the isoforms are 
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only 38% identical (Spencer et al., 1999), with COX-2 having a much larger 
active site due to substitution of the COX-1 ILE523 residue with Val523. This 
increased binding site volume can be utilised by pharmaceutical companies in 
order to make drugs that specifically target the COX-2 enzyme, i.e. that are too 
large to bind to the COX-1 active site (Garavito et al., 2002).  
 
1.3.3.2. Expression and regulation of COX-1 and -2 
 
COX-1 mRNA and protein is expressed constitutively in most tissues and cells 
and is thought to be involved in normal homeostatic processes (Morita, 2002). 
The structure of the COX-1 gene is consistent with that of a housekeeping gene 
(Tanabe & Tohnai, 2002), i.e. it is GC-rich and lacks a canonical TATA or CAAT 
box in its promoter region (Martin Sanz et al., 2006). COX-2 expression is 
inducible upon cell activation and stimulation via proinflammatory stimuli (Hla et 
al., 1999). Proinflammatory factors that have been shown to induce COX-2 
expression include IL-1, TNF-α, INF-γ and LPS (Tanabe & Tohnai, 2002). HGF 
has also been shown to induce COX-2 expression in rat gastric epithelial cells via 
phosphorylation of the c-Met/HGF receptor and activation of the ERK2 signalling 
pathway (Jones et al., 1999). The COX-2 gene has several regulatory elements, 
including NF-κB, NF-IL6 and CRE, which are involved in the transcriptional 
regulation of the gene (Tanabe & Tohnai, 2002). COX-2 expression is regulated at 
the transcriptional and post-transcriptional level (Hla et al., 1999) and activation 
of the MAPK cascade is involved in gene regulation at both levels (Tanabe & 
Tohnai, 2002). 
 
1.3.3.3. Localisation of COX-1 and -2 
 
The intracellular locations of COX-1 and -2 have been previously determined 
using quantitative confocal microscopy (Morita et al., 1995). COX-1 
immunoreactivity was observed within the endoplasmic reticulum and the nuclear 
envelope and while COX-2 immunoreactivity was also seen in these areas, the 
intensity of staining in the nuclear envelope was 2-fold higher than that seen in the 
endoplasmic reticulum. Current evidence suggests that COX-1 and -2 function to 
produce prostaglandins for extracellular housekeeping and differentiative or 
replicative events respectively (Morita et al., 1995). Constitutive expression of 
Introduction 
 
16 
COX-1 makes it readily available to mediate prostaglandin synthesis for normal 
physiological functions, such as modulation of reproductive and cardiovascular 
processes (Miller, 2006), while COX-2 expression is known to be induced during 
differentiative or replicative events (Xie et al., 1991; Dewitt et al., 1993). Previous 
studies suggest that COX-1 and -2 utilise two distinct pools of arachidonic acid, 
with COX-2 responding to a stimulated pool of arachidonic acid, required for 
inflammatory responses, and COX-1 responding to a pool required for 
physiological functions (Reddy & Herschman, 1994). COX-2 expression is 
known to be required for prostaglandin production from endogenous arachidonic 
acid released in response to mitogen stimulation in murine fibroblasts and 
macrophages, while COX-1 is unable to utilise this store (Reddy & Herschman, 
1994).  
 
1.3.3.4. Functions of COX -1 and -2 
 
Specific roles for COX-1 and -2 have been identified using gene disruption 
studies. While neither male nor female fertility appears to be affected in COX-1 
deficient mice, complete lack of COX-1 through homozygous x homozygous 
mating, results in few live offspring (Langenbach et al., 1995), thus highlighting 
the importance of COX-1 in reproduction. Homozygous COX-1 mutant mice 
exhibit decreased platelet aggregation and arachidonic acid-induced inflammation 
(Langenbach et al., 1995), however, these mice survive well, do not exhibit any 
gastric pathology, show less susceptibility to indomethacin-induced gastric 
ulceration and exhibit minimal kidney abnormalities (Langenbach et al., 1995). 
These results are surprising, considering that COX-1 is believed to have a vital 
role in normal cellular physiology. COX-2 deficient mice show normal 
inflammatory responses to exogenous arachidonic acid and show no innate 
gastrointestinal pathology (Morham et al., 1995), they do, however, exhibit 
kidney abnormalities that progressively degenerate with age, and develop a 
susceptibility to peritonitis (Morham et al., 1995). In contrast, non-selective COX 
inhibition via NSAID treatments, has been shown to cause gastrointestinal 
damage (Wallace et al., 2000; Tanaka et al., 2001), thus suggesting that the COX 
enzymes do have an important role in gastrointestinal protection. 
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COX-2 has a role in tumorigenesis, through the stimulation of proliferation and 
angiogenesis and the suppression of apoptosis and the immune response (Howe et 
al., 2001). COX-2 has been shown to be up-regulated in pancreatic (Tucker et al., 
1999), lung, breast and colon (Soslow et al., 2000) cancer. Furthermore, a reduced 
risk of colorectal cancer has been associated with the regular use of NSAIDs 
(Ruder et al., 2011) and the inhibition of COX-2 is believed to play a key role in 
this effect (Schrör, 2011). Aspirin treatment has been shown to reduce the risk of 
colorectal cancers overexpressing COX-2, but not those with weak or absent 
COX-2 expression (Chan et al., 2007). COX independent mechanisms which may 
play a role in this effect include modification of transcription factors, such as NF-
κB, induction of apoptosis and DNA stabilisation (Schrör, 2011). 
 
1.3.4. Prostaglandin receptors 
 
1.3.4.1. Structure and localisation 
 
Prostaglandin effects are mediated through the transmembrane, G-protein coupled 
prostanoid receptors, which were first classified in 1982 (Kennedy et al., 1982). 
There are five key members of the prostanoid receptor family, grouped by the 
ligand with which they bind to, these include DP, EP1-4, FP, IP and TP, which 
bind to PGD, PGE, PGF, PGI and thromboxane respectively (Ushikubi et al., 
1995). Prostaglandins exhibit different biological functions, depending upon the 
receptor with which they bind, and effects may also differ depending on the cell 
type involved (Hata & Breyer, 2004). The prostanoid receptor gene structure has 
been shown to be similar between all receptors and across various species (Boie et 
al., 1995; Ogawa et al., 1995; Regan et al., 1994). The receptors consist of the 
seven hydrophobic, transmembrane domain, characteristic of G-protein coupled 
receptors and a putative extracellular-loop region (Breyer et al., 2001). As PGE2 is 
considered to have the most important role in normal GI physiological processes, 
the focus of this review will be on the structure and function of the EP receptors to 
which PGE2 binds.  
 
Four sub-types of the EP receptor exist, namely EP1, EP2, EP3 and EP4, each 
with varying structures and functional roles. The diverse biological effects of 
PGE2 may be attributed to the different signal transduction pathways that occur 
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upon activation of each receptor sub-type (Hata & Breyer, 2004). The EP 
receptors are encoded by different genes, but are well conserved throughout the 
mammalian species. All of the receptor sub-types are expressed on the plasma 
membrane, however EP3 and EP4 also localise at the nuclear envelope 
(Bhattacharya et al., 1999). EP3 is the only receptor that exhibits multiple 
alternatively spliced variants (Breyer et al., 1994), which can activate different 
second messenger signalling pathways (Pierce and Regan, 1998). Eight different 
EP3 isoforms have been recorded to date (Bilson et al., 2004).  
 
EP receptor expression within the stomach varies greatly between species. For 
instance, in rat stomach tissue, EP1 mRNA was detected in the gastric muscle 
layers, while EP3 and EP4 mRNA was expressed primarily in the gastric mucosal 
layer (Ding et al., 1997). Within cultured gastric epithelial cells, EP3 and EP4 
were expressed in parietal cells, while only EP4 was expressed in gastric mucous 
cells (Ding et al., 1997). In normal human gastric tissue, no EP1 protein was 
detected, EP2 was expressed on the luminal surface of the gastric epithelium, EP3 
was expressed in the gastric epithelium only and was localised to the upper 
mucosal cells and intense EP4 expression was detected in the lamina propria 
mononuclear cells (Takafuji et al., 2002). Limited information is available with 
regards to the expression and localisation of the EP receptors in the normal canine 
gastric epithelium. 
 
Out of the four EP receptor sub-types, EP1 has the lowest affinity for PGE2 with a 
Kd of 16-25 nM (Dey et al., 2006). The affinity of EP2 for PGE2 differs 
significantly between species, with the rat EP2 receptor having the highest affinity 
(Kd=5 nM) and the mouse receptor showing a much lower affinity (Kd=116 nM) 
(Dey et al., 2006). The EP3 and EP4 receptors both have a relatively high affinity 
for PGE2, with Kd values of 0.33-2.9 nM and 0.59-1.27 nM respectively (Dey et 
al., 2006). These variations in affinity between the receptor sub-types may be due 
to the degree of G-protein subunit coupling. It has been reported that a receptor 
that is coupled exhibits a lower affinity for PGE2 than an uncoupled receptor 
(Breyer et al., 2001).  
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1.3.4.2.Functions of the EP receptors 
 
The roles of the specific EP receptors in gastric cytoprotection have been studied 
using both mouse „knockout‟ models and experiments utilising sub-type specific 
EP receptor agonists and antagonists. Pre-treating rats with either PGE2 or an EP1 
specific agonist, dose-dependently prevented HCl/ethanol-induced gastric lesion 
development (Araki et al., 2000), thus it appears that PGE2 provides gastric 
cytoprotection through activation of the EP1 receptor. This finding was confirmed 
using a mouse „knockout‟ model, which demonstrated that the protective effect of 
PGE2 disappeared in mice lacking the EP1 receptor (Araki et al., 2000). 
Furthermore, PGE2 has been shown to dose-dependently protect the gastric 
mucosa against NSAID-induced damage, via activation of the EP1 receptor 
(Suzuki et al., 2001).  
 
Prostaglandins have gastric cytoprotective effects via the regulation of acid, 
bicarbonate and mucus secretion through activation of the EP3, EP1 and EP4 
receptors respectively (Takeuchi et al., 2010). PGE2 has a biphasic effect on acid 
secretion via the activation of different receptors; for instance, EP3 and EP4 
activation cause the inhibition and stimulation of acid secretion respectively (Dey 
et al., 2006). PGE2-mediated inhibition of acid secretion via EP3 receptor 
activation, involves both a direct effect on parietal cells and an indirect effect via 
the inhibition of histamine secretion from ECL cells (Takeuchi et al., 2010). 
Additionally, gastric mucosal blood flow is increased via activation of the EP2, 
EP3 and EP4 receptors, but not the EP1 receptor (Araki et al., 2000). Activation 
of EP2 and EP4 may also be important for gastric cytoprotection, in particular, 
inhibition of ethanol-induced rat gastric mucosal damage has been shown to occur 
via activation of EP2 and EP4 leading to inhibition of LTC4 production (Hattori et 
al., 2008). LTC4 is considered to play an important role in the development of 
ethanol-induced gastric damage via the promotion of vascular disturbances (Higa 
et al., 1991). COX-2-derived PGE2 has been shown to promote the healing of 
gastric ulcers via EP4 receptor activation and the up-regulation of VEGF 
(Hatazawa et al., 2007) and EP4 receptor activation is associated with the 
modulation of cell migration in a variety of cell types (Kim et al., 2010; Ma et al., 
2006). 
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1.3.4.3.EP receptor signalling 
 
Each EP receptor is coupled to a different intracellular signalling pathway (Figure 
1.7). The EP1 receptor activates PLC, causing mobilisation of intracellular 
calcium, EP2 and EP4 activation results in an increase in intracellular cAMP 
levels and EP3 activation leads to a reduction in cAMP (Hull et al., 2004). The 
EP3 receptors are able to couple to multiple G-proteins, upon coupling they 
activate the Gi subunits, leading to inhibition of adenylyl cyclase. They may also 
activate Gs subunits causing an increase in cAMP production (Dey et al., 2006). 
 
 
 
 
Figure 1.7- Diagram illustrating the signal transduction pathways induced via activation of 
the EP receptor sub-types 
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1.4. Non-steroidal anti-inflammatory drugs (NSAIDs) 
 
1.4.1. Discovery and Clinical uses 
 
NSAIDs are routinely used in both human and veterinary medicine to reduce 
inflammation and associated pain. NSAIDs exert their effects via the inhibition of 
prostaglandin production (Vane, 1971) and prostaglandin inhibition has been 
demonstrated in a wide variety of cell types (Vane & Botting, 1996). 
Prostaglandins cause increased vasodilation, which leads to an increase in plasma 
exudation induced by bradykinin and histamine (Williams & Peck, 1977). PGE2 
can also directly promote vasodilation through EP2 signalling (Tilley et al., 2001). 
These effects cause the typical symptoms present in cases of acute inflammation, 
i.e. erythema and oedema.  
 
1.4.2. Adverse effects associated with NSAID use 
 
NSAID use has been associated with adverse effects, including nephrotoxicity 
(Ejaz et al., 2004), adverse cardiovascular effects (Bennett et al., 2005) dyspepsia 
and gastric ulceration (Laine, 2002). In patients regularly taking NSAIDs, the 
point prevalence of gastric ulceration is 15-30% (Laine, 2001). NSAID-induced 
gastric damage may be caused either through topical or systemic action (Laine, 
2002); however, a previous study found that there was no difference in the relative 
risk of developing upper-gastrointestinal bleeding between users of plain and 
enteric-coated aspirin (Kelly et al., 1996). As prostaglandins are involved in the 
regulation of a variety of gastric defence mechanisms, it seems likely that their 
inhibition will contribute to the gastrointestinal adverse effects associated with 
NSAID therapy, although NSAIDs may also induce apoptosis and necrosis of 
gastric mucosal cells in vitro, independently of COX inhibition (Tomisato et al., 
2004). Furthermore, NSAIDs may prevent gastric repair through the reduction of 
mucosal blood flow, which is necessary for epithelial restitution, and by 
preventing EGF from initiating epithelial repair (Wallace, 2008). 
 
As COX-1 is thought to be primarily involved in normal physiological processes, 
it was reasoned that the adverse effects associated with NSAID treatment could be 
avoided through selective COX-2 inhibition. Celecoxib, the first COX-2 selective 
Introduction 
 
22 
inhibitor (collectively known as coxibs) was introduced in December 1998 
(DeWitt, 1999) and since then many more have been developed. COX-2 selective 
antagonists approved for use in dogs include acetamorphin, meclofenamic acid, 
carprofen, etodalac, vedaprofen, deracoxib, firocoxib and meloxicam (Thompson, 
2011). Conflicting evidence exists, regarding the GI tolerability of coxibs in 
comparison with non-selective antagonists. Several endoscopic studies have been 
performed, comparing the incidence of gastric ulceration with coxib and non-
selective NSAID therapy. These studies report a lower incidence of ulceration in 
patients prescribed coxibs, with incidence levels being similar to the placebo 
group (Laine et al., 1999; Simon et al., 1999; Hawkey et al., 2000). Two large, 
randomised controlled trials, the VIGOR and the CLASS trials, were also 
performed to analyse the occurrence of clinically relevant GI events during coxib 
and non-selective NSAID therapy (Bombardier et al., 2000; Silverstein et al., 
2000). These trials also report decreases in clinically important GI events in 
patients taking coxibs compared to traditional non-selective NSAIDs. However, 
previous in vivo investigations have presented contrasting findings. Non-selective 
COX inhibition was found to significantly worsen IA-induced gastric damage in 
rats and selective inhibition of both COX-1 and COX-2 also exacerbated gastric 
lesions (Takeeda et al., 2004), thus suggesting that both enzymes are important for 
gastric protection. A similar study reported that selective COX-1 and -2 inhibition 
caused no gastric damage; however, non-selective inhibition caused gross damage 
(Tanaka et al., 2001). Thus, the role of COX-1 and -2 in gastric protection remains 
unclear. 
 
COX-2 selective inhibitors have also been associated with increased 
cardiovascular risks, primarily an increased incidence of myocardial infarction 
(Bombardier et al., 2000). COX-2 selective inhibitors do not inhibit the 
prothrombotic prostaglandin thromboxane, however, they do inhibit the 
vasodilatory PGI2 (Justice & Carruthers., 2005), thus this prostaglandin imbalance 
may lead to increased thrombosis and an increased cardiovascular risk. Due to 
these associated cardiovascular risks, one of the most widely used COX-2 
selective inhibitors, rofecoxib, was withdrawn from the market in September 2004 
(Jϋni et al., 2004).  
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1.5. Glucocorticoids 
 
1.5.1. Glucocorticoid structure and synthesis 
 
The HPA axis is a complex system of endocrine interactions between the 
hypothalamus, pituitary and adrenal glands. The main role of the HPA axis is to 
maintain homeostasis under conditions of stress. CRH, released from the neurons 
of the paraventricular nucleus of the hypothalamus, regulates the HPA axis and 
stimulates ACTH secretion (Abel & Majzoub, 2005). Glucocorticoids are released 
from the adrenal cortex in response to ACTH stimulation (Chiras, 20011). 
Cortisol is the primary endogenous glucocorticoid in humans, while in rodents the 
main glucocorticoid is corticosterone (Kirschbaum et al., 1992). Glucocorticoids 
are made up of an initial four-ring cholesterol structure, as are all steroids 
(Feldman, 1992). The structures of the major endogenous (cortisol) and synthetic 
(dexamethasone) glucocorticoids are shown in Figure 1.8. Dexamethasone is a 
synthetic glucocorticoid, with potent anti-inflammatory and immunosuppressive 
effects, thus it has widespread clinical applications (Ong et al., 2006). 
Glucocorticoids play a role in critical processes, such as growth, reproduction, 
immune and inflammatory processes (Nicolaides et al., 2010) and the regulation 
of energy metabolism (Vegiopoulos & Herzig, 2007). 
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Figure 1.8- Diagram showing the chemical structure of two common glucocorticoids 
 
1.5.2. Glucocorticoid receptor (GR) 
 
The actions of glucocorticoids are mediated via the intracellular GR. The GR is 
expressed in most tissues; however tissue-specific variation in expression levels is 
evident (Kalinyak et al., 1987). The human GR gene sequence was isolated, via 
nucleotide sequence analysis of cDNA clones in 1985 (Hollenberg et al., 1985). 
The GR gene is located on chromosome 5 and consists of 9 exons (Rhen & 
Cidlowski, 2005), with exon 9 having two highly homologous isoforms, α and β 
(Nicolaides et al., 2010). The GR has a modular structure, comprising of four 
domains, the A/B region which is the N-terminal domain and the C, D and E 
regions, which correspond to the DNA-binding domains, the hinge region and the 
ligand binding domain respectively. The unbound GR exists as a cystolic 
multiprotein complexed with several Hsps, including Hsp90, Hsp70 and Hsp40 
(Stahn et al., 2007). During activation, the glucocorticoid receptor forms a 
complex with a glucocorticoid molecule and translocates to the nucleus where it 
binds to the regulatory region of the gene. Once activated, the GR undergoes 
conformational changes and dissociates from the Hsp molecules (Almawi & 
Melemedjian, 2002). Activated GR can bind to specific GREs in the promoter 
region of the target gene, resulting in activation of gene transcription (Newton, 
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2000) and this process, commonly referred to as transactivation, is believed to be 
responsible for many of the effects of glucocorticoids. Activated GR can also 
interact, either directly or indirectly, with transcription factors involved in the 
regulation of pro-inflammatory gene expressions, such as NF-κB or AP-1.  
 
1.5.3. Glucocorticoid functions 
 
1.5.3.1. General 
 
Glucocorticoids function primarily via the modulation of gene transcription and 
effects on translation and post-translational processes. They can affect the 
production of a wide variety of pro-inflammatory mediators, including cytokines, 
chemokines and adhesion molecules (Goulding & Flowers, 2001). The primary 
function of glucocorticoids involves the metabolism of glucose from non-
carbohydrate sources, for example proteins within muscle tissue (Campbell & 
Reece, 2005); this is useful when the body requires more fuel than can be 
provided from normal glycogen stores. Glucocorticoids inhibit cellular 
degranulation, thus protecting against the release of pro-inflammatory cells, such 
as, granulocytes, mast cells and macrophages. Glucocorticoids also act to suppress 
components of the immune system, for example, they cause a decrease in normal 
B cell proliferation through decreased cytokine production and activate 
programmed cell death of T lymphocytes (Goodman, 2009). Glucocorticoids exert 
anti-inflammatory effects through inhibition of PLA2 production, a pre-cursor of 
arachidonic acid, leading to decreased prostaglandin production (Smith, 2009). 
Glucocorticoids are able to influence the expression of particular growth factors 
and growth hormones, thus allowing them to have a role in the formation of bone 
and cartilage (McMaster & Ray, 2008). Glucocorticoids have also been shown to 
have a regulatory role in vascular smooth muscle contractility (Kornel et al., 
1993). 
 
1.5.3.2. Glucocorticoids and the gastrointestinal tract 
 
Controversy exists with regards to the effects of glucocorticoids on the 
gastrointestinal tract. High-dose steroid therapy has been associated with an 
increased risk of upper gastrointestinal complications in humans (Rodriguez & 
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Hernández-Diaz, 2001). Additionally, glucocorticoid administration to 
experimental rats‟ resulted in the formation of acute gastric erosions (Filaretova et 
al., 1998). The ulcerogenic effects of glucocorticoids are thought to occur due to 
increases in gastric acid and mucus production and gastrin and parietal cell 
hyperplasia (Schäcke et al., 2002). Glucocorticoid-induced gastric damage 
appears to be unrelated to inhibition of prostaglandin synthesis but may be related 
to inhibition of leukotriene synthesis (Wallace, 1987).  
 
Contrastingly, endogenous glucocorticoids have been shown to provide protection 
to the gastric mucosa against injury. Acute increases in stress-induced plasma 
corticosterone levels appear to protect against the development of stress-induced 
ulcers (Filaretova et al., 1998). Glucocorticoids appear to exert gastroprotective 
effects via the modulation of mucosal blood flow (Filaretova et al., 1999) and 
mucus production and the inhibition of gastric motility and microvascular 
permeability (Filaretova et al., 2002). Endogenous glucocorticoids also provide 
protection against NSAID-induced gastric injury (Filaretova et al., 2001; 
Filaretova et al., 2002). 
 
1.5.4. Clinical use 
 
Due to their anti-inflammatory actions, glucocorticoids are routinely used to treat 
a variety of inflammatory conditions, such as IBD, bronchial asthma and 
glomerulonephritis (Waller et al., 2001) and replacement glucocorticoid therapy is 
standard practice for the treatment of adrenal insufficiency (Hahner & Allolio, 
2009), during which inadequate amounts of steroid hormones are produced by the 
adrenal gland. Due to their suppressive effects on the immune system, 
glucocorticoids are often used as part of post-transplantation treatment to prevent 
allograft rejection and as a mainstay treatment for autoimmune disorders (Allison, 
2000). Topical glucocorticoids are used in the treatment of a variety of skin 
disorders, such as psoriasis and dermatitis (Wiedersberg et al., 2008). 
Furthermore, glucocorticoids are often incorporated into cancer therapies, due to 
their ability to limit the growth of cancers associated with the lymphoid tissue and 
blood (Dawson et al., 2002). 
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1.5.5. Adverse effects associated with glucocorticoid use 
 
Glucocorticoid therapy is associated with various adverse effects, including 
delayed wound healing (Schäcke et al., 2002), increases in gastric acid secretion 
during longer-term treatment (Cushman, 1970) and gastric ulceration (Smith, 
2009). Children prescribed long-term glucocorticoid therapy may exhibit signs of 
retarded growth and delayed puberty (Schäcke et al., 2002). Continued use of 
glucocorticoid therapy can also lead to the development of glaucoma or cataracts 
(Smith, 2009) and an increased risk of developing osteoporosis (Schäcke et al., 
2002). As glucocorticoids work to suppress the immune system, an increased 
susceptibility to infections is also associated with glucocorticoid therapy 
(Feldman, 1992). 
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1.6. Helicobacter spp. 
 
1.6.1. Species characteristics 
 
Helicobacter was first described in 1984, by Marshall & Warren, who 
demonstrated the presence of unidentified curved bacilli in the gastric epithelium 
of 58 patients with active chronic gastritis or ulceration. Initially, the bacterium 
was classified as a new species in the Campylobacter genus; however, in 1989 the 
new genus „Helicobacter‟ was established (Goodwin et al., 1989). Since 
classification, the Helicobacter genus now includes 18 different species (Table 
1.1). 
 
Helicobacter spp. are gram-negative, spiral-shaped, actively motile bacteria with 
flagella that colonize the gastrointestinal tract of both humans and animals (De 
Bock et al., 2006). Helicobacter spp. are urease positive, enabling them to survive 
the highly acidic environment in the stomach (Kusters et al., 2006). H. pylori has 
complex growth requirements and is therefore often hard to culture. It requires 
specialised growth medium, supplemented with blood or serum, and a 
microaerophilic environment, with optimal growth at 2-5% O2/5-10% CO2 and 
high humidity levels (Kusters et al., 2006). In older cultures, H. pylori tends to 
transform from its normal helical bacillary morphology into a coccoid form 
(Owen, 1998).  
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Species Major Host 
H. pylori Human 
H. canis Dog, Human 
H. felis Cat, Dog, Human 
H. heilmannii Cat, Dog, Human 
H. bizzozeronii Dog 
H. fennelliae Human 
H. pullorum Poultry, Human 
H. pametensis Wild birds, Pig 
H. cholecystus Hamster 
H. hepaticus Mice 
H. muridarum Rat, Mice 
H. trogontum Rat 
H. bilis Mice, Dog 
Flexispira rappini Dog, Pig, Sheep 
H. cinaedi Human, Hamster 
H. acinonyx Cheetah 
H. mustelae Ferret 
H. nemestrinae Macaque monkey 
H. suis Pig 
 
Table 1.1- The Helicobacter species and their major hosts 
 
1.6.2. Clinical importance and pathogenicity 
 
Nearly half of the world population are estimated to be infected with Helicobacter 
pylori, however many patients remain asymptomatic (Go, 2002). Helicobacter is 
thought to be transmitted via person-person contact, as clustering of infection has 
been found within families (Drumm et al., 1990) and institutionalised young 
people (Laporte et al., 2004). H. pylori organisms colonise the gastric epithelium 
and rarely penetrate into cells, tending to cluster around intracellular junctions 
(Peterson, 1991). More recently, intracellular localisation of Helicobacter spp. has 
been described in the parietal cells and macrophages of laboratory Beagle dogs 
(Lanzoni et al., 2011). Gastric colonisation with H. pylori stimulates cytokine 
secretion from gastric epithelial cells, leading to activation of immune and 
inflammatory cells and the development of chronic, active gastritis (Ernst & Gold, 
2000), which can ultimately lead to gastric ulceration. In cases of acute gastritis, 
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H. pylori infection leads to the degeneration of surface epithelial cells, resulting in 
decreased mucin secretion and an infiltration of neutrophils. In chronic cases of 
gastritis, as well as epithelial degeneration and neutrophil infiltration, an influx of 
lymphocytes and plasma cells leads to chronic inflammation (Dixon, 1995), 
however, even when gastritis is present, only a minority of patients go on to 
develop clinical signs of disease (Kusters et al., 2006). Acute Helicobacter 
infections result in antral inflammation and hypochlorhydria, thought to be caused 
by inhibition of parietal cell function. H. pylori infection has been shown to 
inhibit H
+
/K
+ATPase α-subunit gene expression in AGS cells (Göoz et al., 2000). 
H. pylori associated gastritis may also result in gastric acid hypersecretion, 
through the stimulation of gastrin release (McColl et al., 1998), thus patients 
colonised with H. pylori may present with either increased or decreased acid 
secretion (Schubert & Peura, 2008).  
 
In 0.5-2% of H. pylori infections, patients go on to develop gastric cancer (Fritz & 
Van der Merwe, 2009) and both gastric lymphoma and adenocarcinomas are 
associated with H. pylori infection. Thus in 1994, H. pylori was classified as a 
type I carcinogen in humans by the International Agency for Research on Cancer 
(IARC, 1994). Clinical outcomes of H. pylori infection are mainly determined by 
the virulence factor of the bacterial strain and the most widely studied H. pylori 
virulence factor is CagA, encoded for by the cagA gene. Infection with strains of 
H. pylori carrying the cagA gene is associated with the development of gastric 
carcinoma (Hatakeyama, 2004). Pathogenic strains of H. pylori may also produce 
the vacuolating cytotoxin, VacA, encoded for by the vacA gene (Wada et al., 
2004), which has been shown to cause cytoplasmic vacuolation in MKN-28 cells, 
(Ricci et al., 2002) and in primary human gastric epithelial cells (Smoot et al., 
1996). 
 
1.6.3. Helicobacter spp. found in dogs 
 
Several species of Helicobacter are capable of infecting dogs, for instance, H. 
felis, H. bizzozeronii, H. salmonis, H. bilis, H. heilmannii and Flexispira rappini 
have all been cultivated from canine stomachs (Eaton et al., 1996; Jalava et al., 
1998; Neiger et al., 1999). However, H. pylori has not been found in dogs (Neiger 
& Simpson, 2000), thus suggesting that dogs may not present a zoonotic risk for 
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this common strain of the bacteria. Previous studies have shown that living 
conditions can impact on the prevalence of Helicobacter infection, as dogs housed 
in animal shelters or bred in laboratory colonies were shown to have a higher 
prevalence of Helicobacter infection than pet dogs (Eaton et al., 1996). 
Helicobacter spp. are highly prevalent in both healthy and unwell dogs, 
suggesting that there is not a clear link between the infection and gastric disease in 
dogs (Simpson et al., 2000). Helicobacter infected dogs usually present with 
mononuclear gastritis of mild to moderate severity and no association between 
Helicobacter infection and gastric ulceration or neoplasia in dogs has been made 
to date (Simpson et al., 2000). 
 
1.6.4. Helicobacter infection and NSAID treatment 
 
As Helicobacter infected patients can remain asymptomatic, clinicians may 
unknowingly treat them for other conditions using NSAID therapy. Individually, 
both NSAIDs and Helicobacter infection are major causes of gastrointestinal 
disease, however, little is known about their potential interaction. In a study 
looking at long-term NSAID users, the risk of peptic-ulcer disease was 
significantly higher in H. pylori-positive patients than in H. pylori-negative 
patients (Huang et al., 2002), suggesting a possible interaction between the two. 
Several studies have shown that H. pylori infection leads to increased COX-2 
expression and PGE2 synthesis (Fu et al., 1999; Romano et al., 1998; Chan et al., 
2001) that is reduced following eradication (McCarthy et al., 1999). COX-2 
expression was found to be localised at higher levels in the gastric antrum where 
H. pylori density is greatest (Fu et al., 1999). COX-1 expression also appears to be 
higher in biopsies from H. pylori-positive patients compared to non-infected 
patients (Franco et al., 1999). As H. pylori infection and NSAID therapy have 
opposing effects on PGE2 production, an interaction between the two is likely and 
warrants further study. 
 
1.6.5.Helicobacter infection and cell migration 
 
In addition to causing direct gastric mucosal damage, colonisation with H. pylori 
may lead to changes in the modulation of gastric epithelial cell migration, and a 
number of different mechanisms for this effect have been studied. Focal adhesions 
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and the actin cytoskeleton both have a major role in cell migration, for instance, 
focal adhesion assembly and disassembly helps to coordinate cell movement 
across the ECM and actin polymerisation is essential for cellular protrusion and 
contraction (Ridley et al., 2003). H. pylori-infected gastric epithelial cells 
typically appear elongated, which may be caused by integrin/CagA signalling 
leading to stabilisation of focal adhesions at the rear of the cell (Wessler et al., 
2011). H. pylori has also been shown to stimulate host cell motility via CagA 
interactions with SHP2, a protein-tyrosine phosphatase, and PAR1, a polarity-
regulating kinase (Kikuchi et al., 2012). Furthermore, H. pylori VacA has been 
shown to inhibit re-epithelisation, possibly though the alteration of cytoskeleton 
associated proteins (Pai et al., 2000), while H. pylori adhesion to gastric epithelial 
cells has been associated with disruption of epithelial adhesion molecules, 
including a reduction in adherens junctions (Conlin et al., 2004) and induction of 
MMP-7 expression (Wroblewski et al., 2003).  
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1.7. Aims of the thesis 
 
The overall aim of this thesis was to establish a suitable primary cell culture 
model to investigate the effects of COX antagonism on canine gastric epithelial 
cell migration and to highlight the specific signalling pathways that are involved. 
 
The following key aspects were investigated: 
 
 The effects of both non-selective and COX-2 selective antagonism on the 
modulation of epithelial cell migration. 
 
 The effects of physiological and therapeutic glucocorticoid levels on the 
modulation of epithelial cell migration. 
 
 The characterisation of COX-2 and EP receptor expression in the canine 
gastric epithelium. 
 
 The characterisation of EP receptor subtypes involved in the modulation of 
epithelial cell migration. 
 
 The relationship between COX-2, EP3 and EP4 protein expression and 
various clinical parameters, in order to determine their potential relevance 
as objective markers of GI disease. 
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Chapter 2 - Materials and Methods 
2.1 Materials 
 
2.1.1. General materials 
 
All items were obtained from Sigma-Aldrich Company Ltd., The Old Brickyard, 
Dorset, SP8 4XT unless specified below:  
 
Item Supplier 
17-Phenyl-trinor-PGE2  
(EP1 agonist) 
Santa Cruz Biotechnology, Inc. Bergheimer Str. 
89-2, 69115 Heidelberg, Germany. 
AH 23848 (EP4 antagonist) Santa Cruz Biotechnology, Inc. As above 
Butaprost (EP2 agonist) Santa Cruz Biotechnology, Inc. As above 
Collagenase A Roche Products Ltd. (Pharmaceuticals), Welwyn 
Garden City, AL7 1TW 
Dexamethasone Calbiochem-Novabiochem (UK) Ltd. c/o CN 
Biosciences (UK) Ltd, Beeston,  NG9 2JR 
DPX mounting medium VWR International Ltd. Hunter Boulevard, 
Magna Park, Lutterworth, Leicestershire, LE17 
4XN 
HBSS Life Technologies Ltd, 3 Fountain Drive, 
Inchinnan Business Park, Paisley, PA4 9RF 
ImProm II Reverse 
Transcription kit 
Promega UK Branch Office, Southampton 
Science Park, SO16 7NS 
Indomethacin Calbiochem-Novabiochem (UK) Ltd. As above 
Mastermix (2.5mM MgCl2) Abgene, Thermo Fisher Scientific UK Ltd, 
Loughborough, LE11 5RG 
Novex® Sharp pre-stained 
protein standard 
Life Technologies Ltd. As above 
 
NS-398 Calbiochem-Novabiochem (UK) Ltd. As above 
NuPage® 4-12% gradient 
gels 
Life Technologies Ltd. As above 
 
NuPage® MES SDS running Life Technologies Ltd. As above 
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buffer (20X)  
NuPage® transfer buffer 
(20X) 
Life Technologies Ltd. As above 
ONO-AE1-329 (EP4 agonist) A kind gift from ONO Pharmaceutical Co. Ltd. 
Osaka, Japan 
Paraformaldehyde 16% Thermo Fisher Scientific UK Ltd, Bishop 
Meadow Road, Loughborough, LE11 5RG 
Parameter™ PGE2 kit R&D systems, 19 Barton Lane, Abingdon 
Science Park, OX14 3NB 
Perhydrol 30% Thermo Fisher Scientific UK Ltd. As above 
Pierce BCA protein assay kit Thermo Fisher Scientific UK Ltd. As above 
Propidium iodide Calbiochem-Novabiochem (UK) Ltd. As above 
QIAquick® PCR purification 
kit 
Qiagen House, West Sussex, RH10 9NQ. 
RNeasy® Plus Mini kit Qiagen House. As above 
siGENOME non-targeting 
 siRNA controls 
Thermo Fisher Scientific, Dharmacon Products, 
2650 Crescent Drive, Suite 100 Lafayette, CO 
80026, USA 
SilenceMag™ OZ Biosciences, Parc scientifique de Luminy, 
Zone Luminy Entreprise, 163 avenue de Luminy 
- Case 922, 13288 Marseille cedex 9, France 
siRNA buffer Thermo Fisher Scientific, Dharmacon Products. 
As above 
Sulprostone (EP3 agonist) Santa Cruz Biotechnology, Inc. As above 
TrackIt™ 100bp DNA ladder Life Technologies Ltd. As above 
VectaShield® mounting 
 medium 
Vector Laboratories Ltd. 3 Accent Park, 
Bakewell Road, Peterborough, PE2 6XS 
Vectorstain® ABC kit Vector Laboratories Ltd. As above 
Western Lightning® Plus 
ECL solution 
PerkinElmer, Chalfont Road, Buckinghamshire,  
Seer Green, HP9 2FX 
 
Table 2.1- General materials and suppliers 
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2.1.2. Antibodies 
 
Goat polyclonal anti-EP3, goat polyclonal anti-EP4 and goat polyclonal anti-
COX-2 were all supplied by Santa Cruz Biotechnology, Inc. Bergheimer Str. 89-
2, 69115 Heidelberg, Germany. An HRP-conjugated rabbit anti-goat IgG 
secondary and a goat polyclonal anti-beta actin were supplied by Abcam®, 
Cambridge, UK. A FITC-AffiniPure donkey anti-goat IgG secondary was 
supplied by Stratech Scientific, Oaks Drive, Suffolk CB8 7SY. A biotinylated 
horse anti-goat IgG secondary was supplied by Vector Laboratories Ltd. 3 Accent 
Park, Bakewell Road, Peterborough, PE2 6XS. 
 
2.2. Media and buffers 
 
Solution Recipe 
Amphotericin B 100 mg added  to 50 ml ultra-pure water 
Cell freezing medium 7 ml of DMEM/EMEM (without FBS added),  
2 ml FBS, 1 ml DMSO 
DMEM full medium DMEM (as bought) supplemented with 10% 
FBS, 1% penicillin-streptomycin, 1% L-
glutamine, 0.1% amphotericin B and 0.1% 
gentamycin 
EMEM full medium 100 ml 10X EMEM, 100 ml FBS, 10 ml non-
essential amino acids, 10 ml NaHCO3, 10 ml 
penicillin-streptomycin, 10 ml L-glutamine, 
1ml amphotericin B, made up to 1 L using 
ultra-pure water 
Immunocytochemistry- blocking 
buffer 
1X PBS, 10% donkey serum, 0.1% Triton™ X-
100 
Immunohistochemistry –  
Imidazole/HCl buffer 
6.81 g imidazole made up to 1 L using distilled 
water, 500 ml 0.1M HCl added. pH adjusted to 
7.1 using 0.1M HCl. 
L-glutamine 2.92 g added to 100 ml ultra-pure water 
4% Paraformaldehyde 10 ml Paraformaldehyde (16%) in 30 ml 1X 
PBS 
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PBS (10X) 100 tablets dissolved in 1 L ultra-pure water 
PBS (1X) 88 ml 10X PBS added to 880 ml ultra-pure 
water 
PBS/EDTA 0.18 g EDTA added to 900 ml 1X PBS 
PBS/EDTA/Trypsin 1 ml of trypsin added to 50 ml PBS/EDTA 
RNase buffer 1X PBS, 1% BSA, 10 µg/ml RNase solution 
Stock TAE buffer (50X) 242 g Tris, 57.1 ml glacial acetic acid, 100 ml 
0.5 M EDTA,  made up to 1 L in double 
distilled water 
TAE buffer (1X) 40 ml 50X TAE buffer and 1960 ml double 
distilled water 
1X Tris buffered saline 0.8% saline prepared; 8 g NaCl made up to 1 L 
in distilled water. 100ml stock added to 850 ml 
saline and pH adjusted to 7.4 with 10M HCl. 
Volume adjusted to 1000 ml with 0.8% saline. 
Western blot- cell lysis buffer 1.97 g Trizma HCl, 20 ml glycerol solution, 4 g 
(2%) SDS 
Western blot- running buffer 25 ml NuPAGE® MES SDS buffer (20X) and 
475 ml double distilled water 
Western blot- sample buffer 62.5 mM Tris-HCl (pH 6.8), 2% SDS, 10% 
glycerol, 50 mM DTT, 0.01% bromophenol 
blue 
Western blot- stripping buffer 15 g glycine, 1g SDS, 10 ml Tween® 20 made 
up to 1 L in  double distilled water and pH 
adjusted to 2.2 
Western blot- transfer buffer 50 ml NuPage™ transfer buffer (20X), 200 ml 
methanol, 750 ml double distilled water 
Western blot- washing buffer 1X PBS, 0.1% Tween® 20 
Western blot-blocking buffer 1X PBS, 5% milk powder, 0.1% Tween® 20 
 
Table 2.2- Recipes for cell culture solutions and buffers 
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2.3. Canine endoscopy  
 
Endoscopy samples were collected from patients presenting at the University of 
Liverpool Small Animal Teaching Hospital for vomiting, diarrhoea or weight loss. 
Following diagnostic evaluation, if an endoscopy was required, this was 
performed under general anaesthesia, using either an Olympus SIF O260 9mm 
enteroscope or an Olympus GIF-XQ240 9mm Gastroscope using 2.2mm 
disposable biopsy forceps. Biopsies were collected from the body of the stomach 
and were placed immediately in ice-cold HBSS solution. Owners of participating 
animals were provided with an information sheet prior to attending the clinic and 
animals were only included in the study where signed consent was provided. 
Procedures were scrutinised and approved by the University of Liverpool Ethics 
Committee. 
 
2.4. Isolation of gastric glands 
 
Tissue samples were obtained from either canine cadavers sourced from a local 
RSPCA centre or endoscopic biopsies sourced from patients undergoing routine 
upper GI endoscopy (Section 2.3). In the case of cadaver samples, a section of 4 
cm² mucosal tissue was dissected from the stomach wall and placed in ice-cold 
HBSS prior to preparation. Biopsy samples were approximately 3 mm² and were 
treated in the same way. The samples were minced in a small volume of HBSS 
using a scalpel blade, to increase the exposed surface area. Samples were 
incubated with 1 mM DTT, for 15 min in a 37ºC water bath, shaking at 100 
revs/min and provided with 95% O2/5% CO2. After washing, an HBSS solution 
containing 0.5 mg/ml collagenase A was added, and cells were incubated for a 
further 60 min under the same conditions, to create a suspension of disaggregated 
individual gastric glands. The preparation was triturated (aspirated and expressed 
through a Pasteur pipette) to enhance gland separation through shearing, and then 
left to stand for 45 sec, during which larger undigested tissue fragments 
sedimented. The supernatant was then removed and the isolated glands were 
sedimented out by incubation for 30 min on ice. The resultant supernatant, 
containing single cells and debris, was discarded and the isolated glands were re-
suspended in full medium (Section 2.5.1).  
Materials and methods 
 
 
39 
2.5. Cell culture 
 
2.5.1.Cell culture of isolated glands 
 
Isolated glands were cultured in DMEM medium supplemented with 10% FBS, 
1% L-glutamine, 1% penicillin-streptomycin, 0.1% amphotericin B and 0.1% 
gentamycin. When plated into multi-well dishes, each well also contained the 
appropriate treatment (details of treatments used are described in the 
corresponding chapters). The cells were then incubated at 37ºC in a 5% CO2 
incubator for 48 h prior to analysis (glands derived from cadaver samples were 
incubated for 96 h prior to analysis). 
 
2.5.2.Cell culture of immortalised cell lines 
 
Primary cultures of AGS, MKN-45 and MDCK cells were maintained throughout 
the project. A stock of MDCK cells, at passage 6, was purchased from European 
Collection of Cell Cultures (ECACC, Porton Down, UK) and MDCK cells were 
used at passage number 6-22 throughout the project. AGS and MKN-45 cells, a 
kind gift from Andrea Varro (University of Liverpool), were used at passage 
number 40-65. Cells were grown to a 70% subconfluent monolayer in EMEM 
medium, supplemented with 10% FBS, 1% L-glutamine, 1% penicillin-
streptomycin, 1% sodium bicarbonate, 1% non-essential amino acids and 0.1% 
amphotericin B. Cells were maintained at 37ºC in a 5% CO2 incubator, medium 
was changed twice weekly and the cells were sub-cultured when confluent at 
either 1:3 or 1:10 using a 1 ml trypsin/PBS/EDTA solution. 
 
2.5.3.Cryopreservation of cells 
 
Cell lines were cryopreserved for future use. Cell monolayers were trypsinised to 
obtain a cell suspension; the cells were then pelleted by centrifugation at 1400 
rpm for 4 min and re-suspended in 1 ml of pre-warmed freezing medium 
(consisting of standard medium supplemented with 20% FBS and 10% DMSO) in 
a 1.5 ml cryovial. The cell suspension was frozen slowly in a polystyrene box at -
80ºC before being transferred to liquid nitrogen for long-term storage.  
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2.6. Cell spreading assay 
 
2.6.1.Treatments 
 
Isolated glands were plated into 6-well plates and treated with either medium 
containing vehicle only (controls) or the relevant treatment. Treated glands were 
incubated at 37ºC in a 5% CO2 incubator for either 48 h (biopsy-derived glands) 
or 96 h (cadaver-derived glands) prior to analysis, after which time they had 
adhered to the plate and spread out to form individual cell islands. 
 
2.6.2.Cell fixation and propidium iodide Staining 
 
Propidium iodide was used to stain individual cell nuclei to enable total cell 
counts to be performed. After 48 h in culture, the cell islands were fixed using a 
4% paraformaldehyde solution and the cell membranes were permeabilised with a 
0.2% solution of Triton™ X-100 for 30 min at room temperature. The cells were 
then incubated in PBS containing 1% BSA and 10 μg/ml RNase solution for 1 h at 
room temperature to eliminate background RNA staining. Finally the cells were 
incubated with a 2.5 μg/ml propidium iodide solution for 20 min at room 
temperature. The cells were washed three times using PBS in between all steps. 
                                                                                                                                          
2.6.3.Analysis of epithelial cell island spreading 
 
Cells migrate from individual glands to produce islands of cells and speed of cell 
migration is reflected in the rate of spreading of individual islands. Images were 
captured using a 20X objective on an Olympus CK40-SLP microscope (Olympus, 
Southend-on-Sea, UK), equipped with a cooled 3 megapixel CCD camera 
(Progres® C3, Jenoptik, Germany) and stored as „TIFF‟ files for analysis using 
ImageJ software (Rasband, 1997-2012). The observer was blinded to the 
treatment used in individual wells. The total area of individual cell islands was 
measured and the total number of cells within each island was counted using 
fluorescence microscopy. The area encompassed by the cell nuclei was also 
measured, and subtracting this area from the total spread area provided a 
measurement of fringe area (Figure 2.1). The fringe area gives an approximation 
Materials and methods 
 
 
41 
of the protrusive activity of the cell island and can be corrected for by counting 
the cell nuclei surrounding the outside edge of the island, i.e. those cells which are 
contributing to the protrusive activity. Further details about the parameters used 
for analysis are provided in chapter 3 of this thesis.  
 
 
 
 
Figure 2.1- Analysis of cell island spreading using ImageJ. The black line delineates the total 
spread area, the yellow line delineates the area measurement around the nuclei, the yellow hatched 
area represents the fringe area and the yellow circles represent the edge nuclei. Scale bar: 10 µm 
 
2.7. Scratch wound assay 
 
Cells used for scratch wound experiments were grown to confluence, then serum-
starved for 12 h prior to scratch wounding. Wounding was performed manually 
using a suitable-sized sterile filter pipette tip. Briefly, the pipette tip was scratched 
along the middle of each well to create a wound and dislodged cells were removed 
with two PBS washes. Wound sizes were found to be fairly consistent, with an 
approximate width of 1 mm. Following wounding, the cell medium was replaced, 
either with or without treatments, and the wound was imaged straight after 
wounding and at 24 h post-wounding. Two wounded areas were analysed for each 
well and the image position for a given region of wound was ensured by 
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positioning using a motorised stage. Total migration areas were calculated and 
normalised to control.  
 
Specific time-course and dose-response experiments were performed using an 
Essen Bioscience Incucyte™ Live-Cell Imaging System (Essen BioScience, Inc., 
Welwyn Garden City, UK), allowing time-lapse image series to be gathered. A 
96-pin scratch generator (WoundMaker®, Essen BioScience, Inc., Welwyn 
Garden City, UK) was used to create precise, reproducible wounds in a 96-well 
plate containing confluent monolayers of cells. Dislodged cells were removed 
through washing with PBS and the cell medium was replaced, as before. Wound 
healing was analysed via the IncuCyte™ software package, using three separate 
metrics. These metrics were wound width, wound confluence and Relative Wound 
Density. 
 
2.8. Molecular methods 
 
2.8.1.RNA isolation 
 
RNA was extracted from either whole tissue or cultured cells using a Qiagen 
RNeasy® Plus Mini kit as per manufacturer‟s instructions. Approximately 30 mg 
of tissue or 1x10
7 
cells were used for the procedure. All steps of the protocol were 
performed in an RNase-free environment and all reagents were diluted in RNase-
free water. Genomic DNA was removed using a gDNA Eliminator spin column, 
provided in the kit. The extracted RNA was eluted with 30 µl RNase-free water 
and quantified using a spectrophotometer. RNA samples were stored at -20ºC.  
 
2.8.2.Reverse transcription 
 
RNA was transcribed into cDNA using an IMProm II™ Reverse Transcription 
kit, as per manufacturer‟s instructions. The kit included a positive control of 
kanamycin RNA and specific up-stream and down-stream primers to ensure the 
reverse transcription stage was successful. As a further control, sham cDNA 
samples were produced, into which no reverse transcriptase was added, thus 
showing that the sample does not contain any genomic DNA. Oligo (dT) primer 
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was used to initiate transcription at the poly-A 3‟ tail of the RNA. The following 
thermocycler conditions were used for the reverse transcription reaction: anneal at 
25º C for 3 min, extend at 42º C for 1 h, inactivate reverse transcriptase at 70º C 
for 15 min and hold at 4ºC. The cDNA samples were stored at 4ºC or -20ºC for 
long-term storage. 
 
2.8.3.Polymerase chain reaction (PCR) 
 
Reverse transcription PCR was used to study the expression of COX-2 and the 
prostaglandin receptors, EP3 and EP4. Primers for EP3, EP4, and COX-2, that 
span the exon-exon boundaries, were designed and supplied by Eurofins MWG 
Operon (Ebersberg, Germany). GAPDH primers were designed for use as an 
internal control and also supplied by Eurofins MWG Operon (Ebersberg, 
Germany). Sequences for the designed primers are provided in Table 2.3, and all 
primers were used at a concentration of 12.5 pmol/μl. Primers were designed 
using Primer Blast (http://www.ncbi.nlm. nih.gov/tools/primer-blast/index.cgi), 
based on the predicted cDNA sequence from the canine genome (Table 2.4). 
 
A volume of 2 µl cDNA for each PCR assay was added to 25 µl of Mastermix 
(2.5 mM MgCl2), with 4 µl of each primer pair and 15 µl molecular grade water, to 
give a final reaction volume of 50 µl. The thermocycling parameters used were, 
an initial denaturation step at 94ºC for 5 min, then 40 amplification cycles of 
denaturation at 94 ºC for 20 sec, annealing at 50ºC for 20 sec and extension at 
72ºC for 1 min. The final extension stage was at 72ºC for 5 min and the reaction 
was held at 4ºC. 
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Primer Name Primer Sequence (5’-3’) Product length 
(bp) 
GAPDH forward TCCATCTTCCAGGAGCGAGA 781 
GAPDH reverse CCTTGGAGGCCATGTAGACC 
EP3 forward AAAATGATCTTCAATCAGACA 167 
EP3 reverse CCTTCTTCGAAAGTTTTGTCA 
EP4 forward CCGCTCGTGGTACGGGTGTTC 275 
EP4 reverse GCCATGTCCGGCCACTCTCG 
COX-2 forward AGGATTGGGCCATGGGGTGGA 552 
COX-2 reverse GGGTTGCCGGTGGCAGGAAT 
 
Table 2.3 Primer sequences 
 
cDNA sequence Accession number 
Canine GAPDH NM_001003142 
Canine EP3 NM_001002958 
Canine EP4 NM_001003054 
Canine COX-2 NM_001003354 
 
Table 2.4 Accession numbers for the predicted cDNA sequences from the canine genome 
 
2.8.4.Gel electrophoresis 
 
The samples were run on a 1.5% agarose gel containing 5 μl ethidium bromide 
(500 µg/ml) in 50 ml of 1X TAE buffer. For each assay, 12 µl of sample was 
loaded per well, consisting of 10 μl of each product mixed with 2 μl of loading 
buffer. A ready-to-load TrackIt™ 100bp DNA ladder was used to determine band 
sizes. The gel was run at 120 volts for 30-40 min in 1X TAE buffer and visualised 
under UV light. 
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2.8.5.Sequencing of PCR products 
 
Where possible, PCR products were sequenced commercially (Eurofins MWG 
Operon, Ebersberg, Germany), using the same primers that were used for the PCR 
amplification. A QIAquick® PCR purification kit was used to purify the 
amplified products prior to sequencing. 
 
2.8.6.siRNA Transfection 
 
siRNAs directed against EP3, EP4 and COX-2 (Table 2.5) were designed using 
the Dharmacon siDesign® centre (http://www.dharmacon.com/designcenter/ 
designcenterpage.aspx), and two commercially available siGENOME non-
targeting siRNA controls were purchased. These controls were compared against 
the canine genome by the manufacturers using BLAST (www.ncbi.nlm.nih.gov/ 
BLAST), to ensure that they lacked homology with any known canine sequence. 
Both the control and custom-designed siRNAs were re-suspended in 5X siRNA 
buffer (diluted in RNase-free water) to create a 1 µM stock solution. 
Magnetofection was used to deliver the siRNAs into cultured cells, grown to 
confluence in 12-well plates. The siRNAs were diluted in 100 µl serum-free 
medium per well, to yield a final siRNA concentration of 10 nM (as 
recommended by the manufacturer). SilenceMag™, a transfection reagent, was 
vortexed prior to use and 2 µl was added to each 100 µl of diluted siRNA and 
thoroughly mixed through vigorous pipetting. The resulting siRNA/SilenceMag™ 
solution was incubated at room temperature for 20 min, after which the solution 
was added, drop by drop, onto cells cultured in 900 µl serum-free medium, to give 
a final cell culture volume of 1000 µl per well. The cell culture plate was then 
placed onto a magnetic plate for 15 min at room temperature. After transfection, 
the cells were cultured for 3 h in serum-free medium to improve gene silencing, as 
per manufacturer‟s instructions, after which they were cultured in medium 
containing 10% FBS for 24 h. Serum-free medium was then added to the cells for 
12 h prior to analysis in order to induce the expression of EP3, EP4 and COX-2. 
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siRNA Name siRNA sense sequence  
EP3  UUUAUCUGCUGCUAAGAAAUU 
EP4  GCAAAGCAAUAGAGAAGAUUU 
COX-2 CAAAAGAGAUUGUGGAAAAUU 
 
Table 2.5- siRNA sequences 
2.8.7.Western Blotting 
 
2.8.7.1. Protein extraction 
 
MDCK cells were grown to confluence in either a 25cm
3
 flask or a 12-well plate. 
Once confluent, cells were washed with ice-cold PBS, the PBS was drained and 
the cells were trypsinised, and then centrifuged twice in EMEM media for 4 min 
at 1400 rpm to obtain a cell pellet. The cells were lysed by adding 250 µl of lysis 
buffer to the cell pellet. Lysates were then sonicated (Sonicor, Sonicor Instrument 
Corporation, USA) for 3 x 10 sec bursts to shear the DNA and reduce sample 
viscosity. Protein was extracted from primary cell islands using the same method, 
however due to lower cell densities only 50 µl of lysis buffer was used. Protein 
was also extracted from mucosal tissue samples stored at -80ºC. A 5 mg sample of 
tissue was homogenised in 300 µl lysis buffer using a Qiagen TissueLyser II 
(Qiagen House, West Sussex) set at 11 Hz for 5 min. The tissue and lysis buffer 
solution was then agitated constantly for 2 h at 4ºC, after which the solution was 
centrifuged at 12,000 rpm for 20 min at 4ºC. The resulting supernatant, containing 
the extracted protein, was sonicated as described above.  
 
2.8.7.2. Determination of protein concentration 
 
To determine the protein concentration of the lysates, a Pierce BCA protein assay 
kit was used. A series of BSA standards were made up and 25 µl of all standards 
and unknown protein samples were pipetted into a 96-well plate in duplicate. Into 
each well, 200 µl of working reagent was added and the plate was incubated at 
37ºC for 30 min. The absorbance was then measured at 570 nm using a 
Multiskan® FC microplate reader (Thermo Fisher Scientific UK, Loughborough). 
The average absorbance measurements for the blank standard replicates were 
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subtracted from the absorbance measurements of each individual standard and 
unknown sample replicates. A standard curve was constructed by plotting the 
average blank-corrected absorbance measurement for each standard against its 
concentration in µg/ml. Protein concentrations of the unknown samples were 
determined using the standard curve. 
 
2.8.7.3. Western blots 
 
Sample solutions were prepared in sample buffer to give a total solution volume 
of 10 µl. Samples were then heated at 80ºC for 10 min and centrifuged for 10 sec 
at 12,000 rpm. Ready-cast NuPage™ 4-12% gradient gels were used for 
electrophoresis in an Xcell SureLock™ mini-gel tank (Life Technologies Ltd, 
Paisley, UK). The tank was filled with running buffer and 15 µl of each sample 
and Novex® Sharp pre-stained protein standard were loaded. The gel was run at 
200 volts for 35 min using a PowerPac™ power supply (BioRad House, Hemel 
Hempstead, UK). Separated proteins were transferred from the gel onto a 
nitrocellulose membrane at 30 volts for 90 min using transfer buffer. Non-specific 
binding sites were blocked on the blotted membrane by incubation with the 
blocking buffer at 4ºC overnight. The primary antibody, diluted in the blocking 
buffer, was added to the membrane and incubated at room temperature for 2 h. 
The EP3, EP4 and COX-2 primary antibodies were all diluted to 1:200. An HRP-
conjugated secondary antibody, diluted to 1:10,000, was used to detect the bound 
antibodies using a Western Lightning® Plus ECL solution. Membranes were 
visualised using a UVP ChemiDoc-It® imaging system (Ultra-Violet Products 
Ltd, Cambridge, UK). 
 
2.8.7.4. Stripping and re-probing membrane 
 
Membranes were stripped and re-probed for beta-actin as a loading control. 
Membranes were incubated with stripping buffer in a 50ºC pre-heated roller blot 
for 30 min. The membrane was then washed 6 times in a 0.1% PBS/Tween® 20 
solution, for 5 min per wash. Following this, the membrane was re-probed for 
beta-actin, diluted to 1:1000, using the method described previously.  
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2.8.7.5. Intra-assay variability of Western blot analysis 
 
Intra-assay variability was evaluated by running replicate samples in a single 
assay and calculating a value for the coefficient of variation (Figure 2.2). 
Coefficient of variation was calculated as the ratio of the standard deviation to the 
mean, multiplied by 100, which was 10%.  
 
 
 
Figure 2.2- Western blot analysis of replicate samples; Six replicates containing equal amounts 
of MKN-45 protein were loaded and analysed for EP3 and beta actin expression. The EP3 band 
intensity was normalised to the corresponding beta actin intensity. 
2.8.7.6. Dot blots 
 
Protein extracts for dot blotting were prepared as described previously (Section 
2.8.7.1) and the protein concentration of each sample was determined using the 
Pierce BCA protein assay (Section 2.8.7.2). 2 µl of each sample was dotted onto a 
nitrocellulose membrane, 1 cm apart. The membrane was allowed to dry for 30 
min at room temperature, and then blocked by incubation with the blocking buffer 
at 4ºC overnight. The primary antibody, diluted in the blocking buffer, was added 
to the membrane and incubated at room temperature for 2 h. An HRP-conjugated 
secondary antibody was used to detect the bound antibodies using a Western 
Lightning® Plus ECL solution. Antibodies were diluted to the same 
concentrations as used for the western blot protocol (Section 2.8.7.3). 
 
2.8.7.7. Densitometry 
 
Densitometric quantification was performed using ImageJ software (Rasband, 
1997-2012). The band intensity of the protein of interest was normalised to the 
corresponding beta actin band intensity.  
62 kDa 
42 kDa 
EP3 
β actin 
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2.9. Immunological Methods 
 
2.9.1.Immunohistochemistry 
 
Immunohistochemistry techniques were performed by Veterinary Pathology, 
University of Liverpool. Paraffin wax was dissolved in xylene and rehydrated in 
graded alcohols. Endogenous peroxidases were inactivated by 30 min incubation 
in freshly prepared 0.5% H2O2. Slides were washed with TBS (pH 7.4) and non-
specific binding was blocked with horse serum for 10 min at room temperature. 
Slides were incubated with the primary antibodies (diluted in TBS to the 
appropriate concentration) overnight at 4°C. Slides were then washed with TBS 
and incubated with the secondary antibody (diluted in TBS) for 30 min at room 
temperature. Slides were washed again with TBS and incubated for 30 min with a 
Vectorstain® ABC solution (9 µl Reagent A, 9 µl reagent B in 100 µl TBS) 
(Vector Laboratories Ltd. Peterborough). Following a TBS wash, coverplates 
were removed and slides were incubated for 10 minutes with 3,3′-
diaminobenzidine tetrahydrochloride (DAB) with 0.01% H2O2 in 0.1M imidazole 
buffer (pH 7.1) at room temperature. Slides were then washed three times with 
TBS and once with distilled water and counterstained using Papanicolaou‟s 
haematoxylin, dehydrated in ascending alcohols and cleared in xylene. Finally, 
the slides were mounted using DPX and a coverslip. 
 
2.9.2. Immunocytochemistry 
 
Cells were cultured on 4-well chamber slides (Lab-Tek II CC2 chamber slide 
system) and fixed in 4% paraformaldehyde. Cells were washed twice with PBS 
and incubated in blocking buffer for 30 min at room temperature. The PBS wash 
was repeated and the cells were incubated with the appropriate antibody for 2 h at 
room temperature. The primary antibodies were diluted to the appropriate 
concentration, as directed in the data sheets, using the blocking buffer as the 
antibody diluent. The cells were incubated with the conjugated secondary 
antibody at room temperature in a dark, moist atmosphere for 1 h, after which the 
chambers were removed and the slides were mounted using Vectashield® (to 
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minimise photobleaching) and coverslips. Stained cells were examined using the 
Olympus CK40-SLP microscope (Olympus, Southend-on-Sea, UK). 
 
2.9.3.PGE2 ELISA 
 
PGE2 ELISAs were performed using a Parameter™ PGE2 kit. Cell culture 
supernatants were collected, aliquoted and stored at -20ºC prior to use. A set of 
PGE2 standards were made, ranging in concentration from 2500 pg/ml to 39 
pg/ml. The calibrator diluent was used as the zero standard (0 pg/ml). To each 
well, 150 µl of standard, control or sample was added followed by 50 µl of 
primary antibody solution. An additional set of wells, containing only 200 µl of 
calibrator diluent, were set up to detect non-specific binding. The plate was sealed 
and incubated for 1 h at room temperature on a microplate shaker (Grant Bio 
PMS-1000 microplate shaker, Thermo Fisher Scientific UK, Loughborough) set at 
500 rpm. The PGE2 conjugate was then added, the plate sealed and incubated for a 
further 2 h at room temperature on the shaker. Each well was aspirated and 
washed four times using the wash buffer provided in the kit. The plate was blotted 
dry against clean paper towels. Into each well, 200 µl of substrate solution was 
added and the plate was incubated for 30 min at room temperature in the dark. In 
order to terminate the reaction, 100 µl of the kits stop reagent was added to each 
well, causing a colour change from blue to yellow. The optical density of each 
well was read within 30 min, using a Multiskan® FC microplate reader (Thermo 
Fisher Scientific UK, Loughborough) set to 450 nm.  
 
2.10. Statistics 
 
Statistical analysis was performed as described in individual chapters, using Excel 
2007 (Microsoft) and Stata Statistical Software: Release 11 (StataCorp. 2009) and 
the xtmixed command. Minitab® 16 Statistical Software (Minitab® Inc., 2010) 
was used to construct scatter plots and individual value plots for data analysis. 
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Chapter 3 - Characterisation of the model used for studying migration in 
primary gastric epithelial cell islands 
 
 
3.1 Introduction 
 
Gastric epithelial restitution (GER) has an important role in the maintenance of 
gastric epithelial integrity in response to injury (Lacy & Ito, 1984). GER is a 
complex process involving the coordination of various signalling cascades, for 
instance, signalling via EGF/TGF-α and activation of the EGF receptor and PI3K 
(Tétreault et al., 2008). Furthermore, dynamic changes to the actin cytoskeleton 
occur, including the initial formation of actin purse strings, followed by the 
formation of lamellae protrusions (Lotz et al., 2000). Local paracrine signalling 
pathways between multiple cell lineages present in gastric glands may also be 
important for the modulation of gastric epithelial migration. Several important 
paracrine mediators of gastric epithelial migration have been identified, in 
particular gastrin, a gastric hormone secreted by G cells. Gastrin has been shown 
to stimulate AGS cell migration in vitro via the paracrine release of EGF receptor 
ligands, leading to transactivation of the EGF receptor (Noble et al., 2003) and 
blockade of the EGF receptor using a monoclonal antibody leads to a reduction 
in cell migration (Kato et al., 1999).   
 
Epithelial and mesenchymal cell interactions also play an important role in the 
paracrine regulation of gastric epithelial migration, for instance HGF, produced 
by gastric fibroblasts, has been shown to mediate prostaglandin effects on cell 
migration in a paracrine manner (Takahashi et al., 1996). HGF mRNA is not 
present in the gastric mucosa, thus suggesting that epithelial-mesenchymal 
interactions are essential for its effect (Tsuji et al., 1995). HGF has also been 
shown to induce activation of the COX-2 gene in gastric epithelial cells via 
phosphorylation of the c-met/HGF receptor and activation of the ERK2 signal 
transduction pathway (Jones et al., 1999).  
 
Current models used for studying cell migration rely on the use of immortalised 
cell lines or suspensions of dissociated cells (Murakami et al., 1998; Pai et al., 
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2001; Kim et al., 2012). To most accurately recapitulate the signalling 
mechanisms involved in in vivo gastric migratory processes, this investigation 
applied the use of a multicellular model. This model utilises individual isolated 
canine gastric glands consisting of a representative mixture of all cell types found 
in vivo, thus allowing the investigation of both local autocrine and paracrine 
signalling events. This type of model has previously been used to study in vitro 
gastric cell migration using glands isolated from rabbit (Berglindh & Öbrink, 
1976), human (Wroblewski et al., 2003), mouse (Pagliocca et al., 2008) and rat 
(Azerkan et al., 2001) mucosal samples. Canine gastric mucosa has not been 
studied in this fashion, thus the aim of this chapter was to establish a 
reproducible model to enable the study of canine gastric epithelial cell migration.  
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3.2. Materials and methods 
 
3.2.1.Sample collection 
 
Samples were collected as described previously (Section 2.3 and Section 2.4). 
Canine gastric mucosal samples from both endoscopic biopsies and cadaver 
sources were used in this investigation. 
 
3.2.2.Gastric gland isolation and culture 
 
Intact gastric glands were isolated from mucosal tissue samples (Section 2.4) and 
cultured as described previously (Section 2.5.1). 
 
3.2.3.Time-lapse experiments 
 
Spreading of individual gastric glands was observed using the Essen Incucyte™ 
live-cell imaging system (Essen BioScience, Inc., Welwyn Garden City, UK), 
with images captured at 1 h intervals over a period of 54 h.  
 
3.2.4.Cell spreading assays 
 
Preliminary experiments were performed in order to better understand the 
process of cell spreading in our model and to determine the most appropriate 
parameters to use for measuring spreading. Cell spreading assays were 
performed as described previously (Section 2.6).  
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3.3. Results 
 
3.3.1.Isolated gastric glands 
 
The gastric glands isolated from mucosal tissue samples were intact and varied in 
length between approximately 0.2 mm and 0.9 mm (Figure 3.1), depending on 
the conditions of the protocol. However, once the protocol had been established, 
the majority of the isolated glands were nearer to 0.9 mm long. 
 
In previous studies, collagenase digestion has been successfully used to isolate 
gastric glands from mucosal tissue samples (Wroblewski et al., 2003; Pagliocca 
et al., 2008; Berglindh & Ӧbrink, 1976). As described previously (Berglindh & 
Ӧbrink, 1976), tissue incubated with collagenase for a short period of time 
provided a low yield of intact gastric glands, due to incomplete tissue separation. 
However, longer incubation times resulted in suspensions of shorter gastric 
glands and areas of visible damage where single cells had dissociated from the 
gland (Figure 3.2), thus it was considered important to adhere to fairly stringent 
incubation times. 
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Figure 3.1- Photomicrograph of an intact viable gastric gland in culture. 
Magnification of 20X; scale bar: 50µm 
 
 
 
Figure 3.2- Photomicrograph of a damaged gastric gland in culture. 
Damaged areas highlighted with arrowhead. Magnification of 20X; scale bar: 50µm 
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3.3.2.Time-lapse analysis characterising canine gastric gland cell 
spreading 
  
Using time-lapse microscopy we were able to observe the sequence of events 
involved in the spreading of individual canine gastric glands. Isolated glands 
cultured on plasticware adhered to the substrate within 2 h and cells migrated out 
of the glands to form islands (Figure 3.3b). Once adhered, cells appear to flatten 
out and, after 12 h in culture, the cells located at the periphery of the island were 
seen to project active membrane protrusions (Figure 3.3d and Figure 3.4). Cell-
cell contacts were maintained throughout the spreading process and cells fully 
spread to form monolayer cell islands after 48 h in culture (Figure 3.3g and 
Figure 3.5). A fragment of gastric gland tissue often remained at the centre of 
spreading islands (Figure 3.6), this has been described previously and confirms 
that the epithelial cells are migrating out of intact gastric glands (Smoot et al., 
2000). The cell islands survived for up to 7 days in culture, after which they were 
seen to break apart and epithelial cells transformed into mesenchymal-like cells 
(Figure 3.7).  
 
Frequent contaminations were initially observed in cell cultures isolated from 
cadaver-derived mucosal tissue (Figure 3.8). Through microbiological culture, 
the major contaminant was identified as a Staphylococcus species, although 
fungal organisms were also frequently identified. It was determined that this 
contamination was occurring during tissue collection, thus more stringent aseptic 
isolation practices were put in place, including the thorough disinfection of all 
dissection tools and surfaces in between sample collections. In addition, all cell 
cultures were supplemented with gentamycin, which is described as being more 
effective for the control of bacterial growth in culture than penicillin-
streptomycin (Fischer, 1975). These control measures were effective at 
eliminating the contamination in subsequent cell cultures. 
 
Differences in the spreading behaviour between gastric glands isolated from 
endoscopy- and cadaver-derived tissue were observed. Glands isolated from 
cadaver-derived tissue exhibited slower rates of spreading; with fully spread 
monolayer cell islands being achieved after 96 h in culture, compared with 48 h 
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for those derived from endoscopies. As a substantially greater number of glands 
were isolated from the larger volumes of cadaver-derived tissue, the effect of cell 
density on spreading rate was investigated. Cultures containing increasing 
numbers of glands were set up and observed, to identify differences in spreading 
speed. Although cultures containing lower numbers of cadaver-derived gastric 
glands exhibited quicker spreading speeds (data not presented), monolayer 
islands still took 96 h to fully form, and thus the differences observed are not 
explained by a cell culture „over-crowding‟ effect. 
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Figure 3.3- Time-lapse microscopy phase contrast images of an isolated canine gastric gland 
(derived from an endoscopic biopsy) spreading to form a cell island. (a.) 0 h,( b.) 2 h, (c.) 6 h, 
(d.) 12 h, (e.) 24 h, (f.) 36 h, (g.) 48 h, (h.) 54 h; magnification of 10X; scale bar: 10µm 
  
 
 
 
 
Figure 3.4- Photomicrograph of a cultured spreading gastric gland after 12 h in culture. 
Magnification of 40X; scale bar: 10µm 
  
 
 
 
a. b. c. d. 
e. f. g. h. 
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Figure 3.5- Quantification of biopsy-derived gastric gland spreading over 54 h. Data was 
derived from the time-lapse images presented in Figure 3.3. 
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Figure 3.6- Photomicrograph showing a gland fragment present at the centre of a cultured 
spreading epithelial cell island. Magnification of 20X; scale bar: 10µm 
 
  
 
Figure 3.7- Photomicrograph showing cultured epithelial cells transforming into 
mesenchymal-like cells. Magnification of 20X; scale bar: 10µm 
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Figure 3.8- Photomicrograph showing bacterial contamination (seen as small black lines, 
highlighted by arrows) of cell culture. Magnification of 20X; scale bar: 10µm 
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Looking more closely at the cellular protrusions projected by cells at the 
periphery of the islands, there appears to be two distinct types of protrusion. The 
majority of cells project broad, thin, sheet-like protrusions which are 
characteristic of lamellipodia (Lauffenburger & Horwitz, 1996) (Figure 3.9a) and 
time-lapse images reveal that these protrusions are dynamic, constantly changing 
shape as the cells spread out. Certain cells also exhibit thin, needle-like 
protrusions, characteristic of filopodia (Lauffenburger & Horwitz, 1996) (Figure 
3.9b).  
          
Certain cells present within the epithelial islands exhibited a mottled appearance 
(Figure 3.10) and this is characteristic of parietal cells due to the presence of 
many mitochondria in the cytoplasm (Schultheis et al., 1998). There appeared to 
be many cells of this type within individual cell islands and they were present in 
the majority of islands. This is not suprising, given that parietal cells have been 
shown to constitute around 50% of the total cell volume of an isolated gastric 
gland (Berglindh & Ӧbrink, 1976). Cells adjacent to these appear to have a much 
smoother appearance (Figure 3.10). Spindle-shaped cells characteristic of 
fibroblasts (Murray et al., 2009) were also identified in culture (Figure 3.11).  
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Figure 3.9- Cultured cell islands showing (a.) broad, sheet-like protrusions characteristic of 
lamellipodia (arrowhead) and (b.) finger-like protrusions characteristic of filopodia (*). 
Magnification of 40X; scale bar: 10µm 
            
 
 
 
 
 
Figure 3.10- Representative photomicrograph highlighting the morphology of suspected 
parietal cells (arrowheads). Magnification of 40X; scale bar: 10µm 
  
 
 
 
 
* * 
a. b. 
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Figure 3.11- Representative photomicrograph highlighting the presence of fibroblasts in 
culture (arrowheads). Magnification of 20X; scale bar: 10µm 
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3.3.3.Parameters used to analyse cell spreading 
 
In order to determine the most appropriate parameters for analysis of cell 
spreading in this model, preliminary spreading experiments were carried out 
using gastric epithelial cell islands cultured from canine endoscopic biopsy 
samples. In previous cell spreading studies, measurement of the area of 
individual cells has typically been used to represent migration speed (Arthur & 
Burridge, 2001; Flevaris et al., 2007; Sanders et al., 2009). In a study using a 
similar model to that described here, cell spreading was calculated as the mean 
cell island area, normalised for cell number (Wroblewski et al., 2003). When 
comparisons are made between the total spread area of individual cell islands, 
this value provides some indication of the speed of migration. Thus, to calculate 
cell spreading in this model, measurements were made of the total area 
encompassing each island after 48 h in culture. As individual cell islands are 
made up of varying cell numbers (ranging from approximately 2-90 cells per 
island), the relationship between total area and cell count was analysed. A 
positive linear association was found to exist between these parameters (Figure 
3.12), thus the spreading behaviour of an individual cell can be represented by 
normalising the total island area for cell number.  
 
The total spread area values for islands with cell counts > 60 were found to be 
smaller than expected, based on the linear relationship of the data (Figure 3.12– 
blue dots). Cell crowding in islands with larger cell counts may affect the 
spreading behaviour of cells and could explain this decrease in spreading 
activity. As shown visually in Figure 3.13, cells occupying islands containing > 
60 cells remain more tightly packed than those in islands containing fewer cells. 
Based on these findings, a cut-off value of 60 cells was implemented in 
subsequent experiments. Cell islands consisting of less than 10 cells were also 
discounted, in order to ensure that a representative mixture of cell lineages was 
present in each cell island. Thus, only islands with cell counts of between 10 and 
60 were analysed in subsequent experiments.  
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Figure 3.12- Scatterplot diagram to identify the relationship between total spread area and 
total cell count. Dashed lines represent the cut-off values used in subsequent investigations. The 
line on the graph indicates a linear regression line.  
 
 
The projection of cellular protrusions, such as lamellae, is a crucial part of cell 
migration (Ridley et al., 2003), thus protrusive activity of cells within our model 
was also characterised. A characteristic fringe, representing cellular protrusions, 
is present around the periphery of cell islands. These protrusions are extended 
beyond the location of the cells, thus the protrusive area can be calculated by 
subtracting the area encompassed by the cell nuclei (using propidium iodide 
staining) from the total spread area (Figure 2.1). This novel calculated area is 
referred to as the fringe area and is larger for cells that are protruding more 
actively. As only cells around the periphery of islands are thought to contribute 
to the projection of cell protrusions, it was considered appropriate to normalise 
the fringe area to the edge cell count and the linear relationship between these 
two parameters is shown in Figure 3.14. 
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Figure 3.13- Photomicrographs highlighting the differences in spreading behaviour of 
islands with (a.) smaller and (b.) larger (> 60) cell counts. Magnification of 20X; scale bar: 
10µm 
  
 
 
 
 
 
 
 
 
 
 
 
a. b. 
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Figure 3.14-  Scatterplot diagram to identify the relationship between total fringe area and 
edge cell count. The line on the graph indicates a linear regression line.  
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3.4. Discussion 
 
This chapter describes the development of an appropriate model for studying the 
spreading of primary canine epithelial cells from isolated gastric glands. Much of 
the previous work on epithelial cell spreading and migration has relied upon the 
use of disaggregated cell suspensions or immortalised cell lines (Kato et al., 
1999; Buchanan et al., 2003; Sanders et al., 2009; Kim et al., 2012). In vitro 
models representative of an intact gastric epithelium have been successfully used 
to study human (Wroblewski et al., 2003), mouse (Pagliocca et al., 2008) and 
rabbit (Berglindh & Ӧbrink, 1976) cells, however, to our knowledge, such a 
model has not previously been used to isolate glands from canine tissue. Thus, 
the model presented here uses previously published techniques (Wroblewski et 
al., 2003; Pagliocca et al., 2008; Berglindh & Ӧbrink, 1976), to isolate intact 
glands from the canine gastric epithelium. In published studies, cell islands 
prepared in this way contain representative mixtures of cell types present in vivo 
including chief cells, parietal cells, surface mucous cells, and additionally 
mesenchymal cells. Based on morphology we were able to identify cells 
characteristic of parietal cells within islands and mesenchymal-like cells in 
culture.  
 
The protocol used in previous studies (Wroblewski et al., 2003; Pagliocca et al., 
2008; Berglindh & Ӧbrink, 1976) was adapted to enable the reproducible 
isolation of viable canine gastric glands. A collagenase concentration of 0.5 
mg/ml, as used previously (Wroblewski et al., 2003), was found to provide a 
suitable gland yield, thus this concentration was used in all subsequent 
experiments. Various collagenase digestion times were trialled in order to 
determine the optimal time for maximal gland isolation. Shorter digestion times 
were found to give a low yield of glands and left large fragments of tissue 
undigested, whereas enzymatic cell damage occurred when tissue was digested 
for longer time periods. The optimal digestion conditions were determined to be 
two 30 min collagenase incubations and washing the tissue samples with HBSS 
in between the digestion steps was found to limit the presence of excess tissue 
fragments in the final cell cultures. 
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Due to the limited availability of gastric mucosal samples from routine 
endoscopies, samples were also obtained from canine cadavers sourced from a 
local animal shelter. For endoscopy-derived samples, clinical data including 
Helicobacter status, the presence of certain inflammatory indicators and the final 
clinical diagnosis, including the presence of gastric adenocarcinoma or 
lymphoma, were recorded. Furthermore, the breed, sex, neutering status and age 
of the dog were recorded. The limitation of using cadaver-derived material is the 
absence of clinical data; only breed, neutering status and an estimation of age 
could be recorded for these samples. Despite this limitation, larger volumes of 
mucosa could be taken from the cadavers, allowing a high yield of gastric glands 
and a greater throughput of experiments. 
 
Time-lapse microscopy enabled us to observe the spreading behaviour of 
epithelial cells from isolated gastric glands. Time-lapse analysis was performed 
using a heated incubation chamber, allowing cells to be observed in real-time. 
Cell-cell contacts were maintained throughout the spreading process and cells did 
not detach from the islands. The extension of dynamic cellular protrusions was 
observed after 12 h in culture and these protrusions were characteristic of both 
lamellipodia and filopodia. Lamellipodia and filopodia are formed at the leading 
edge of the cell via actin polymerisation and are essential for cell motility (Small 
et al., 2002). It has been suggested that lamellipodia function to promote cell 
movement over a surface, whereas filopodia perform an exploratory role in order 
to direct migration (Mejillano et al., 2004). The Arp 2/3 protein complex has a 
key role in the formation of lamellipodia, via promotion of actin assembly 
(Machesky, 2008) and this complex is regulated by the SCAR/WAVE complex 
(Ibarra et al., 2005). Filopodia formation is known to be controlled by proteins, 
such as fascin and Mena/VASP (Machesky, 2008). In order to stabilise these 
cellular protrusions, adhesions are made between the actin cytoskeleton and the 
extracellular matrix (Horwitz & Webb, 2003).  
 
After 48 h in culture, biopsy-derived cells had fully spread from the isolated 
gastric glands to form monolayer cell islands, thus analysis of cell spreading in 
subsequent experiments was performed at this time point. In contrast, cells 
isolated from cadaver-derived tissue took substantially longer to spread, with 
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fully spread monolayer islands being observed after 96 h in culture. This 
difference in spreading behaviour was found to be independent of cell plating 
density. When cultured for longer time periods, epithelial cell islands survived 
for up to 7 days, adhered to the culture vessel with no biological substratum, as 
found previously (Basque et al., 1999). After 7 days in culture, cell islands were 
seen to break apart and epithelial cells transformed into mesenchymal-like cells. 
This process is referred to as epithelial-mesenchymal transition (EMT), and 
involves increases in MMP expression, basement membrane degradation and cell 
detachment, changes in the cytoskeletal arrangement (Murray, Knight & Laurent, 
2009) and altered cell-cell interactions (Radisky, 2005). EMT plays an important 
role in embryonic development (Shook & Keller, 2003) and the metastatic spread 
of cancer cells (Iwatsuki et al., 2010). 
 
These preliminary experiments were undertaken in order to characterise cell 
spreading in this model and to assess the suitability of certain parameters for 
measuring spreading. Previous studies have analysed cell spreading via the 
measurement of the relative area of individual cells (Arthur & Burridge; Sanders 
et al., 2009). Within this model, as in previous similar models (Wroblewski et al., 
2003), cell spreading was calculated as the mean cell island area, normalised for 
cell number. Previous studies have found no evidence of proliferation in similar 
cell island models (Wroblewski et al., 2003) and thus increases in cell area were 
attributed to cell migration and spreading. Given the importance of active cell 
protrusion in the process of spreading, the protrusive activity of cell islands was 
also determined through the measurement of fringe area, normalised for outer 
edge cell number. The novel measurement of fringe area described in this 
investigation is representative of cell protrusive activity only, and as such is less 
likely to be influenced by cell-cell interactions, thus it may provide a more robust 
representation of spreading activity. Cells spanning the outside edge of epithelial 
islands respond to a „wound-like‟ environment and spread over the surrounding 
substrate. Wounded epithelial cell monolayers have been shown to form cellular 
outgrowths at the wound edge, with a highly active leader cell located at the tip 
and the enhanced motility of this cell appears to pull neighbouring cells forwards 
(Omelchenko et al., 2003). Thus, activity of cells spanning a wound edge, or in 
this case the outer edge of cell islands, play a key role in driving the spreading of 
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epithelial cell sheets and as such, measurement of this activity, represented by 
fringe area in this model, provides important information about the spreading 
behaviour of cells.  
 
In summary, the protocol described in this chapter enables the reproducible 
isolation of intact, viable gastric glands, representative of their structure in vivo. 
Thus, this is a physiologically relevant primary culture model that can be used 
for the study of canine gastric epithelial cell spreading.   
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Chapter 4 - Characterising the effects of COX antagonism on epithelial cell 
migration and spreading 
 
4.1 Introduction 
 
COX-2-derived PGE2 is known to directly regulate cell migration via 
transactivation of the EGF receptor, leading to activation of the PI3K/Akt 
pathway (Buchanan et al., 2003) and prostaglandins may also indirectly modulate 
restitution by maintaining a favourable microenvironment (Morris, 1986). 
Endogenous prostaglandins have been shown to mediate the promotion of 
intestinal epithelial restitution by growth factors (Zushi et al., 1996) and non-
selective COX inhibition has been shown to impair the migration of human 
gastric epithelial monolayers via inhibition of stress fibre formation and FAK 
and tensin phosphorylation (Szabó et al., 2002). COX-2 has an important role in 
the modulation of HGF-stimulated restitution (Horie-Sakata et al., 1998). HGF 
was shown to increase COX-2 expression in RGM-1 cells and selective 
inhibition of COX-2 significantly delayed wound repair (Horie-Sakata et al., 
1998). Furthermore, COX-2 and PGE2 are considered to be important for the 
migration of cancer cells. PGE2 was shown to promote the migration of 
chondrosarcoma cells by up-regulating the expression of α2β1 integrin through 
activation of the EP1, PLC, PKCα, c-Src and NF-κB –dependant signalling 
pathway (Liu et al., 2010). COX-2 over-expression is associated with the 
enhanced motility and invasiveness of breast cancer cells (Singh, 2005). 
 
Whilst the role of COX in cell migration and spreading has been widely studied, 
little focus has been given to its effects in a multicellular model. The overall aim 
of this investigation was to test the hypothesis that COX-2-derived PGE2 
mediates epithelial cell migration and spreading in vitro. Given the importance of 
epithelial cell migration and spreading in the repair of gastric damage, this 
investigation used intact isolated gastric glands, which form multicellular 
monolayer islands, to determine the role of COX enzymes in gastric epithelial 
cell migration and spreading. A scratch wound assay, using an immortalised cell 
line, was used to support the primary cell experiments, enabling a high 
throughput of reproducible experiments to be performed. Using both kidney and 
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gastric epithelial cell lines and cells derived from both humans and canines, 
provides evidence that any observed effects are not cell-type or species specific. 
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4.2. Materials and methods 
 
4.2.1.Cell line scratch wound assays 
 
4.2.1.1. Cell culture 
 
MDCK, MKN-45 and AGS cells were cultured using conditions described 
previously (Section 2.5.2). 
 
4.2.1.2. Scratch wound assay 
 
Scratch wounds were performed as described previously (Section 2.7). Cells 
were serum starved for 12 h prior to scratch wounding, cells were then treated 
with either 50 µM indomethacin or 10 µM NS-398, made up in serum-free 
medium, for 24 h. Control wells contained the vehicle only (both chemicals were 
dissolved in DMSO). The observer was blinded to the treatment used in 
individual wells. 
 
4.2.1.3. Statistics 
 
A total of six individual experiments were performed, with two separate areas 
analysed for each scratch wound. The data was presented as the mean difference 
in scratch wound width, with values normalised to the mean control value within 
each experiment. Statistical analysis was performed with SPSS 20 (IBM Corp.), 
using one-way analysis of variance. The criteria for statistical significance was 
set at P<0.05. 
 
4.2.2.Primary cell island spreading experiments 
 
4.2.2.1. Sample collection 
 
Samples were collected as described previously (Section 2.3). All gastric 
mucosal tissue samples used in this study were obtained from routine canine 
endoscopic biopsies. 
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4.2.2.2. Gastric gland isolation 
 
Intact gastric glands were isolated from mucosal tissue samples as described 
previously (Section 2.4). 
 
4.2.2.3. Gastric gland culture 
 
Isolated glands were cultured in serum-supplemented medium (10% FBS), with 
either 50 µM indomethacin or 10 µM NS-398. Control wells contained the 
vehicle only (both chemicals were dissolved in DMSO). Glands were cultured 
for 48 h at 37°C in a 5% CO2 incubator, at which point they had fully spread to 
form monolayer cell islands. The observer was blinded to the treatment used in 
individual wells. 
 
4.2.2.4. Dose-response experiments 
 
Initially, dose-response experiments were performed for each NSAID in order to 
characterise the relationship between drug dose and cell spreading and to 
determine the best dosage to use in subsequent experiments. Briefly, isolated 
glands were cultured in the appropriate medium plus the NSAID in increasing 
doses for 48 h. Values for total area and fringe area were taken as described 
previously (Section 2.6.3). The lowest dose of NSAID at which a visible effect 
could be seen was used in subsequent experiments.  
 
4.2.2.5. Analysis of epithelial cell island spreading 
 
Cell spreading in individual cell islands was analysed as described previously 
(Section 2.6.3). 
 
4.2.2.6. PGE2 ELISA 
 
PGE2 ELISAs were performed to analyse the effects of NSAID treatment on 
PGE2 concentration in cell culture supernatants. ELISAs were performed as 
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described previously (Section 2.9.3). A commercially available PGE2 ELISA kit 
(R&D Systems) was used. 
 
4.2.2.7. Statistics 
 
A total of five experiments, using biopsy samples from five dogs were performed 
and each experiment consisted of measurements from approximately 75 different 
cell islands, approximately 25 islands per treatment. There was an inevitable 
clustering within the observations because each biopsy sample was used in 
testing the effect of each treatment. The analysis acknowledged this by using a 
mixed-effects linear regression with the biopsy identity declared as a random 
effect. The measurements for both total area and fringe area were corrected for 
by cell number and subjected to a logarithmic transformation. Significant 
differences were indicated by P<0.05 for all data. Statistical analysis was 
performed using Stata Statistical Software: Release 11 (StataCorp. 2009) and the 
xtmixed command.  
 
For the dose-response experiments, one biopsy sample was analysed per 
treatment, with approximately 20 glands analysed per concentration. One-way 
analysis of variance was used to analyse statistical differences between the 
treatment groups. SPSS 20 (IBM Corp.) was used to perform the analysis and the 
criteria for statistical significance was set at P<0.05. 
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4.3. Results 
 
4.3.1.Non-selective and COX-2 selective antagonism impairs MDCK 
scratch wound healing  
 
In this investigation, scratch wound assays were performed on confluent 
monolayers of MDCK cells in order to assess the effects of indomethacin (a non-
selective COX antagonist) and NS-398 (a COX-2 selective antagonist) on 
immortalised epithelial cell wound healing. In order to negate the effects of 
serum components, the MDCK cells were serum starved for 12 h prior to scratch 
wounding. Confluent monolayers of MDCK cells were scratch wounded and 
cultured in either serum-free medium alone (control) or serum-free medium 
supplemented with 50 µM indomethacin or 10 µM NS-398. Both non-selective 
and COX-2 selective antagonism markedly inhibited the healing of scratch 
wounds, when compared to control (Figure 4.1). Analysis of percentage wound 
closure, normalised to control, showed that treatment with both indomethacin 
and NS-398 significantly reduced wound healing over 24 h (Figure 4.2). 
 
4.3.2.Non-selective and COX-2 selective antagonism inhibits PGE2 
production in MDCK cells 
 
In order to assess the effects of both indomethacin and NS-398 treatment on 
PGE2 production by serum-starved MDCK cells, a commercially available PGE2 
ELISA kit was used. Indomethacin and NS-398 inhibited PGE2 concentration by 
79.2% and 76.6% respectively (Table 4.1 and Figure 4.3). 
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Figure 4.1- Phase contrast photomicrographs highlighting the effect of non-selective 
(indomethacin, 50µM) and COX-2 selective (NS-398, 10µM) antagonists on MDCK scratch 
wound healing after 24 h treatment. Images taken at magnification of 10X; scale bar: 10µm 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Control Indomethacin NS-398 
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Figure 4.2- Effect of non-selective (indomethacin, 50 µM) and COX-2 selective (NS-398, 10 
µM) antagonists on MDCK scratch wound healing. Data (presented as mean +/- SEM) were 
normalised to control and analysed using one-way analysis of variance.. There was a significant 
effect of treatment, with both indomethacin and NS-398 significantly impairing wound healing 
(p<0.001, indicated by *). 
 
Unknowns O.D PGE2 concentration (pg/ml) 
Control 0.599 253.79 
Indomethacin 0.815 52.68 
NS-398 0.798 59.34 
 
Table 4.1- O.D values and calculated PGE2 concentrations for MDCK cell supernatants 
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Figure 4.3- Effect of non-selective (indomethacin, 50 µM) and COX-2 selective (NS-398, 10 
µM) antagonism on PGE2 concentration in supernatants obtained from cultured MDCK 
cells 
 
4.3.3.Non-selective and COX-2 selective antagonism impairs wound 
healing in human epithelial cell lines 
 
To ensure that the observed effects were not specific to cells of canine origin, the 
effects of COX antagonism on scratch wound healing in two human epithelial 
cell lines, AGS and MKN-45 cells, were analysed. Both of these cell lines are 
derived from a human gastric adenocarcinoma. Analysis of percentage wound 
closure normalised to control shows that treatment with both indomethacin and 
NS-398 significantly reduced wound healing over 24 h in both cell lines (Figure 
4.4), thus suggesting that the effects of COX antagonism on epithelial cell 
migration are not species-specific. 
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Figure 4.4- Effect of non-selective (indomethacin, 50 µM) and COX-2 selective (NS-398, 10 
µM) antagonists on MKN-45 and AGS cell scratch wound healing. Data (presented as mean 
+/- SEM) were normalised to control and analysed using one-way analysis of variance. There 
was a significant effect of treatment for both cell types, with both indomethacin and NS-398 
significantly impairing healing (p<0.001, indicated by *). 
 
 
4.3.4.Effect of non-selective and COX-2 selective antagonism on epithelial 
cell spreading and protrusive activity 
 
4.3.4.1. Dose-response experiments 
 
A dose-response experiment was performed for both indomethacin and NS-398, 
in order to find the optimal concentration to use in subsequent experiments. 
Treatment with indomethacin at concentrations above 50 µM was shown to cause 
a statistically significant decrease in both total area per cell and fringe area per 
cell (Figure 4.5), thus, in subsequent experiments indomethacin was used at a 
concentration of 50 µM. Comparison between treatment concentrations of NS-
398 showed that treating with concentrations above 10 µM caused a statistically 
significant decrease in both total area per cell and fringe area per cell (Figure 
4.6), thus, in subsequent experiments NS-398 was used at a concentration of 10 
µM. At concentrations of 500 µM, NS-398 caused significant cell damage; cell 
death was confirmed via a trypan blue exclusion assay (data not presented). 
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Figure 4.5- Dose response curve for indomethacin (non-selective COX antagonist). Data 
(presented as mean +/- SEM) was analysed using one-way analysis of variance. Indomethacin, at 
doses higher than 50 µM, significantly decreased both total area per cell and fringe area per cell 
(p<0.001, indicated by *). 
 
 
 
Figure 4.6- Dose response curve for NS-398 (COX-2 selective antagonist). Data (presented as 
mean +/- SEM) was analysed using one-way analysis of variance. NS-398, at doses higher than 
10 µM, significantly decreased both total area per cell and fringe area per cell (p<0.05, indicated 
by *). 
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4.3.4.2. Non-selective and COX-2 selective antagonism impairs 
epithelial cell spreading and protrusive activity 
 
Five independent cell spreading experiments, using biopsy samples from five 
dogs were carried out for the purpose of this study. The dogs varied by breed, 
age and sex and, as samples were obtained via routine endoscopies, the dogs 
were presenting at the Small Animal Hospital with varying gastrointestinal 
symptoms. The effects of indomethacin and NS-398 were assessed by measuring 
the effect of each drug on 25 individual cell islands in each experiment. Values 
for mean total spread area corrected for by cell count and mean fringe area 
corrected for by edge cell count were calculated for each experimental treatment, 
as well as a control treatment, containing the vehicle only.  
 
Treatment with indomethacin at 50 μM caused a 14.3% inhibition in total spread 
area per cell and a 63.6% inhibition in fringe area per cell (Figure 4.7). 
Treatment with the COX-2 selective antagonist, NS-398 at 10 μM caused similar 
decreases to indomethacin, with a 21.4% inhibition in total spread area and a 
65.5% inhibition in fringe area per cell (Figure 4.7). The effects of COX 
antagonism on cell spreading can also be observed visually (Figure 4.8). 
Furthermore, analysis of distance between neighbouring cells, reveals that cells 
within islands treated with both indomethacin and NS-398 remain in closer 
proximity to each other compared to cells in the control islands (Figure 4.9). 
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Figure 4.7- Effect of non-selective (indomethacin, 50 µM) and COX-2 selective (NS-398, 10 
µM) antagonists on the migration of primary canine gastric epithelial cell islands. Data 
(presented as mean +/- SEM) was analysed by mixed-effects regression. There was a significant 
effect of treatment, with both indomethacin and NS-398 significantly impairing cell spreading 
and protrusive activity (p<0.05, indicated by *). 
 
4.3.4.3. Non-selective and COX-2 selective antagonism inhibits PGE2 
production in canine epithelial cells 
 
In biopsy-derived canine gastric epithelial cells, 48 h treatment with 
indomethacin and NS-398 inhibited PGE2 concentration by 93.4% and 89.3% 
respectively (Table 4.2 and Figure 4.10). 
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Figure 4.8- Representative photomicrographs highlighting the effects of non-selective 
(indomethacin, 50 µM) and COX-2 selective (NS-398, 10 µM) antagonists on the spreading 
of primary gastric epithelial cell islands. Cell nuclei have been stained with propidium iodide; 
images taken at magnification of 20X; scale bar: 10µm 
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Figure 4.9- Effect of non-selective (indomethacin, 50 µM) and COX-2 selective (NS-398, 10 
µM) antagonists on the average distance between neighbouring cells in cultured islands. 
Data (presented as mean +/- SEM) was analysed using one-way analysis of variance. There was a 
significant effect of treatment on distance between neighbouring cells, with both indomethacin 
and NS-398 causing a significant decrease in distance (p<0.05, indicated by *). 
 
Unknowns O.D PGE2 concentration (pg/ml) 
Control 0.582 287.53 
Indomethacin 0.955 18.90 
NS-398 0.888 30.76 
 
Table 4.2- O.D values and calculated PGE2 concentrations for canine gastric epithelial cell 
island supernatants 
 
 
 
Figure 4.10- Effect of non-selective (indomethacin, 50µM) and COX-2 selective (NS-398, 
10µM) antagonists on PGE2 concentration in supernatants obtained from cultured canine 
gastric epithelial cell islands 
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4.4. Discussion 
 
Previous in vitro studies of gastric epithelial cell migration and spreading have 
involved the use of cultures of fully dispersed surface epithelial cells or 
immortalised cell lines (Murakami et al., 1998; Pai et al., 2001; Kim et al., 2012), 
however, in these models the cell-cell interactions and cell polarity that are seen 
in vivo are not preserved. The cell spreading model used in this investigation 
utilised individual intact gastric glands which contain multiple cell types, namely 
surface epithelial cells, chief cells, parietal cells and endocrine cells (Schubert & 
Peura, 2008). Normal cell-cell contacts and cell polarity are maintained in this 
model, thus making it a more representative model for in vivo activity. 
Furthermore, the cell preparation may also contain gastric fibroblasts isolated 
from mucosal tissue along with the gastric glands, thus any paracrine signalling 
occurring between mesenchymal and epithelial cells may be maintained. 
Paracrine signalling may play an important role in the regulation of epithelial cell 
migration. HGF has been reported to promote gastric epithelial cell migration via 
a paracrine mechanism (Takahashi et al., 1995). HGF is produced by 
mesenchymal cells and binds to the Met/HGF receptor present on epithelial cells 
(Schmassman et al., 1997). Gastrin-mediated paracrine signalling has been 
shown to induce gastric epithelial cell migration through activation of the EGF 
receptor, the erbB2 receptor and the MAPK pathway (Noble et al., 2003). TGF-
α, produced via the parietal cells and bFGF of stromal origin, have also been 
shown to enhance canine oxyntic mucosal cell migration, presumably in a 
paracrine manner (Kato et al., 1999).  
 
The major limitation of using this primary cell culture model is the limited 
availability of tissue for gland isolation. To overcome this factor, scratch wound 
assays were performed to support the primary cell experiments. Scratch wound 
analysis is convenient for performing a large number of highly reproducible 
experiments (Cory, 2011) and scratch wound models have been successfully 
used in previous studies to observe the effects of COX antagonism on gastric 
epithelial cell wound healing (Pai et al., 2001; Giap et al., 2002). Using both 
kidney and gastric epithelial cell lines and cells derived from both humans and 
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canines, demonstrated that the observed responses are not cell-type or species 
specific. 
 
Given the importance of cell migration and spreading in maintaining gastric 
epithelial integrity (Terano, 2001), the aim of this study was to compare the 
effects of both a non-selective and a COX-2 selective antagonist on epithelial cell 
migration and spreading in vitro. Clinical studies have shown that treatment with 
COX-2 selective antagonists leads to less adverse gastrointestinal effects 
compared with traditional non-selective antagonists (Laine et al., 1999; Simon et 
al., 1999; Hawkey et al., 2000). The findings presented in this chapter indicate 
that both non-selective and COX-2 selective antagonism significantly inhibits 
gastric epithelial cell spreading (total area per cell) and protrusive activity (fringe 
area per cell). Similar responses were observed with the scratch wound healing 
assay, with both indomethacin and NS-398 causing a significant delay in wound 
closure of epithelial cell monolayers of human and canine origin. In a 
preliminary dose-response experiment, the effects of indomethacin and NS-398 
on epithelial cell migration were shown to be dose-dependent. Through the use 
of a trypan blue exclusion assay, the concentrations of drugs used in this study 
were determined to have no cytotoxic effect on the cells. ELISA analysis 
confirmed that PGE2 production was markedly reduced by treatment with both 
indomethacin and NS-398 and the extent to which NS-398 treatment inhibited 
PGE2 production was similar to that seen with indomethacin, thus suggesting that 
the majority of PGE2 produced via epithelial cells in this model is derived from 
COX-2. NS-398 has previously been shown to be highly selective for COX-2, 
with a COX-1/COX-2 ratio of 22, compared to 0.029 for indomethacin (Kato et 
al., 2001). Thus, these findings suggest that COX-2 derived PGE2 has an 
important role in the modulation of epithelial cell migration and spreading in 
vitro. 
  
Consistent with our findings, previous studies have shown that both non-
selective and COX-2 selective antagonists impair the re-epithelialisation of 
wounded gastric monolayers in vitro (Pai et al., 2001) and gastric ulcer healing in 
rats in vivo (Shigeta et al., 1998). Contrastingly, a study by Giap and colleagues 
(2002) disagreed with our findings, suggesting that COX-2 specific inhibition 
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had no effects on basal wound re-epithelialisation of a gastric cell line 
monolayer, however non-selective COX inhibition significantly reduced re-
epithelialisation, indicating the importance of COX-1 in this effect. Notably, in 
this study cells were not serum-starved prior to scratch wounding as they were in 
experiments presented here. As reported in this thesis, serum-starvation induces 
COX-2 expression in cultured gastric epithelial cells (Section 6.3.2), thus this 
may account for the lack of response. Additionally, COX-2 selective inhibition 
did significantly reduce bFGF-stimulated wound re-epithelialisation (Giap et al., 
2002) and as our primary cell preparation consists of multiple cell types, 
paracrine bFGF signalling could be taking place. 
 
It has previously been reported that aspirin treatment leads to poorly formed 
lamellipodia at the wound edge (Yoshizawa et al., 2000), thus suggesting that 
cytoskeletal disruption may play a role in the suppression of wound repair by 
COX antagonism. Indomethacin and NS-398 have both been shown to have a 
direct effect on the cytoskeleton via disruption of actin stress fibre formation, 
reduction in c-Src activity and a decrease in FAK and tensin phosphorylation 
(Pai et al., 2001), all of which are very important for cell migration (Ridley et al., 
2003). In this investigation, cells treated with both indomethacin and NS-398 
were still able to extend protrusions, as observed visually, however, both 
treatments were shown to significantly decrease the area of cell protrusions 
around the epithelial islands (fringe area). Thus, this suggests that the inhibitory 
effect of COX antagonism on epithelial cell migration may occur via changes to 
the cytoskeletal arrangement, causing a reduction in protrusive activity. This 
phenomenon could be further investigated through the use of phalloidin staining 
to detect filamentous actin, which, due to time constraints could not be 
performed as part of this study. 
 
In summary, the findings presented in this chapter highlight the importance of 
COX-2 derived prostaglandins in the regulation of epithelial cell migration and 
spreading in vitro. Disruption to the cytoskeletal structure of the cells and 
inhibition of cellular protrusion formation may explain the inhibitory effects of 
COX antagonism on epithelial cell migration and spreading.  
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Chapter 5 - Effects of glucocorticoid receptor agonism and antagonism on 
epithelial cell migration and spreading 
  
5.1 Introduction 
 
Glucocorticoids exert their effects by binding to the intracellular GR, which is 
expressed in virtually all cell types (Turner et al., 2006). Once activated, the GR 
regulates the transcription of responsive target genes (Barnes, 1998). Endogenous 
glucocorticoids play an important role in a variety of physiological functions, such as 
the regulation of metabolism, immune response and electrolyte homeostasis (Lu & 
Cidlowski, 2006). Glucocorticoids are also known to have a suppressive effect on 
inflammation, via up-regulation of the transcription of genes coding for anti-
inflammatory proteins and inhibition of the expression of several pro-inflammatory 
genes (Barnes, 1998). Glucocorticoids can alter the transcription of certain cytokine 
genes, such as TNF, IL-1 and IL-6 and inhibit the production of the pro-
inflammatory prostaglandins (O‟Connor et al., 2000). For this reason, 
glucocorticoids are widely used in the treatment of inflammatory conditions such as 
IBD, asthma, rheumatoid arthritis and autoimmune diseases (Barnes, 1998).  
 
Exogenous glucocorticoid administration has been associated with an increased risk 
of gastric ulceration (Bandyopadhyay et al., 1999) and a delay in ulcer healing (Luo 
et al., 2004). Treating with NSAIDs and glucocorticoids concurrently causes a 
greater risk of gastric ulceration compared to using either treatment alone (Rodriguez 
& Hernández-Diaz, 2001). Exogenous glucocorticoid administration blocks the 
release of arachidonic acid from phospholipids (Hong & Levine, 1976), thus 
depriving COX of substrate, this effect is mediated by lipocortin-1 (Croxtall et al., 
1995) and as a result, PGE2 production is decreased. PGE2 down-regulation at the 
gastric ulcer margin of rats treated with dexamethasone has been described 
previously (Luo et al., 2004).  
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Furthermore, stress has been identified as a predisposing factor for the development 
of gastric ulceration (Silen et al., 1981). Glucocorticoid secretion is induced in 
response to stress (Sapolsky et al., 2000), via activation of the HPA axis (O‟Connor 
et al., 2000). Glucocorticoids modulate the stress response by altering gene 
expression, transcription and translation (O‟Connor et al., 2000), leading to 
inhibition of various pro-inflammatory mediators, such as cytokines. Previous 
studies have used animal models to show that both physical (Hase et al., 1975; 
Filaretova et al., 1998) and psychological (Menguy, 1960) stressors induce gastric 
ulceration. However, more recent studies have shown that acute increases in stress-
induced plasma corticosterone levels appear to protect against the development of 
stress-induced ulcers (Filaretova et al., 1998). The gastroprotective effects of 
glucocorticoids may be mediated through the maintenance of gastric mucosal blood 
flow (Filaretova et al., 1999), glucose homeostasis and mucus production and the 
inhibition of gastric motility and microvascular permeability (Filaretova et al., 2005). 
 
The aim of this study was to test the hypothesis that glucocorticoid receptor 
signalling modulates epithelial cell migration and spreading in vitro. Given the 
importance of epithelial cell migration and spreading in maintaining the integrity of 
the gastric mucosa (Terano, 2001), the effects of both GR agonism and antagonism 
on epithelial cell wound healing and canine gastric epithelial cell spreading were 
investigated. Previous studies have shown that dexamethasone treatment leads to an 
inhibition in smooth muscle cell migration via suppression of MMP activity (Pross et 
al., 2002) and impairs wound healing in vivo in rats (Durmus et al., 2003). In 
particular, dexamethasone treatment has been associated with impaired gastric cell 
migration of a co-culture of gastric fibroblasts and epithelial cells (Takahashi et al., 
2003) and TNF-α stimulated rat gastric epithelial migration (Luo et al., 2009). 
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5.2. Materials and methods 
 
5.2.1.Cell line scratch wound assays 
 
5.2.1.1. Cell culture 
 
MDCK cells were cultured as described previously (Section 2.5.2). 
 
5.2.1.2. Scratch wound assay 
 
Scratch wounds were performed as described previously (Section 2.7). Cells were 
serum-starved for 12 h prior to scratch wounding, after which they were treated with 
either 1 µM dexamethasone, dissolved in DMSO or 1 µM RU-38486, dissolved in 
ethanol. Both treatments were made up in serum-free medium. Serum-free control 
wells contained the vehicle only and medium containing 10% FBS was used as a 
positive control. The observer was blinded to the treatment used in individual wells. 
 
5.2.1.3. Dose-response experiments 
 
Dose-response experiments were performed on scratch wounded monolayers in 
order to characterise the relationship between drug dose and cell migration. Serum-
starved, wounded monolayers were cultured with various concentrations of 
dexamethasone for 24 h prior to analysis. 
 
5.2.1.4. Statistics 
 
A total of six individual experiments were performed, with two separate areas 
analysed for each scratch wound. The data was presented as the mean difference in 
scratch wound width, with values normalised to the mean control value within each 
experiment. Statistical analysis was performed with SPSS 20 (IBM Corp.), using 
one-way analysis of variance. The criteria for statistical significance was set at 
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P<0.05. For the dose-response assays, three individual experiments were performed, 
analysing two separate areas for each wound. 
 
5.2.2.Primary cell island spreading experiments 
 
5.2.2.1. Sample collection 
 
Samples were collected as described previously (Section 2.3). All gastric mucosal 
tissue samples used in this study were obtained from routine canine endoscopic 
biopsies. 
 
5.2.2.2. Gastric gland isolation 
 
Intact gastric glands were isolated from mucosal tissue samples as described 
previously (Section 2.4). 
 
5.2.2.3. Gastric gland culture 
 
Isolated glands were cultured in serum-supplemented medium (10% FBS), either 
alone or with 1 µM dexamethasone or 1 µM RU-38486. Glands were cultured for 48 
h at 37°C in a 5% CO2 incubator, at which point they had fully spread to form 
monolayer cell islands. The observer was blinded to the treatment used in individual 
wells. 
 
5.2.2.4. Dose-response experiments 
 
Dose-response experiments were performed for both dexamethasone and RU-38486 
in order to characterise the relationship between drug dose and cell island spreading. 
Briefly, isolated glands were cultured in serum-supplemented medium (10% FBS) 
plus the treatment in increasing doses for 48 h. Values for total area and fringe area 
were taken as described previously (Section 2.6.3). 
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5.2.2.5. Analysis of epithelial cell island spreading 
 
Cell spreading in individual cell islands was analysed as described previously 
(Section 2.6.3). 
 
5.2.2.6. Statistics 
 
A total of five experiments, using biopsy samples from five dogs were performed 
and each experiment consisted of measurements from approximately 75 different cell 
islands, approximately 25 islands per treatment. There was an inevitable clustering 
within the observations because each biopsy sample was used in testing the effect of 
each treatment. The analysis acknowledged this by using a mixed-effects linear 
regression with the biopsy identity declared as a random effect. The measurements 
for both total area and fringe area were corrected for by cell number and subjected to 
a logarithmic transformation. Significant differences were indicated by P<0.05 for 
all data. Statistical analysis was performed using Stata Statistical Software: Release 
11 (StataCorp. 2009) and the xtmixed command.  
 
For the dose-response experiments, one biopsy sample was used per treatment, with 
approximately 20 glands analysed per concentration. One-way analysis of variance 
was used to analyse statistical differences between the treatment groups. SPSS 20 
(IBM Corp.) was used to perform the analysis and the criteria for statistical 
significance was set at P<0.05. 
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5.3. Results 
 
5.3.1.The effects of GR agonism on MDCK scratch wound healing vary with 
dose 
 
Given the contrasting evidence available for the role of glucocorticoids in epithelial 
wound repair, one of the aims of this investigation was to determine the effects of 
dexamethasone, at varying doses, on MDCK wound healing. For the purpose of this 
investigation, scratch wound assays were performed on serum-starved confluent 
monolayers of MDCK cells. As commercially available FBS contains certain growth 
factors, binding proteins and hormones, as well as mean cortisol levels of 0.5 µg/ml 
(Price & Gregory, 1982), medium supplemented with 10% FBS served as a positive 
control.  
 
Physiological cortisol levels were calculated to be approximately 0.1 µM. A 
pharmacological dose of dexamethasone was calculated as 1 µM, based on the 
therapeutic anti-inflammatory dose used in dogs. Pharmacological dexamethasone (1 
µM) and sub-physiological dexamethasone doses (<0.1 µM) both caused a 
statistically significant inhibition of MDCK scratch wound healing compared to the 
serum-free control. In addition, treatment with 10% FBS significantly promoted 
MDCK scratch wound healing (Figure 5.1).  
  
5.3.2.Both agonism and antagonism of the GR impairs wound healing in 
MDCK cells 
 
In order to characterise the effects of GR agonism and antagonism on MDCK wound 
healing, further scratch wound assays were performed on serum-starved confluent 
cell monolayers. Scratch wounds were made as described previously (Section 2.7) 
and cells were treated with either serum-free medium or medium containing 1 µM 
dexamethasone or 1 µM RU-38486. The glucocorticoid receptor antagonist, RU-
38486, was used to study the effects of glucocorticoid absence on migration. RU-
38486 at a concentration of 1 µM has previously been shown to completely block 
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apoptosis mediated by 1 µM dexamethasone in rat C6 glioma cells (Morita et al., 
1999), thus we chose to use this concentration in our studies.  
 
Both dexamethasone-induced GR agonism and GR antagonism via RU-38486 
significantly impaired MDCK wound healing, compared to the serum-free control. 
After 24 h, cells treated with serum-free medium had migrated to cover 
approximately 70% of the wound area. However, in cells treated with 
pharmacological dexamethasone and RU-38486 wounds were only 3% and 5% 
closed respectively (Figure 5.2). FBS appears to increase wound healing, as cells 
treated with 10% FBS had migrated to cover approximately 80% of the wound area 
after 24 h (Figure 5.3). Furthermore, cells along the wound edge appear to form less 
cellular protrusions when treated with dexamethasone and RU-38486 compared to 
the serum-free control (Figure 5.4). 
 
Analysis of percentage wound closure normalised to the serum-free control, shows 
that both pharmacological dexamethasone and RU-38486 cause a statistically 
significant reduction in MDCK wound healing over 24 h, while FBS significantly 
increased wound healing (Figure 5.5). 
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Figure 5.1- Dose-response curve showing the effects of varying dexamethasone concentrations 
on MDCK cell scratch wound healing. Data (presented as mean +/- SEM) were normalised to a 
serum-free control and analysed using one-way analysis of variance. There was a significant effect of 
glucocorticoid concentration, with supra- and sub-physiological concentrations of glucocorticoid 
significantly impairing healing. Furthermore, treatment with 10% FBS significantly promoted wound 
healing (p<0.05, indicated by *, p<0.001, indicated by **). 
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Figure 5.2- Representative photomicrographs highlighting the effects of serum-free medium, 
pharmacological dexamethasone (1µM) and GR antagonism (RU-38486) (1µM) on MDCK 
wound healing after 24 h treatment. Images taken at magnification of 10X; scale bar: 10µm 
 
 
 
 
Figure 5.3- Representative photomicrographs highlighting effects of serum-starvation and 10% 
FBS on MDCK wound healing. Images taken at magnification of 10X; scale bar: 10µm 
 
 
 
Figure 5.4- Representative photomicrographs of scratch wounded MDCK cells, highlighting 
cellular protrusions (arrowheads) at the wound edge. Images taken at magnification of 20X; scale 
bar: 10µm 
Serum-free control Dexamethasone RU-38486 
10%  FBS Serum-free control 
Serum-free control Dexamethasone  RU-38486  
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Figure 5.5- Effect of serum-free medium, 10% FBS, pharmacological dexamethasone and GR 
antagonism (RU-38486) on MDCK scratch wound healing. Data (presented as mean +/- SEM) 
were normalised to the serum-free control and analysed using one-way analysis of variance. There 
was a significant effect of treatment, with both pharmacological dexamethasone and RU-38486 
significantly impairing healing and FBS significantly promoting wound healing when compared to 
control (p<0.05, indicated by *, p<0.001, indicated by **). 
 
5.3.3.Gastric epithelial cell spreading and protrusive activity is not affected by 
treatment with pharmacological dexamethasone or a GR antagonist  
 
Five independent spreading experiments, involving biopsies from five dogs were 
carried out for the purpose of this study. The dogs varied by breed, age and sex and 
as samples were obtained via routine endoscopies, the dogs were presenting at the 
Small Animal Hospital with varying gastrointestinal symptoms. The effects of 
dexamethasone and RU-38486 were assessed by measuring the effect of each drug 
on 25 individual cell islands in each experiment. Values for mean total spread area 
corrected for by cell count and mean fringe area corrected for by edge cell count 
were calculated for each experimental treatment, as well as a control treatment, 
containing FBS only. 
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Treatment with either pharmacological dexamethasone or RU-38486 had no 
statistically significant effects on either cell spreading (total area per cell) or the 
protrusive activity (fringe area per cell) of canine gastric epithelial cell islands 
(Figure 5.6 and Figure 5.7) when compared to  the FBS control. Looking more 
closely at the individual cell islands (Figure 5.6), neither treatment appeared to 
prevent cells around the outside edge of islands from projecting normal cellular 
protrusions.  
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Figure 5.6- Representative photomicrographs highlighting the effects of 10% FBS, 
pharmacological dexamethasone (1µM) and GR antagonism (RU-38486) (1µM) on the 
spreading of primary gastric epithelial cell islands. Cell nuclei have been stained with propidium 
iodide; images taken at magnification of 20X; scale bar: 10µm  
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Figure 5.7- Effects of 10% FBS, pharmacological dexamethasone (1µM) and the GR antagonist, 
RU-38486 (1µM), on the spreading of primary canine gastric epithelial cell islands. Data 
presented as mean +/- SEM 
 
5.3.4.Varying doses of dexamethasone and RU-38486 have no effect on 
epithelial cell spreading and protrusive activity 
 
Given our previous findings (Section 5.3.3), we investigated whether higher or lower 
doses of dexamethasone and RU-38486 would have a statistically significant effect 
on gastric epithelial cell island spreading. Drug concentrations ranging from 0.1 µM 
to 10 µM were used for both treatments. The dose-response results show that there 
was no statistically significant effect for either drug on total spread area per cell or 
fringe area per cell (Figure 5.8 and Figure 5.9) when compared to the FBS control. 
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Figure 5.8- Dose response curve for dexamethasone. Data presented as mean +/- SEM 
 
 
Figure 5.9- Dose response curve for RU-38486 (GR antagonist). Data presented as mean +/- SEM 
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5.4. Discussion 
 
The aim of this investigation was to characterise the effects of glucocorticoids on 
epithelial cell migration and spreading in vitro by looking at the effects of GR 
agonism and antagonism. Two different models were used to study these effects, a 
scratch wound healing assay, using an immortalised epithelial cell line and a primary 
gastric epithelial cell spreading model, incorporating interactions between multiple 
cell types. 
 
This study provides evidence that both dexamethasone and RU-38486 impair the 
healing of scratch wounded MDCK monolayers, thus suggesting that the GR has an 
important role in the modulation of epithelial cell wound healing. This supports 
previous studies which have reported an inhibition of epithelial wound healing in 
vivo following dexamethasone treatment (Petroutsos et al., 1982; Durmus et al., 
2003). Dexamethasone has been associated with increased cellular adhesion to the 
ECM and increased expression of α1 and β1 integrin subunits on the cell surface 
(Murakami et al., 1998). Since interactions with the ECM can influence the 
migratory properties of cells (Murakami et al., 1998), this could explain the 
impairment in wound healing observed following dexamethasone treatment. 
Dexamethasone also inhibits COX-2 activity and thus the production of PGE2 
(Bandyopadhyay et al., 1999). PGE2 is known to stimulate cell migration via 
activation of the PI3K/Akt pathway through EGF receptor transactivation (Buchanan 
et al., 2003). COX-2 derived PGE2 was previously shown to have an important role 
in MDCK wound healing (Section 4.3.1). 
 
Whilst exogenous glucocortioids have been reported to inhibit wound repair 
(Durmus et al., 2003), endogenous glucocorticoids appear to have a role in the 
regulation of wound repair via increased cell migration and proliferation and 
increased expression of certain growth factors and ECM proteins (Grose et al., 
2002). Due to current evidence highlighting the opposing effects of physiological 
and pharmacological glucocorticoid levels on wound repair, the effects of varying 
glucocorticoid concentrations on MDCK scratch wound healing were examined. 
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Wounded monolayers treated with 10% FBS appeared to re-epithelialise fairly 
quickly, with approximately 80% of the wound area being covered after 24 h, while 
wounds in serum-starved monolayers were only 70% covered after 24 h. FBS 
contains many components which may influence cell migration, including 
physiological levels of cortisol. Commercially available FBS contains mean cortisol 
levels of 0.5 µg/ml (Price & Gregory, 1982). Thus when diluted to 10% in media, 
our cultures contained approximately 0.05 µg/ml of cortisol and the normal canine 
basal cortisol plasma levels are in the range of 0.006-0.06 µg/ml (Vaden et al., 
2009). The results prsesented in this chapter also show that pharmacological (1 µM) 
and sub-physiological (<0.1 µM) doses of dexamethasone cause a significant 
inhibition of MDCK wound healing. Previous studies have shown that similar 
pharmacological concentrations of dexamethasone cause an inhibition of in vitro cell 
migration in a variety of cell types (Pross et al., 2002; Piette et al., 2009; Luo et al., 
2009) and wound healing in vivo (Durmus et al., 2003). Glucocorticoid deficiency 
has been shown to aggravate indomethacin-induced gastric lesions (Filaretova et al., 
2002), thus suggesting that physiological glucocorticoid levels are involved in 
gastroprotection.  
 
Given the association between glucocorticoid therapy and the development of gastric 
ulceration (Bandyopadhyay et al., 1999), the effects of glucocortioids on gastric 
epithelial cell spreading, an important process involved in the maintenance of gastric 
epithelial integrity, were determined. A study conducted by Takahashi and 
colleagues (2003) reported an inhibition of gastric epithelial restitution following 
dexamethasone treatment. Similarly, under conditions of glucocorticoid deficiency, 
gastric lesions induced through indomethacin treatment have been shown to be 
significantly worse (Filaretova et al., 2002), thus the effects of glucocorticoid 
deficiency in our model were also studied using the GR antagonist, RU-38486. 
Although there has been extensive work conducted to study the effects of 
glucocorticoids on cell migration and spreading, there has been little study of their 
effects in a multicellular model, such as that used in this investigation.  
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The results presented in this chapter show that both GR agonism by 1µM 
dexamethasone and GR antagonism by 1 µM RU-38486 had no effect on cell 
spreading or the protrusive activity of cells in canine gastric epithelial cell islands, 
when compared to the FBS control. The effects of a wide range of doses of both 
dexamethasone and RU-38486 were studied, to ensure that the response was not 
dose dependant, however no statistically significant effect was found at any 
concentration. These results are suprising given that dexamethasone has previously 
been shown to impair the migration of gastric epithelial cells alone (Luo et al., 2009) 
or in coculture with gastric fibroblasts (Takahashi et al., 2003). RU-38486, also 
known as mifepristone, has also previously been shown to inhibit gastric cancer cell 
migration in vitro (Li et al., 2004).  
 
The major difference between the previous studies and this investigation is the use of 
a multicellular model. The previous studies examining the effects of dexamethasone 
and GR on cell migration and spreading involve the use of dispersed cultures of 
gastric mucosal epithelial cells, discounting other cell types present in the gastric 
mucosa, such as parietal cells, chief cells and endocrine cells. As this study utilises 
intact gastric glands, the model should include a representative mixture of all cell 
types present in the gastric gland in vivo, therefore intercellular paracrine signalling 
between cells in this culture or direct cellular interactions could explain the lack of 
effects observed. Paracrine signalling has been investigated to some extent, via the 
use of a co-culture of gastric epithelial cells and gastric fibroblasts and 
dexamethasone was reported to inhibit gastric epithelial cell migration via the 
depletion of HGF mRNA expression and release by gastric fibroblasts (Takahashi et 
al., 2003). However, this study used RGM-1 cells, a cell line made up of a single cell 
type, thus intercellular signalling networks between different gastric epithelial cell 
lineages were not evaluated.  
 
Several mechanisms have been reported for the effects of dexamethasone on cell 
migration. Dexamethasone inhibits migration via GR-dependant inhibition of the 
ERK1/2/MAPK pathway (Piette et al., 2009) and suppresses the release of HGF 
(Takahashi et al., 2003) and MMP-2 (Pross et al., 2002). Additionally, 
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dexamethasone inhibits TNF-α stimulated COX-2 expression, PGE2 production and 
cell migration (Luo et al., 2009). These previous studies have all used cells that have 
either been serum-starved for 24 h prior to assay (Li et al., 2004; Luo et al., 2009) or 
cultured in serum-free medium during the assay (Li et al., 2004; Pross et al., 2002). 
HGF activation and secretion can be dose-dependantly stimulated in fibroblasts 
cultured with FBS at concentrations of 1% to 10% (Ohshima et al., 2002), similarly, 
FBS can activate ERK-1 and -2 (Lee et al., 2001). Dexamethasone also inhibits 
COX-2 expression, and thus PGE2 release (Takahashi et al., 2003) and as reported 
previously (Section 4.3.4.2), COX-2 derived PGE2 has a role in the modulation of 
cell migration in our model. ELISA analysis revealed that FBS contains relatively 
small amounts of PGE2.  
 
Furthermore, Yang and colleagues (2008) conducted a study looking at the effects of 
serum exposure and cell density on the localisation and function of the GR in 
primary human lung fibroblast cultures. Serum stimulation up-regulated GR mRNA 
and protein expression in both confluent and subconfluent cells. In subconfluent 
cells, the GR showed perinuclear localisation, whereas in confluent cells it was 
expressed both in the cytosol and nucleus and this was not caused by increased GR 
activation, as dexamethasone increased GR-GRE binding in both confluent and 
subconfluent cells. Confluent cells expressed 4.2 ± 1.6 times more basal GR protein 
than subconfluent cells. GR function was also affected by cell density, for instance, 
in subconfuent cells the GR binds to the transcription factor, C/EBP-α, leading to 
p21
(Waf1/Cip1)
 expression and suppressed proliferation, whereas in confluent cells, GR 
binds to C/EBP-β, inducing p27(Kip) expression. As the gastric epithelial cells used in 
our model are both serum-stimulated and in subconfluent cell islands, it is difficult to 
compare the effects observed with those seen in previous experiments using serum-
starved confluent monolayers. Taking these findings into account, serum stimulation 
could explain why no effect was observed. Ideally, all assays would be peformed on 
serum-starved cells in order to induce cell cycle synchronisation and to minimise 
analytical interference. However, given that treatments were applied immediately 
after the isolation of gastric glands, serum-free medium was not used because it was 
assumed to prevent gland spreading.  
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Another possible reason for the lack of glucocorticoid effect would be if the cells in 
this model do not express GR. However, GR is known to be expressed ubiquitously 
in the majority of tissues (Kalinyak et al., 1987). GR expression has previously been 
described in parietal cells (Kanemasa et al., 1999), chief cells and gastric endocrine 
cells (Tarasova et al., 1996). GR immunoreactivity in the nuclei of parietal cells was 
shown to diminsh in adrenolectomised rats (Kanemasa et al., 1999), thus suggesting 
that GR immunoreactivity is dependant on the presence of its ligand. Activation of 
GR regulates the expression of GR mRNA in a tissue-specific manner (Kalinyak et 
al., 1987), thus GR expression can vary greatly among cell types, which may 
influence cellular responses to glucocorticoids. Immunocytochemical analysis of GR 
expression in our cultured gastric epithelial cell islands was attempted, however the 
pattern of fluorescence observed was indistinct and non-specific (data not presented). 
In future studies it would be useful to to perform double immunofluorescence 
labelling in order to characterise cell type and GR expression. Primers were designed 
for the analysis of GR mRNA expression in this model, however due to time 
constraints RT-PCR analysis was not performed. Other methods considered for 
analysis of GR expression in this model include, in situ mRNA hybridisation and 
RNase protection analysis. In situ hybridisation and RNase protection analysis have 
been successfully used to study GR mRNA expression in rat tissue (Freeman et al., 
2004). The advantage of in situ hybridisation is that it enables anatomical 
localisation of the receptor. Additionally, characterisation of HGF and MMP 
secretion within our model would be useful in order to characterise the specific 
effects of dexamethasone on their regulation. HGF secretion by primary gastric 
fibroblasts has been characterised previously using a specific ELISA kit (Takahashi 
et al., 2003). MMP sercretion and activity can be effectively analysed using substrate 
zymography techniques. These methods were also not performed due to time 
constraints. 
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Chapter 6 - Characterising the expression of COX-2 and the prostaglandin 
receptors, EP3 and EP4 in epithelial cells 
 
6.1. Introduction 
 
The actions of COX-derived PGE2 are mediated by the G-protein-coupled EP 
receptors (Narumiya et al., 1999) and it has been demonstrated that EP3 and EP4 
have important roles in the promotion of both cell migration and wound healing. For 
cell migration, EP4 activation has been shown to promote endothelial cell migration 
via ERK activation (Rao et al., 2007), lung cancer cell migration via cellular Src 
tyrosine phosphorylation (Kim et al., 2010) and to regulate metastatic breast cancer 
cell migration via cAMP signalling (Timoshenko et al., 2003). Furthermore, 
activation of the EP3 receptor promotes the migration of human arterial smooth 
muscle cells and CHO cells, transfected to overexpress the EP3 receptor (Blindt et 
al., 2002). 
 
For wound healing, PGE2/EP receptor-mediated signalling has been shown to have 
an important role in the modulation of scratch wound healing, thus, COX-2 derived 
PGE2 stimulates ISMF wound healing via EP2, EP3 and EP4 receptor activation 
(Iwanaga et al., 2012). PGE2/EP4 signalling indirectly stimulates ISMF migration by 
inducing growth factor secretion, while EP3 activation may have a direct effect 
(Iwanaga et al., 2012). However the mechanism underlying these effects is unclear. 
 
EP receptor activation also modulates gastrointestinal mucosal integrity. PGE2 
promotes the healing of gastric ulcers via EP4 receptor activation, leading to up-
regulation of VEGF expression (Hatazawa et al., 2007). Treatment with an EP4 
selective agonist alleviates NSAID-induced damage and promotes mucous epithelial 
regeneration (Jiang et al., 2009). The EP4 agonist also accelerates gastric ulcer 
healing in the absence of NSAID, suggesting EP4 agonism may promote the healing 
of both existing and NSAID-aggravated ulceration (Jiang et al., 2009). 
 
Chapter 6 
 
 111 
An important role for COX-2 derived PGE2 in epithelial cell spreading and scratch 
wound healing was described previously (Chapter 4). In view of this it was 
considered important to study the expression of EP3, EP4 and COX-2 within 
epithelial cells. Thus, the aim of this study was to test the hypothesis that COX-2, 
EP3 and EP4 are expressed within the normal canine gastric epithelium and in 
cultured epithelial cells and that their expression is readily induced in response to 
acute stressors.  
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6.2. Materials and methods 
 
6.2.1.PCR 
 
6.2.1.1. RNA isolation 
 
To identify the presence of specific mRNA transcripts, RNA was isolated from 
cultured epithelial islands and MDCK cells as previously described (Section 2.8.1) 
 
6.2.1.2. Reverse transcription 
 
RNA was transcribed into cDNA as previously described (Section 2.8.2). 
 
6.2.1.3. PCR 
 
Reverse transcription PCR, as described previously (Section 2.8.3) was used to 
determine gene expression in cDNA samples. Samples were run on a 1.5% agarose 
gel. 
 
6.2.1.4. Sequencing of PCR products 
 
Where possible, PCR products were sequenced commercially by Eurofins MWG 
Operon (Eurofins MWG Operon, Ebersberg, Germany), using the same primers that 
were used for the PCR amplification. A QIAquick® PCR purification kit (Qiagen) 
was used to purify the amplified products prior to sequencing. 
 
6.2.2.Western blotting 
 
6.2.2.1. Protein extraction 
 
Protein was extracted from cultured cells and mucosal tissue (Section 2.8.7.1) and 
protein concentration was determined using a BCA protein assay kit, as described 
previously (Section 2.8.7.2). 
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6.2.2.2. Western blots 
 
Western blotting was carried out as described previously (see section 2.8.7.3). The 
primary antibodies used were anti-EP3 goat polyclonal antibody at 1:200, anti-EP4 
goat polyclonal antibody at 1:200 and anti-COX-2 goat polyclonal antibody at 1:200. 
The secondary antibody was a rabbit polyclonal anti-goat IgG (HRP-conjugated) 
used at 1:10,000. Blots were stripped and re-probed as previously described (Section 
2.8.7.4) using an anti-beta actin goat polyclonal antibody at 1:1000 and a rabbit 
polyclonal anti-goat IgG (HRP-conjugated) at 1:10,000. 
 
6.2.3.Dot blots 
 
Dot blots were performed in order to compare expression in larger sample numbers, 
using the same antibodies and dilutions used for the Western blot assays, as 
described previously (see section 2.8.7.6).  
 
6.2.4.Immunohistochemistry 
Immunohistochemistry techniques were performed by Veterinary Pathology, 
University of Liverpool as described previously (Section 2.9.1). The primary 
antibodies used were anti-EP4 goat polyclonal antibody at 1:50 and anti-COX-2 goat 
polyclonal antibody at 1:400. The secondary antibody was a biotinylated horse anti-
goat IgG, used at 1:100 in both cases. 
 
6.2.5.Immunocytochemistry 
 
Immunocytochemistry techniques were used to localise protein expression in 
cultured epithelial cell islands, using the primary antibodies described previously at 
1:250. The secondary antibody used was a FITC-conjugated donkey anti-goat IgG 
used at 1:200. The methods for this procedure are described in detail in chapter 2 
(Section 2.9.2).  
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6.3. Results 
 
6.3.1.COX-2 mRNA expression in primary canine gastric epithelial cells 
 
RT-PCR was used to confirm the expression of COX-2 in cultured gastric epithelial 
cells isolated from biopsy-derived mucosal tissue. The resulting PCR product was of 
the predicted size (Figure 6.1). Attempts to sequence this product were unsuccessful. 
 
6.3.2.COX-2 protein expression in primary canine gastric epithelial cells, and 
the cell lines MKN-45 and MDCK 
 
COX-2 expression in cultured gastric epithelial cells from both cadaver and biopsy 
samples was determined by Western blot analysis. COX-2 protein was detected at 
very low levels in only one of the three cadaver–derived cell samples and no COX-2 
expression was detected in three biopsy-derived cell samples (Figure 6.2). 
Furthermore, the COX-2 protein was detected in MKN-45 cells but not in MDCK 
cells (Figure 6.2). 
 
To determine the effects of serum-starvation on COX-2 protein expression, MDCK 
and gastric epithelial cells were grown in serum-free conditions for 12 h prior to 
protein extraction. COX-2 protein expression was induced via serum-starvation in all 
cell types (Figure 6.3).  
 
6.3.3.COX-2 protein expression in tissue from multiple individuals 
 
COX-2 protein expression in whole gastric mucosal tissue samples was determined 
using dot blot analysis. Tissue samples used for this assay were stored at -80ºC 
immediately after collection. The results of the dot blot analysis reveal varying 
COX-2 protein expression between individual samples (Figure 6.4 and Figure 6.6), 
however, densitometry revealed no statistically significant difference between the 
mean COX-2 protein expression levels, corrected for beta actin, in biopsy- and 
cadaver-derived tissue samples (Figure 6.5) 
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Figure 6.1- RT-PCR analysis of COX-2 mRNA expression in cultured gastric epithelial cells. 
Lane 1: Track It™ 100bp ladder, Lane 2: cDNA from gastric epithelial cells isolated from biopsy-
derived canine mucosal tissue. The predicted size of the PCR product was 552 bp. 
 
 
 
 
 
 
 
Figure 6.2- Western blot analysis of COX-2 protein expression in MKN-45 (lane 1) and MDCK 
(lane 2) cells, biopsy-derived cells from three individuals (lanes 3-5) and cadaver-derived cells 
from three individuals (6-8), all cultured in serum-containing (10% FBS) medium (upper 
panel). Beta actin was used as a loading control (lower panel).  
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Figure 6.3- Western blot analysis of COX-2 protein expression in cells grown in serum-
containing (10% FBS) medium (lanes 1-3) and serum-starved cells (lanes 4-6). Serum starvation 
leads to increased expression of COX-2 in MDCK, biopsy- and cadaver-derived cells (upper panel); 
beta actin expression (lower panel) is unaffected.  
 
 
 
 
 
 
Figure 6.4- Dot blot analysis of COX-2 protein expression in biopsy- and cadaver-derived 
gastric mucosal tissue (left panel). Beta actin was used as a loading control (right panel). 
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Figure 6.5- Dot blot densitometry quantifying COX-2 protein expression in biopsy- and 
cadaver-derived gastric mucosal tissue. Values normalised to corresponding beta actin signal. 
 
 
 
Figure 6.6- Dot blot densitometry quantifying COX-2 protein expression in individual biopsy- 
and cadaver-derived gastric mucosal tissue samples. Values normalised to corresponding beta 
actin signal. 
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6.3.4.Localisation of COX-2 expression in normal canine gastric mucosa 
 
Immunohistochemistry analysis of canine gastric mucosa, revealed COX-2 
immunoreactivity in the gastric glands (Figure 6.7). Cells were stained with 
haematoxylin and eosin and were identified based on their morphology. Strong 
COX-2 staining was observed for chief cells and weak staining for parietal cells 
(Figure 6.7). 
 
Furthermore, immunocytochemistry was used to localise COX-2 expression in 
cultured gastric epithelial cell islands. Approximately 90% of cells within the 
epithelial islands were shown to strongly express COX-2. In cells that did express 
COX-2, a granular cytoplasmic staining pattern was apparent, with perinuclear 
localisation (Figure 6.8). Some cells showed no or very weak COX-2 expression, 
based on their morphology, these appear to be parietal cells (Figure 6.8).
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Figure 6.7- Immunohistochemical localisation of COX-2 in the canine gastric mucosa. Black arrows indicate weakly stained parietal cells and white 
arrows indicate strongly stained chief cells. Scale bar: 20µm 
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Figure 6.8- Immunocytochemical staining of COX-2 in a cultured canine gastric epithelial cell island; a.) bright field image, b.) fluorescence image, c.) 
fluorescence image superimposed onto bright field image. Arrow indicates a non-expressing cell. Magnification of 40X; scale bar 10µm 
 
 
a. b. c. 
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6.3.5.EP3 and EP4 receptor mRNA expression in primary canine gastric 
epithelial and MDCK cells  
 
Expression of EP3 and EP4 mRNA in MDCK and biopsy-derived canine gastric 
epithelial cells was determined using RT-PCR. EP3 and EP4 mRNA was expressed 
in both cell types (Figure 6.9). The housekeeping gene, GAPDH was used as an 
internal positive control. The PCR products were purified and sent away for 
sequencing to confirm their identity. The sequencing results showed that both PCR 
products had 99% homology with the published EP3 and EP4 cDNA sequences (data 
not presented). 
 
Analysis of EP1 and EP2 mRNA expression was attempted in both cultured gastric 
epithelial cells and MDCK cells, however no detectable bands were obtained. 
 
6.3.6.EP3 and EP4 protein expression in primary canine gastric epithelial 
cells, and the cell lines MKN-45 and MDCK  
 
EP3 and EP4 protein expression in canine gastric epithelial, MDCK and MKN-45 
cells was determined using Western blot analysis. An initial experiment, using cells 
grown in serum-containing medium, identified high levels of EP3 expression in 
MKN-45 cells and cadaver–derived gastric epithelial cells. In contrast, relatively low 
expression was detected in biopsy-derived gastric epithelial cells and no expression 
was detected for MDCK cells (Figure 6.10). EP4 protein expression was detected 
only in cadaver-derived gastric epithelial cells (Figure 6.10). The observed bands of 
approximately 62 kDa and 53 kDa correspond with the predicted size. A 42 kDa 
band was identified using a beta actin antibody and confirmed even loading. 
 
In order to simulate an acute stress response in vitro, cells were serum-starved for 12 
h prior to protein extraction, EP3 and EP4 expression was then analysed and 
compared to expression in cells maintained in serum-containing medium. Serum-
starvation induced EP3 and EP4 expression in all cell types (Figure 6.11). In cells 
maintained in serum-containing medium, no EP3 expression was detected and EP4 
was only expressed in cadaver-derived gastric epithelial cells (Figure 6.11). 
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Contrastingly, cadaver-derived gastric epithelial cells were previously shown to 
express EP3 protein when grown in serum-containing medium (Figure 6.10).  
 
Expression of EP3 and EP4 was compared in cultured cells from cadavers and 
biopsies (n=4 for each). Expression was corrected for loading variation by 
normalising to beta actin expression. Cadaver-derived cells had a significantly higher 
expression of EP3 and EP4 (Figure 6.12 and Figure 6.13). There was also some 
variation in protein expression between individual samples obtained from the same 
source (Figure 6.14).  
 
6.3.7.EP3 and EP4 protein expression in tissue from multiple individuals 
 
Inter- and intra-group variations in EP3 and EP4 protein expression between the 
biopsy- and cadaver-derived groups were studied further, via dot blot experiments 
using tissue samples that were stored at -80ºC immediately after collection. Dot blot 
analysis confirmed a statistically significant increase in EP3 expression in cadaver-
derived tissue (Figure 6.15 and Figure 6.16), compared with biopsy tissue. A slight 
increase in EP4 protein expression was observed for cadaver-derived tissue; however 
this difference was not statistically significant (Figure 6.15 and Figure 6.16). 
Notably, variation in both EP3 and EP4 protein expression between individual 
samples was observed (Figure 6.17). 
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Figure 6.9- RT-PCR analysis of EP3 (lanes 4-5) and EP4 (lanes 6-7) mRNA expression in 
cultured gastric epithelial and MDCK cells. Lane 1: Track It™ 100bp ladder, Lanes 2, 4 & 6: 
cDNA from MDCK cells, Lanes 3, 5 and 7: cDNA from gastric epithelial cells isolated from biopsy-
derived mucosal tissue. GAPDH was used as a positive control and the product sizes are indicated 
below the corresponding lanes. 
 
 
 
 
 
Figure 6.10- Western blot analysis of EP3 and EP4 protein expression in MDCK (lanes 1-2) and 
MKN-45 (lanes 3-4) cells, biopsy-derived cells from two individuals (lanes 5-6) and cadaver-
derived cells from two individuals (lanes 7-8), all cultured in serum-containing (10% FBS) 
medium (upper panels). Beta actin was used as a loading control (lower panels). 
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Figure 6.11- Western blot analysis of EP3 and EP4 protein expression in cells grown in serum-
containing (10% FBS) medium (lanes 1-3) and serum-starved cells (lanes 4-6). Serum starvation 
leads to increased expression of EP3 and EP4 in MDCK, biopsy- and cadaver-derived cells (upper 
panels); beta actin expression (lower panels) is unaffected.  
 
 
 
 
 
Figure 6.12- Western blot analysis of EP3 and EP4 protein expression in biopsy- (lanes 2-5) and 
cadaver-derived (lanes 6-9) gastric epithelial cells cultured in serum-containing (10% FBS) 
medium (upper panels). Cells isolated from four individuals were analysed for each group. MKN-45 
cells were used as a positive control (lane 1). Beta actin was used as a loading control (lower panels). 
Expression of both EP3 and EP4 was significantly higher in cadaver-derived gastric epithelial cells. 
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Figure 6.13- Western blot band densitometry quantifying EP3 and EP4 protein expression in 
gastric epithelial cells isolated from biopsy- and cadaver-derived tissue. Values, corrected for 
loading using beta actin and analysed using a paired t-test, show increased EP3 and EP4 expression in 
cadaver-derived cells compared to biopsy-derived cells (*= P < 0.05). MKN-45 cells were used as a 
positive control. 
 
 
Figure 6.14- Western blot band densitometry quantifying EP3 and EP4 protein expression in 
cultured gastric epithelial cells isolated from biopsy- or cadaver-derived tissue. Values 
normalised to corresponding beta actin signal. 
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Figure 6.15- Dot blot analysis of EP3 (upper left panel) and EP4 (lower left panel) protein 
expression in cadaver and biopsy-derived gastric mucosal tissue. Beta actin was used as a loading 
control (right panels). 
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Figure 6.16- Dot blot densitometry quantifying EP3 and EP4 protein expression in biopsy- and 
cadaver-derived gastric mucosal tissue. Values, corrected for loading using beta actin and analysed 
using a paired t-test, show increased EP3 expression in cadaver-derived tissue compared to biopsy-
derived tissue (*= P < 0.001).  
 
 
 
Figure 6.17- Dot blot densitometry quantifying EP3 and EP4 protein expression in individual 
biopsy- and cadaver-derived gastric mucosal tissue samples. Values normalised to corresponding 
beta actin signal. 
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6.3.8.Localisation of EP4 receptor expression in normal canine gastric 
mucosa 
 
Immunohistochemical localisation of EP4 in cadaver-derived gastric mucosal tissue 
showed faint positive staining of the parietal cells (Figure 6.18). 
Immunocytochemistry analysis of cadaver-derived gastric epithelial islands revealed 
EP4 expression in a single cell. The cell expressing EP4 showed predominately 
cytoplasmic staining (Figure 6.19). 
 
Immunocytochemical analysis of EP3 expression in cultured gastric epithelial 
islands was unsuccessful, only non-specific, diffuse cytoplasmic staining was 
observed in these experiments (data not presented). 
 
 
Chapter 6 
 
 
129 
 
 
      
Figure 6.18- Immunohistochemical staining of EP4 in the canine gastric mucosa showing faint positive staining of the parietal cells. Scale bar: 20µm 
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Figure 6.19- Immunocytochemical staining of EP4 in a cultured canine gastric epithelial cell island; a.) bright field image, b.) fluorescence image, c.) 
fluorescence image superimposed onto bright field image. Arrow indicates an expressing cell. Magnification of 40X; scale bar 10µm
a. b. c. 
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6.4. Discussion 
 
The data presented in this chapter provides evidence for the expression of COX-2 
and the prostaglandin receptors, EP3 and EP4 within primary cultured gastric 
epithelial cell islands and two immortalised epithelial cell lines, commonly used to 
study cell migration. COX-2 mRNA was shown to be expressed in cultured gastric 
epithelial cells isolated from biopsy-derived tissue. Although the resulting PCR 
product could not be sequenced, a single band of the appropriate size was produced. 
COX-2 expression in normal human and rabbit gastric mucosa has been reported 
previously (Zimmermann et al., 1998). However, using Western blot techniques, 
COX-2 protein expression was undetectable in gastric epithelial cells cultured in 
serum-containing medium. This discrepancy between mRNA and protein expression 
could be attributed to various factors. The PCR procedure could be amplifying 
genomic DNA instead of cDNA; however this is unlikely as specific steps to 
eliminate genomic DNA are incorporated into the RNA extraction protocol. 
Additionally, protein degradation during the Western blot procedure can be ruled out 
as bands of the expected sizes were obtained for the loading control. The 
discrepancies between mRNA and protein expression could indicate decreased 
protein translation. COX-2 expression is regulated at the transcriptional and post-
transcriptional levels (Tanabe & Tohnai, 2002). Post-transcriptional regulation of 
COX-2 is mediated through the AU-rich element (ARE) within the COX-2 mRNA 
3'-untranslated region (3'UTR) (Dixon et al., 2003). The protein, TIA-1 binds to the 
ARE-containing 3'UTR of COX-2 mRNA and acts as a translational silencer (Dixon 
et al., 2003). Thus, although COX-2 gene transcription is apparent, the resulting 
mRNA may not be translated into protein or translation may be highly regulated. 
 
Acute stress through serum starvation induced COX-2 protein expression in both 
gastric epithelial and MDCK cells. As the protein was detected in serum-starved 
cells, problems with antibody specificity can be ruled out. This data suggests that 
serum-starvation causes substantial changes in the regulation of COX-2 protein 
expression. This result is not surprising, given that COX-2 is known to be highly 
inducible by a variety of stimuli (Chandrasekharan & Simmons, 2004). The MKN-
45 cell line was found to express COX-2 protein even when cultured in serum-
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containing medium. This finding is supported by a previous study, which describes 
over-expression of COX-2 mRNA in MKN-45 cells cultured in serum-containing 
medium (Tsuji et al., 1996). MKN-45 cells are derived from human gastric 
carcinomas and COX-2 is known to be up-regulated during carcinogenesis (Cao & 
Prescott, 2002), thus this could account for the observed differences in expression.  
Furthermore, dot blot analysis revealed variation in COX-2 protein expression 
between individual protein samples extracted from mucosal tissue. There was no 
statistically significant difference in expression between protein samples extracted 
from biopsy- and cadaver- derived tissue. 
 
Immunohistochemical localisation of COX-2 in the canine gastric mucosa 
demonstrated specific staining, with strong immunoreactivity detected in chief cells 
and weak immunoreactivity in parietal cells. Immunocytochemistry revealed strong 
COX-2 immunostaining in approximately 90% of cells in a cultured gastric epithelial 
island. Cells expressing COX-2 showed a perinuclear and granular cytoplasmic 
staining pattern. This evidence supports previous findings that COX-2 functions 
primarily within the nuclear envelope (Morita et al., 1995). Based on their 
morphology, the cells showing no COX-2 immunoreactivity appear to be parietal 
cells, thus conflicting with the immunohistochemistry findings. Given that the tissue 
samples used in these experiments were obtained from two different cadaver sources, 
their clinical characteristics will vary and this may influence protein expression.  An 
example of this is the influence of Helicobacter infection on COX-2 expression. H. 
pylori is associated with marked COX-2 expression in the parietal cells, which is 
reduced following successful eradication (McCarthy et al., 1999). Thus, the 
differences in COX-2 expression observed could be explained by the presence of 
Helicobacter infection in the tissue sample used for immunohistochemical analysis. 
 
As the prostaglandin receptors, EP3 and EP4 are known to be important for the 
modulation of cell migration (Blindt et al., 2002; Rao et al., 2007) and scratch 
wound healing (Iwanaga et al., 2012), their expression and localisation in epithelial 
cells was also characterised. Prior studies have reported EP3 and EP4 mRNA 
expression in the gastric mucosa (Ding et al., 1997), the kidney (Breyer & Breyer, 
2000) and more specifically in cultured rabbit gastric epithelial cells (Takahashi et 
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al., 1999). EP3 and EP4 mRNA was detected in both MDCK and biopsy-derived 
gastric epithelial cells and the identity of the resulting PCR products was confirmed 
through sequencing. For the purpose of this study, gastric epithelial cells were 
isolated from tissue collected from the body of the canine stomach; both EP3 and 
EP4 mRNA have previously been found in the body of the rat stomach (Ding et al., 
1997). EP3 mRNA was found to be more abundant in the body of the stomach than 
in the antrum, whereas EP4 mRNA was more abundant in the antrum. Analysis of 
EP1 and EP2 mRNA expression was attempted; however, no detectable bands were 
obtained. A previous study reported that EP1 and EP2 mRNA was not expressed in 
cultured rabbit gastric epithelial cells (Takahashi et al., 1999).  
 
Western blot analysis revealed EP3 and EP4 protein expression in cadaver-derived 
gastric epithelial cells, maintained in serum-containing medium. Biopsy-derived 
gastric epithelial cells expressed low levels of EP3 protein and no EP4 protein. 
Whilst EP3 expression was detected in both biopsy- and cadaver-derived cells grown 
in serum-containing medium (Figure 6.10 and Figure 6.12), an additional experiment 
showed no expression (Figure 6.11). The cells assayed in these two experiments 
were derived from different individuals; thus the differences could be a result of 
varying expression between individuals or variation in the cell isolation protocol. 
However, based on sample size (n=2 and n=4 vs. n=1), it seems reasonable to deduce 
that EP3 is expressed in the majority of cultured gastric epithelial cells.  EP3 protein 
was found to be expressed in MKN-cells maintained in serum-containing medium, 
thus these cells were used as a positive control in subsequent experiments. Notably 
MDCK cells maintained in serum-containing medium, showed no expression of EP3 
protein, however given that beta actin expression was not detected, degradation of 
protein or insufficient loading of MDCK protein cannot be ruled out. EP4 was not 
detected in MDCK, MKN-45 or biopsy-derived gastric epithelial cells grown in 
serum-containing medium. 
 
Prior to sample collection, cadaver tissue is exposed to a number of stressors, 
including ischemia and hypoxia. Stressors such as these have been associated with 
changes in EP receptor expression. Stress-induced ischemia causes changes in the 
dimer/monomer ratio of all the EP receptors, and changes in the immunoreactivity of 
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the EP3 receptor (Osborne et al., 2009). Additionally, expression of PTGER4, the 
gene coding for the EP4 receptor is known to be induced in response to hypoxia, 
independently of the COX/PG system (Catalano et al., 2011). PTGER4 signalling 
and hypoxia, in combination, were shown to promote cellular proliferation (Catalano 
et al., 2011). Thus, it is not surprising that EP3 and EP4 expression is induced in 
cadaver-derived cells. Similarly, acute stress via serum-starvation induced both EP3 
and EP4 expression in MDCK and gastric epithelial cells isolated from biopsy and 
cadaver tissue. Analysis of protein expression in gastric mucosal tissue, revealed a 
significant increase in EP3 expression in cadaver-derived tissue, compared with 
biopsy-derived tissue, however, there was no significant increase in EP4 expression. 
This difference may be associated with the additional components, such as muscle 
and connective tissue and microvascular networks, that will be present in gastric 
mucosal tissue samples. 
 
EP4 expression was localised to parietal cells in the normal gastric mucosa. Tissue 
sections used for immunohistochemistry were obtained from cadaver sources, thus 
supporting the previous finding that EP4 is expressed in cadaver-derived gastric 
epithelial cells. In addition, immunocytochemistry analysis of cadaver-derived 
cultured gastric epithelial islands, revealed cytoplasmic EP4 staining in a single cell. 
Additional staining was observed, however, this appeared to represent non-specific 
cellular staining. Modest EP4 staining of epithelial cells lining the gastric pit has 
been demonstrated in a previous study (Takafuji et al., 2002). More specifically, 
parietal cells in the rat gastric mucosa have been shown to express EP4 (Ding et al., 
1997). 
 
The findings presented here provide evidence that COX-2 and the prostaglandin 
receptors, EP3 and EP4 are inducible in primary and immortalised cell types in 
response to acute stress, such as serum-starvation. In addition, gastric epithelial cells 
isolated from cadaver-derived mucosal tissue samples show increased expression of 
the EP3 and EP4 protein. Variation between individual samples suggests that clinical 
factors may influence EP receptor protein expression.  
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Chapter 7 - The role of individual EP receptors in epithelial cell migration and 
spreading 
 
7.1 Introduction 
 
The PGE2 receptors, EP1-4 are G-protein-coupled receptors that exert their effects 
via different intracellular signal transduction pathways. Activation of the EP1 
receptor induces an increase in intracellular Ca
2+
 and a modest increase in IP3 
production (Watabe et al., 1993), EP2 and EP4 induce an increase in intracellular 
cAMP formation (Regan, 2003), and EP3 primarily signals through the inhibition of 
adenylate cyclase, leading to decreased cAMP formation (Naruyima et al., 1999). 
Furthermore, EP2 and EP4 can activate Tcf/Lef signalling, part of the Wnt signalling 
pathway, through PKA and PI3K dependant pathways respectively (Fujino et al., 
2002). The different splice variants of EP3 have been shown to couple to different G 
proteins and activate different signalling pathways (Namba et al., 1993). 
 
While EP receptor signalling is reported to have an important role in cell migration, 
the role of individual EP receptor isoforms is unclear. Activation of the EP4 receptor 
appears to promote migration in various cell types (Rao et al., 2007; Kim et al., 
2010), thus EP4 antagonism has been highlighted as a potential target for cancer 
treatment. EP4 antagonism has been associated with a marked decrease in tumour 
growth and metastasis via stimulation of VEGF-C and lymphangiogenesis in situ 
(Xin et al., 2012) and inhibition of breast cancer metastasis in vitro (Ma et al., 2006). 
Furthermore, signalling via the EP2, EP3 and EP4 receptors stimulates wound 
closure in an ISMF cell monolayer (Iwanaga et al., 2012) and EP4 agonism was 
shown to prevent indomethacin-induced gastric lesions and to promote the healing of 
existing ulcers by inducing proliferation (Jiang et al., 2009). 
 
Although EP3 and EP4 signalling is known to have an important role in cell 
migration and spreading, the importance of this with regards to canine gastric 
epithelial cell migration and spreading has not been investigated. Thus the aim of 
this investigation was to test the hypothesis that EP3 and EP4 receptor signalling has 
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a critical role in the modulation of epithelial cell migration and spreading. In order to 
test this hypothesis, the effects of sub-type specific EP receptor agonists and an EP4 
antagonist were assessed. 
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7.2. Materials and methods 
 
7.2.1.Cell line scratch wound assays 
 
7.2.1.1. Cell culture 
 
MDCK, MKN-45 and AGS cells were cultured as described previously (Section 
2.5.2).  
 
7.2.1.2. Scratch wound assay 
 
Scratch wounds were performed as described previously (Section 2.7). Cells were 
serum starved for 12 h prior to scratch wounding, then treated with either 50 µM 
indomethacin, 1 µM PGE2, 10 µM 17-phenyl-trinor-prostaglandin E2 (EP1 agonist), 
10 µM Butaprost (EP2 agonist), 10 µM Sulprostone (EP3 agonist), 10 µM ONO-
AE1-329 (EP4 agonist) or 5 µM AH-23848 (an EP4 antagonist) for 24 h at 37°C in a 
5% CO2 incubator. All treatments were made up in serum-free medium. Control 
wells contained the vehicle only (all dissolved in DMSO) and the observer was 
blinded to the treatment used in individual wells. 
 
7.2.1.3. Statistics 
 
A total of six individual experiments were performed, with two separate areas 
analysed for each scratch wound. The data was presented as the mean difference in 
scratch wound width, with values normalised to the mean control value within each 
experiment. Statistical analysis was performed with SPSS 20 (IBM Corp.), using 
one-way analysis of variance. The criteria for statistical significance was set at 
P<0.05. 
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7.2.2.Primary cell island spreading experiments 
 
7.2.2.1. Sample collection 
 
Samples were collected as described previously (Section 2.4). All gastric mucosal 
tissue samples used in this study were obtained from canine cadavers. 
 
7.2.2.2. Gastric gland isolation 
 
Intact gastric glands were isolated from mucosal tissue samples as described 
previously (Section 2.4). 
 
7.2.2.3. Gastric gland culture 
 
Isolated glands were cultured in serum-supplemented medium (10% FBS) 
immediately after isolation, for 48 h at 37°C in a 5% CO2 incubator. The cells were 
then cultured in serum-free conditions for 24 h prior to treatment. After 24 h, the 
treatments described previously (Section 7.2.1.2) (made up in serum-free medium) 
were added and the spread cell islands were cultured for a further 24 h. The observer 
was blinded to the treatment used in individual wells. 
 
7.2.2.4. Analysis of epithelial cell island spreading 
 
Cell spreading in individual cell islands was analysed as previously described 
(Section 2.6.3). 
 
7.2.2.5. Statistics 
 
A total of six individual experiments, using samples from six canine cadavers were 
performed. In each individual experiment, measurements were taken from 10 islands 
for each treatment. There was an inevitable clustering within the observations 
because each biopsy sample was used in testing the effect of each treatment. The 
analysis acknowledged this by using a mixed-effects linear regression with the 
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biopsy identity declared as a random effect. The measurements for both total area 
and fringe area were corrected for by cell number and subjected to a logarithmic 
transformation. Significant differences were indicated by P<0.05 for all data. 
Statistical analysis was performed using Stata Statistical Software: Release 11 
(StataCorp. 2009) and the xtmixed command.  
 
7.2.3.Sirius red staining 
 
Isolated gastric glands were cultured in serum-supplemented (10% FBS) medium for 
48 h, until fully spread into monolayer cell islands. Cell islands were fixed with 4% 
paraformaldehyde and Sirius red staining was carried out by Veterinary Pathology, 
University of Liverpool. 
 
7.2.4.siRNA transfection 
 
MDCK cells were transfected with EP3, EP4 or scrambled siRNA, as previously 
described (Section 2.8.6), and transfection success was confirmed by Western 
blotting. 
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7.3. Results 
 
7.3.1.Effect of EP receptor agonists and an EP4 antagonist on epithelial cell 
scratch wound healing 
 
To investigate which EP receptor subtypes are involved in epithelial cell scratch 
wound healing, the effects of sub-type specific agonists and the EP4 antagonist were 
assessed (Figure 7.1). To induce EP receptor expression, cells were serum-starved 
for 12 h prior to treatment. Indomethacin caused a statistically significant decrease in 
wound healing in all cell lines, as reported previously (Section 4.3.1). PGE2 and the 
EP3 receptor agonist, sulprostone, significantly increased wound healing in MDCK 
cells. Furthermore,  the EP4 agonist, ONO-AE1-329, significantly impaired wound 
healing in MDCK and AGS cells, while AH-23848 (an EP4 antagonist) produced a 
significant increase in wound healing in all cell lines.  
 
 
Figure 7.1- Effects of indomethacin, PGE2, EP 1-4 agonists and an EP4 antagonist on the 
healing of scratch wounds in serum-starved MDCK, AGS and MKN-45 cell monolayers. Data 
(presented as mean +/- SEM) were normalised to control and analysed using one-way analysis of 
variance (p<0.05, indicated by *, p<0.001, indicated by **). 
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7.3.2.Effect of EP receptor agonists and an EP4 antagonist on gastric 
epithelial cell island spreading 
 
The involvement of EP receptor subtypes in gastric epithelial cell island spreading 
was also assessed using specific EP receptor agonists and an EP4 receptor 
antagonist. Gastric epithelial cell islands were serum-starved for 12 h prior to 
agonist/antagonist administration. PGE2 and ONO-AE1-329 (EP4 agonist) both 
decreased protrusive activity (fringe area per cell), while AH-23848 (EP4 antagonist) 
enhanced protrusive activity (Figure 7.2). 
 
 
Figure 7.2- Effects of indomethacin, PGE2, EP 1-4 agonists and an EP4 antagonist on gastric 
epithelial cell island spreading. Data (presented as mean +/- SEM) were normalised to control and 
analysed by mixed-effects linear regression (p<0.05, indicated by *, p<0.001, indicated by **). 
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statistically significant effect on the total spread area of the cell islands. On closer 
analysis of the data, it was found that the effects of the EP4 antagonist AH-23848 on 
total spread area were very variable between samples (Figure 7.3). In 2 of the 6 
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found to be significantly smaller, thus the data violates the assumption of equal 
variance between groups. In contrast, these major variations did not occur when 
analysing fringe area (Figure 7.4). 
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Figure 7.3- Box plot summary of the variation that exists between treatment effects on total 
spread area per cell; numbers 1-6 represents biopsy number, * indicates outliers. Cell islands 
derived from biopsies 1 and 5 had a mean cell count of 26, while those from biopsies 2, 3, 4 and 6 had 
a mean cell count of 49, p<0.001 using one-way analysis of variance . 
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Figure 7.4- Box plot summary showing much less variation between treatment effects on fringe 
area per cell; numbers 1-6 represents biopsy number, * indicates outliers. 
 
7.3.3.Sirius red staining of mucus-secreting cells 
 
Mucus-secreting cells, identified by Sirius red staining, were primarily located 
towards the periphery of gastric epithelial cell islands (Figure 7.5). 
 
7.3.4.EP3 and EP4 silenced by siRNA transfection  
 
Given the previous findings, EP3 and EP4 specific siRNAs were designed in order to 
determine whether siRNA transfection could down regulate EP3 and EP4 protein 
expression. As shown in Figure 7.6, expression of both EP3 and EP4 in cultured 
MDCK cells was completely abolished 48 h after transfection with the 
corresponding siRNA. No off-target effect was seen in either beta-actin or the non-
targeted EP receptor for each experiment. Transfection with a scrambled siRNA as a 
negative control showed no effect on protein expression. 
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Figure 7.5- Sirius red staining (red) of mucus-secreting cells in a cultured gastric epithelial cell 
island. Arrows highlight examples of stained cells. Images taken at magnification of 20X; scale bar: 
10µm 
 
 
 
 
Figure 7.6- Western blot analysis of MDCK cells transfected with EP3 and EP4 siRNA (upper 
panels). Beta actin was used as a loading control (lower panels). Control cells were not transfected 
and all samples were run in duplicate, the band sizes are indicated at the side of the image. 
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7.4. Discussion 
The data presented in this chapter provides evidence that PGE2 signalling via the 
EP3 and EP4 receptors modulates epithelial cell migration and spreading. 
Furthermore, EP3 and EP4 signalling elicits specific functional responses in scratch-
wounded epithelial monolayers and spreading epithelial cell islands. 
 
As reported in chapter 6 of this thesis, EP3 and EP4 protein expression is induced by 
serum starvation (Section 6.3.6), thus cultured MDCK, MKN-45 and AGS cell lines 
were serum starved for 12 h prior to scratch wounding. The treatment responses 
observed were variable between the different cell lines, however, the observation 
that indomethacin significantly decreases wound healing in all cell types is 
consistent with our previous finding that COX-derived PGE2 plays an important role 
in epithelial cell wound healing (Section 4.3.1). MDCK wound healing was 
increased by PGE2 and the EP3 agonist, sulprostone, while the EP4 agonist, ONO-
AE1-329, inhibited wound healing in both MDCK and AGS cells. The selective EP4 
antagonist, AH-23848, was shown to promote wound healing in all cell types. 
Although individual cells presumably express both receptor types, these findings 
suggest that the effects of PGE2 on MDCK cell migration in this model are 
principally mediated by EP3 receptor activation. This is consistent with previous 
findings that EP3 receptor stimulation promotes cell migration (Blindt et al., 2002; 
Li et al., 2011).  
 
PGE2 and sulprostone were found to have no significant effect on the healing of 
scratch-wounded AGS and MKN-45 cell monolayers. While EP3 expression was 
previously detected in cultured MKN-45 cells (Section 6.3.6), its expression in AGS 
cells was not determined. Thus AGS cells may not express EP3, which could explain 
the absence of an effect. Furthermore, AGS and MKN-45 cells are gastric cancer 
derived cell lines, whilst MDCK cells are an immortalised cell line derived from the 
normal canine kidney (Leighton et al., 1970), thus it is not surprising that they 
respond differently. As G-proteins activated by EP receptors may differ between cell 
types and, more specifically, the EP3 receptor can exist as multiple splice variants, 
responses to PGE2-EP receptor signalling may be cell-type specific. Furthermore, 
differences in PGE2 signalling between normal and malignant cells have been 
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described in a recent study (Tveteraas et al., 2012). PGE2 stimulation of MH1C1 
hepatocarcinoma cells was shown to cause EGF receptor phosphorylation and EGF 
receptor-dependant phosphorylation of ERK and Akt via FP receptor activation and 
ADAM-mediated release of EGF receptor ligands. However, in normal primary rat 
hepatocytes, PGE2 induced the up-regulation of Ras/ERK and PI3K/Akt signalling 
downstream of the EGF receptor (Tveteraas et al., 2012), mediated primarily though 
the Gi protein (Dajani et al., 2008), which couples to the EP3 receptor (Narumiya et 
al., 1999). These findings suggest that different prostanoid receptors and signalling 
pathways may be involved in PGE2-mediated effects on normal and malignant cells 
and that PGE2 signalling may be mediated by both direct intracellular and indirect 
intercellular signalling. 
  
Fringe area per cell was measured as a surrogate for lamellipodia formation, a key 
component of cell spreading, which occurs in leading edge cells in spreading cell 
sheets. Spread area per cell provides a measure of absolute cell migration. In the 
current study there was marked inter-assay variation in total area per cell. This may 
reflect the fact that the largest areas per cell were seen in samples where cell counts 
per island were lower i.e. where fringe area contributes more to total area leading to 
a bleed-through of effects on fringe area into total area measurement. Epithelial cells 
at the periphery of individual cell islands represent leading edge cells of a spreading 
sheet and thus, significant changes in fringe area were considered to reflect a key 
change in spreading activity. 
 
In contrast to previous findings (Section 4.3.4.2), PGE2 was shown to decrease 
protrusive activity of primary epithelial cells. This may reflect the fact that the cells 
used in these investigations were derived from a different source, (cadaver-derived in 
this investigation and biopsy-derived in the previous investigation). Biopsy-derived 
cells express some EP3 and little or no EP4, whereas, cadaver-derived cells express 
higher levels of EP3 and a 4-fold increase in EP4 protein (Section 6.3.6). Both PGE2 
and EP4 agonism were shown to inhibit cellular protrusive activity while the EP4 
antagonist, AH-23848, increased cell protrusion. Together, these findings suggest 
that EP4 is the functionally predominant receptor for PGE2 signals in this system. 
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Contrastingly, EP3 agonism was found to have no effect on fringe area. Activation 
of the EP3 and EP4 receptors produces opposing effects on cAMP production, with 
EP3 and EP4 causing an inhibition and stimulation in production, respectively 
(Narumiya et al., 1999). Thus if a single cell expressed both EP3 and EP4 the effects 
of PGE2 at EP4 may predominate over EP3. Furthermore, a prior study localising 
EP3 and EP4 mRNA expression in rat gastric epithelial cells, reported that mucus-
secreting cells express EP4 mRNA only, while parietal cells express both EP3 and 
EP4 (Ding et al., 1997). EP4 receptor signalling is known to mediate PGE2-
stimulated mucus secretion (Takahashi et al., 1999), while acid secretion is regulated 
via the opposing effects of EP3 and EP4 activation (Kato et al., 2005). Chief cells 
have been shown to express low levels of EP3 and no EP4 (Northey et al., 2000). 
These observations suggest that surface mucous cells may be the key expressors of 
EP4 in our system. Sirius red staining suggested a peripheral distribution for mucus-
secreting cells in our cell islands and the limited immunohistochemical data (Section 
6.3.8) was consistent with expression in peripheral cells. Together, these findings 
would be consistent with fringe area being primarily influenced by EP4 signalling. 
This would explain why EP3 agonism had no effect on the fringe area and also why 
the effects of PGE2 appear to be mediated by EP4 signalling in this system. In order 
to confirm which cell types were expressing EP3 and EP4, dual-labelling 
immunocytochemistry could be used. 
 
The findings presented in this chapter provide evidence that PGE2-mediated effects 
on cell migration and spreading can vary significantly, depending on the EP receptor 
profile of the cell; however, PGE2 signalling via the EP3 and EP4 receptors does 
appear to have an important role in the modulation of epithelial cell migration and 
spreading. PGE2 stimulation was shown to cause different functional responses in 
two distinct models of cell migration. In MDCK cells, EP3 signalling appears to 
positively regulate cell migration, while EP4 activation acts as a negative regulator. 
Furthermore, in this system EP3 receptor activation appears to be the predominant 
determinant of PGE2-induced migration. In primary gastric epithelial cells, 
protrusive activity is influenced by EP4 signalling. EP4 activation inhibited, while 
EP4 antagonism stimulated protrusive activity. EP4 activation appears to 
predominate in mediating the PGE2 inhibition of protrusive activity in this system. In 
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order to confirm the role of EP3 and EP4-mediated PGE2 signalling in the regulation 
of cell migration, receptor knockdown using siRNA would be the next logical step. 
Suitable siRNAs have been designed, which successfully and selectively diminished 
the expression of both EP3 and EP4 in MDCK cells (Section 7.3.4).  
 
Future studies are necessary to determine which signal transduction pathways are 
involved in the effects reported here. COX-2 derived PGE2 is known to regulate cell 
migration via transactivation and phosphorylation of the EGF receptor (Buchanan et 
al., 2003), thus analysis of EP-dependant activation of the EGF receptor may provide 
further insight into the signalling cascades involved in these effects. Furthermore, 
given that EP3 and EP4 signal through the regulation of intracellular cAMP levels 
(Narumiya et al., 1999), and that the cAMP-dependant PKA pathway has a central 
role in the regulation of actin cytoskeletal arrangement and migration (Howe, 2004), 
EP receptor-mediated cAMP activation could be assessed through the use of a gene 
reporter assay to monitor changes in gene expression.  
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Chapter 8– Characterising the relationship between various clinical parameters 
and COX-2, EP3 and EP4 protein expression 
 
8.1 Introduction 
 
GI disease is associated with changes in both COX-2 and EP receptor expression, for 
instance COX-2 is known to be up-regulated in IBD (Singer et al., 1998) and 
Helicobacter pylori-induced gastritis in humans (Fu et al., 1999) and markedly 
different EP receptor expression and localisation has been described in normal and 
inflamed human colonic mucosal tissue (Takafuji et al., 2000). There is also 
evidence highlighting the association between COX-2/PGE2 signalling and gastric 
cancer, with COX-2 overexpression previously reported in colorectal cancer 
(Maekawa et al., 1998), and gastric adenocarcinoma (Lim et al., 2000). Furthermore, 
EP4 protein expression has been shown to be increased in colorectal cancer (Chell et 
al., 2006), whereas EP3 mRNA is down-regulated (Shoji et al., 2004). 
 
Endoscopy is a routinely used tool in the diagnosis of dog and cat GI disease and 
gastric biopsies may provide important information about both gastric disease and 
pathologic changes across the whole GI tract (Lidbury et al., 2009). However, 
considerably different interpretation of clinical biopsy histopathology findings is a 
problem (Willard et al., 2002) and real efforts have been made to try and standardise 
endoscopic evaluation at both the gross and histopathological level (Washabau et al., 
2010). As such there is potential merit in trying to identify objective markers that 
might correlate with disease and/or functional histopathological changes. Thus the 
aim of this study was to test the hypothesis that COX-2, EP3 and EP4 protein 
expression can be used as objective markers of certain GI diseases.  
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8.2. Materials and Methods 
 
8.2.1.Dot blotting 
 
8.2.1.1. Protein extraction 
 
Protein was extracted from tissue samples collected during routine endoscopic 
biopsies and stored at -80°C, as described previously (Section 2.8.7.1). 
 
8.2.1.2. Dot blots 
 
Dot blots were performed as described previously (Section 2.8.7.6) in order to 
compare protein expression in large sample numbers. 
 
8.2.2.Clinical data 
 
Clinical data was obtained from the hospital clinical record, the endoscopic report 
and the histopathology report (from either Veterinary Pathology, University of 
Liverpool or Bridge Pathology, Bristol) and interpreted by a clinician. The 
histopathological changes used to evaluate gastric inflammation follow the standards 
of the WSAVA Standardization Group (Day et al., 2008). In addition to WSAVA 
histopathological scoring, the presence or absence of spiral bacteria was also noted, 
and if present the localisation of spiral bacteria was categorised as being in the 
superficial mucus layer (superficial) or the gastric glands (deep) according to the 
histopathology report. 
 
8.2.3.Cell vacuolation scoring 
 
Cell islands isolated from 9 separate biopsy-derived tissue samples were analysed for 
vacuolation, with scores given to 3 separate islands per sample. Cell vacuolation was 
scored on a scale of 0-5, where 0 indicates no vacuolation and 5 indicates severe 
vacuolation. Scoring was carried out by an observer blinded to the Helicobacter 
status. Immunohistochemical analysis of biopsy samples was carried out by 
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Veterinary Pathology, University of Liverpool in order to determine the 
Helicobacter status. 
 
8.2.4.Statistics 
 
Individual value plots were used to provide a graphical representation of the effects 
of each parameter on COX-2, EP3 and EP4 protein expression. The Kruskall-Wallis 
one-way analysis of variance on ranks was used for analysis of statistical differences. 
Statistical analysis was performed using the Minitab®15 Statistical Software and the 
criteria for statistical significance was set at P<0.05. The effects of Helicobacter 
status on cell vacuolation were analysed using one-way analysis of variance. SPSS 
20 (IBM Corp.) was used to perform the analysis and the criteria for statistical 
significance was set at P<0.05. 
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8.3. Results 
 
8.3.1.The effects of spiral bacteria on EP3, EP4 and COX-2 protein expression  
 
For the purpose of this investigation, clinical data from 36 patients was analysed, of 
these there were 19 neutered females, 15 neutered males, 1 non-neutered female and 
1 non-neutered male. The mean age was 8 years (range 2-15 years) and none of the 
patients were taking NSAIDs prior to inclusion in the study. 17 patients were shown 
to be Helicobacter-positive, while 19 patients did not have Helicobacter infection. 
Deep Helicobacter infection was noted in 3 cases. 
 
The association between the presence of superficial and deep spiral bacteria in the 
gastric mucosa and EP3, EP4 and COX-2 expression was analysed. Neither 
superficial nor deep spiral bacteria had any significant effect on EP3 or EP4 protein 
expression (Figure 8.1a, b, d and e). Samples positive for superficial spiral bacteria 
showed significantly higher COX-2 expression, however, there was overlap between 
COX-2 expression levels in the spiral bacteria positive and negative groups (Figure 
8.1c). Deep spiral bacteria did not significantly affect COX-2 expression and 
samples positive for deep spiral bacteria, showed a similar level of COX-2 protein 
expression to negative samples (Figure 8.1f). 
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Figure 8.1- Individual value plot analysis of EP3 (a and d), EP4 (b and e) and COX-2 (c and f) expression against the presence of superficial spiral (upper 
panel) or deep spiral (lower panel) bacteria; F= false, T= True; * represents significantly higher COX-2 intensity values in spiral bacteria-positive samples than 
in spiral bacteria-negative samples using the Kruskall -Wallis one-way analysis of variance on ranks (p < 0.05). 
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8.3.2.The effects of age, gender, neutering status, breed, inflammation and 
gastric cancer on  EP3, EP4 and COX-2 protein expression  
 
The influence of additional clinical variables on protein expression was also 
investigated. No significant association was found between EP3, EP4 and COX-2 
protein expression and any of the other clinical variables investigated (data not 
presented). The variables investigated include the age, gender, neutering status and 
breed of the patient and the impact of gastric inflammation, as indicated by the 
dominant population of pro-inflammatory cells (intraepithelial lymphocytes, 
lymphoplasmacytic, lymphofollicular, eosinophillic and neutrophillic).  The effects 
of gastric cancer on protein expression were also considered, however, none of the 
patients studied were diagnosed with gastric lymphoma and as such an association 
could not be determined. In addition, only 1 patient of the 36 studied was diagnosed 
with gastric adenocarcinoma, thus statistical analysis could not be performed; 
however, relatively low levels of EP3, EP4 and COX-2 protein were expressed in 
this tissue sample. 
 
8.3.3.The effects of Helicobacter spp. on gastric epithelial cell vacuolation 
 
Throughout this investigation, it was noted that certain gastric epithelial cell islands 
in culture developed intracellular vacuoles (Figure 8.2). The association between 
vacuolation and the presence of Helicobacter spp. in the tissue from which the cells 
were isolated was investigated. Cell vacuolation was scored on a scale of 0-5, where 
0 indicates no vacuolation and 5 indicates severe vacuolation, such as that seen in 
Figure 8.2. Cells isolated from Helicobacter-positive mucosal tissue samples, were 
found to have significantly higher vacuolation scores than cells isolated from 
Helicobacter-negative samples (Figure 8.3). However, no differences in spreading 
behaviour were observed in vacuolated cell islands. 
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Figure 8.2- Severe vacuolation (score of 5) in a gastric epithelial cell island isolated from 
Helicobacter-positive biopsy-derived tissue. Arrows indicate intracellular vacuoles. Images taken at 
magnification of 20X; scale bar: 10 µm 
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Figure 8.3- Effects of Helicobacter status on vacuolation in cultured gastric epithelial cell 
islands; Vacuolation was scored on a scale of 0-5, where 0 = no vacuolation and 5 = severe 
vacuolation. Data (presented as mean +/- SEM) was analysed using one-way analysis of variance. 
Cells isolated from Helicobacter-positive tissue samples showed significantly higher levels of 
vacuolation than cells isolated from Helicobacter-negative tissue samples (p<0.05, indicated by *). 
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8.4. Discussion 
 
The data presented in this chapter provides evidence that COX-2 protein expression 
is up-regulated in the canine gastric mucosa during infection with spiral bacteria, 
while EP3 and EP4 protein expression is unaffected. The majority of current work 
has focused on the effects of H. pylori infection, given that it is a highly prevalent 
human pathogen (Khalifa et al., 2010). Although H. pylori has not been identified in 
dogs (Neiger & Simpson, 2000), Helicobacter species reported in the canine 
stomach include H. felis, H. bilis, Flexispira rappini, H. bizzozeronii, H. salomonis 
and H. Heilmannii (Eaton et al., 1996; Jalava et al., 1998; Neiger et al., 1999). In 
previous studies, COX-2 mRNA and protein expression have been shown to be 
markedly up-regulated in the gastric mucosa of human patients with H. pylori-
positive gastritis when compared with normal mucosa (Fu et al., 1999). Additionally, 
COX-2 expression is higher in tissue samples from patients with H. pylori-positive 
gastritis than in H. pylori-negative gastritis (Fu et al., 1999), thus induced COX-2 
expression may be a direct response to H. pylori infection, as opposed to the 
presence of gastritis. Furthermore, increased COX-2 protein expression is reduced 
following successful eradication of H. pylori (McCarthy et al., 1999). In vitro studies 
have confirmed the effects of Helicobacter on COX-2 expression, for instance, 
culturing H. pylori with a normal gastric epithelial cell line for 24 h, was shown to 
cause a 6-fold increase in COX-2 protein expression and a subsequent increase in 
PGE2 production (Shen et al., 2006). Similarly, H. pylori up-regulated COX-2 
mRNA expression and PGE2 release in the human adenocarcinoma cell line, MKN-
28 in vitro (Romano et al., 1998).  
 
H. pylori infection has been shown to activate NF-κB in human gastric epithelial 
cells both in vitro and in vivo (Keates et al., 1997), as the COX-2 gene contains an 
NF-κB binding site in its promoter region (Tanabe & Tohnai, 2002), this could be a 
potential mechanism for COX-2 induction. Such a mechanism has been described for 
the induction of COX-2 expression by H. pylori in human gastric epithelial cells in 
vitro (Chang et al., 2004). H. pylori was reported to act through the toll-like 
receptors, TLR2 and TLR9 to activate PI/PLCɣ, which induces PKCα and c-Src 
activation, leading to the tyrosine phosphorylation of IKKα/β. The NIK/IKKα/β 
pathway is also activated and both pathways converge, resulting in the 
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phosphorylation and degradation of IκBα and activation of NF-κB in the COX-2 
promoter region, leading to the induction of COX-2 gene expression (Chang et al., 
2004). Exposure of the AGS gastric cancer cell line to Helicobacter pylori has been 
shown to activate NF-kB signaling, COX-2 expression and paracrine activation of 
cell migration and invasion (Varro et al., 2004). Furthermore, COX-2 is a potentially 
important paracrine regulator of PAI-2, a key factor in the regulation of epithelial 
cell apoptosis and cell migration (Varro et al., 2004). 
 
While it is clear that Helicobacter infection induces the expression of COX-2 in vivo 
and in vitro, the data obtained during this investigation suggests that other factors 
may play a role in this. While COX-2 protein expression was markedly increased in 
some samples positive for spiral bacteria, certain samples expressed similar levels of 
COX-2 to samples negative for spiral bacteria, thus suggesting that other factors may 
influence the effects of spiral bacteria on protein expression. No correlation was 
found between the samples expressing high COX-2 and any of the other clinical 
parameters, however, due to the small sample size, the effects of breed on protein 
expression could not be meaningfully investigated. Thus, future studies using a 
larger sample size are needed to further investigate the association between COX-2 
expression and breed. The presence of spiral bacteria was further categorised as 
colonising deep within the gastric glands, however the presence of deep spiral 
bacteria was found to have no significant effect on COX-2, EP3 or EP4 protein 
expression. However, it is interesting that in the small number of cases where deep  
Helicobacter infection was noted, COX-2 and EP4 expression was low. 
 
In this study, cultured gastric epithelial cell islands isolated from mucosal tissue 
samples positive for Helicobacter were shown to have increased cytoplasmic 
vacuolation. Approximately 50% of H. pylori isolates in Western countries produce 
the cytotoxin, VacA, which induces cytoplasmic vacuolation in eukaryotic cells 
(Maeda et al., 1998). A previous study reported similar cytoplasmic vacuolation to 
that seen here, in primary cultures of human gastric epithelial cells, incubated with 
the H. pylori vacuolating cytotoxin and primary cells were significantly more 
sensitive to the effects of the cytotoxin than cell lines (Smoot et al., 1996). The VacA 
cytotoxin appears to be unique to the H. pylori species (Beswick et al., 2006) and 
much less is known about the virulence of non-H. pylori Helicobacters. However H. 
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trogontum has been shown to cause similar vacuolation in ileal epithelial cells 
(Moura et al., 1998). Clearly, more work needs to be done in order to characterise 
virulence factors associated with other Helicobacter species. Given the association 
between Helicobacter status and cultured gastric epithelial cells described in this 
chapter, it seems possible that the Helicobacter are colonising intracellularly and as 
such survive antibiotic treatment in the culture medium. H. bizzozeronii and H. felis 
have recently been reported to localise intracellularly in parietal cells and 
macrophages in the fundic mucosa of Beagle dogs (Lanzoni et al., 2011). 
 
The relationship between protein expression and gastric inflammation, as indicated 
by various markers, was also investigated. The WSAVA Gastrointestinal 
Standardization Group has produced a set of standards for the characterisation of 
inflammatory changes in endoscopic biopsy samples from the gastrointestinal 
mucosa of small companion animals (Day et al., 2008). These reporting guidelines 
were used to evaluate inflammatory changes in the biopsy samples used in this 
investigation. The inflammatory changes reported include the presence of 
intraepithelial lymphocytes, lymphoplasmacytic, eosinophillic and neutrophillic 
infiltration and lymphofollicular hyperplasia. No association was found between 
EP3, EP4 and COX-2 protein expression and gastric mucosal inflammation. 
Increased COX-2 expression in H. pylori gastritis and in tissue adjacent to gastric 
ulceration has been previously described (Jackson et al., 2000). Additionally, a study 
comparing PGE2 receptor expression in normal and inflamed human colonic mucosa, 
reported a significant increase in EP4 expression in the mucosal T-lymphocytes of 
inflamed tissue (Cosme et al., 2000) and EP4 epithelial expression in the inflamed 
mucosa was more intermittent compared with the even distribution seen in the 
normal mucosa (Cosme et al., 2000). Furthermore, during inflammation non-surface 
epithelial cells newly and significantly express EP2 and EP3 (Takafuji et al., 2000). 
As such, the lack of relationship found between protein expression and markers of 
inflammation is surprising. 
 
The most common neoplasm to affect the canine stomach is gastric carcinoma 
(Carrasco et al., 2011). Particular breeds show an increased risk for developing 
gastric carcinoma (Willard, 2012) and little is known about its pathogenesis, but it is 
assumed to be similar to that of human gastric carcinoma. Many of the markers of 
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malignancy that are associated with increased COX-2 expression, for instance, 
invasion and metastasis (Han, 2003) are related to increased cell migration. As only 
1 of the 36 patients studied was diagnosed with gastric adenocarcinoma, no 
meaningful conclusions could be made with regards to its influence on protein 
expression. Furthermore, none of the patients studied were diagnosed with gastric 
lymphoma. The over-expression of COX-2 in gastric cancer tissue has been 
previously reported (Lim et al., 2000; Mao et al., 2007) and was significantly related 
to metastasis and the depth of invasion (Mao et al., 2007). Increased COX-2 
expression has been identified as an independent prognostic marker for poor 
outcome in gastric cancer and COX-2 is considered an important treatment target in 
a number of veterinary tumours, particularly transitional cell carcinoma (Doré, 
2011). COX-2 over-expression is related to advanced tumour penetration depth, 
lymph node metastases and non-curative operation (Mrena et al., 2005). COX-2 
over-expression is more prevalent in larger tumours and in more invasive cancers, 
i.e. cancers with more metastatic nodes and a greater invasion depth (Han, 2003). A 
previous study comparing COX-2 protein expression in gastric carcinoma tissue 
samples and paired samples from adjacent normal mucosal tissue, found that the 
carcinoma tissue expressed significantly higher COX-2 levels (Murata et al., 1999). 
In this investigation, the tissue sample obtained from the patient diagnosed with 
gastric adenocarcinoma, expressed relatively low levels of EP3, EP4 and COX-2 
protein.  
 
Little is known about EP receptor expression in gastric cancer. In veterinary patients, 
COX-2 and EP1 and EP2 expression are markedly increased in bone tumours 
(Millanta et al., 2012). In human GI tract tumours, EP3 expression is known to be 
markedly decreased in colon cancer tissue and its down-regulation is thought to 
contribute to colon carcinogenesis (Shoji et al., 2004). In contrast, EP4 protein 
expression has been shown to be increased in colorectal cancers (Chell et al., 2006). 
Thus, EP3 and EP4 clearly have a role in carcinogenesis and more work needs to be 
carried out in order to determine the nature of this role in gastric cancer. As samples 
used for this investigation are obtained from routine endoscopic biopsies and gastric 
carcinoma is relatively uncommon, the study size was very small. A retrospective 
evaluation of COX-2, EP3 and EP4 immunoreactivity in canine gastric tumours 
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using archived material would allow for a larger sample size and would be a valuable 
staring point to evaluate a potential role for these proteins in canine gastric cancer.
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Chapter 9 – Final discussion 
 
9.1 Overview of the major findings of the project 
 
The major findings presented in this thesis are that a.) a previously used primary cell 
culture model can be reproducibly used to study canine gastric epithelial cell 
spreading, b.) COX-2-derived PGE2 has an important role in the modulation of 
epithelial cell migration and spreading, c.) GR signalling is also involved in 
epithelial cell migration and spreading; however, its effects are complex and warrant 
further study, d.) COX-2, EP3 and EP4 expression in cultured epithelial cells is 
readily induced by acute stressors, d.) EP3 and EP4 signalling is involved in PGE2-
mediated effects on cell migration and spreading and elicits different functional 
responses in two different cell migration models. Furthermore, activation of EP3 or 
EP4 was shown to have opposing effects on MDCK cell migration and spreading, 
and e.) COX-2 expression is induced in dogs infected with spiral bacteria. 
 
9.1.1.Characterisation of a new model for studying cell migration in the canine 
gastric epithelium 
 
One of the main aims of this project was to develop a reproducible primary cell 
culture model, enabling the study of the mechanisms and signalling pathways 
involved in canine gastric epithelial defence. Previous work has established such a 
model for studying rabbit (Berglindh & Öbrink, 1976), human (Wroblewski et al., 
2003), mouse (Pagliocca et al., 2008) and rat (Azerkan et al., 2001) gastric 
epithelium, however, this model has not previously been used in dogs. Given the 
difficulties encountered in understanding the correlation between histopathology and 
disease in canine GI biopsies (Willard et al., 2002), the findings reported here and in 
further potential studies using this model might provide potentially useful objective 
criteria by which to assess these biopsies. This model allows isolation of intact 
multicellular gastric glands, thus more closely resembling the gastric epithelium in 
vivo than cultures of dispersed epithelial cells. For this project, mucosal tissue 
samples were obtained from dogs undergoing routine endoscopies and, once the 
techniques for gastric gland isolation were established, cultures of viable glands were 
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reproducibly obtained. In order to quantify cell migration within this model the rate 
of gland spreading over 48 h was measured as a surrogate for cell migration speed 
and lamellipodia protrusion, represented by the measurement of fringe area, was 
analysed as an index of spreading activity.  
 
9.1.2.COX antagonism and epithelial cell migration and spreading 
 
Non-selective and COX-2 selective antagonism was shown to inhibit epithelial cell 
migration in scratch wounded monolayers and spreading epithelial cell islands. 
Furthermore, non-selective and COX-2 selective antagonism decreased PGE2 in both 
primary and immortalised epithelial cells to a similar extent. These findings suggest 
that COX-2 derived PGE2 is important for the regulation of epithelial cell migration 
and spreading and support previous findings that COX-2 selective antagonism 
impairs the re-epithelialisation of wounded gastric monolayers in vitro (Pai et al., 
2001) and gastric ulcer healing in vivo (Shigeta et al., 1998). COX-2 selective 
antagonists have been associated with less adverse gastrointestinal effects compared 
with traditional non-selective antagonists (Laine et al., 1999; Simon et al., 1999; 
Hawkey et al., 2000), however, a requirement for both COX-1 and -2 inhibition in 
the pathogenesis of NSAID-induced gastric injury has been previously described 
(Wallace et al., 2000; Takeuchi, 2012). COX-2 expression and PGE2 production is 
induced in ulcerated gastric tissue (Takahashi et al., 1998) and COX-2-derived PGE2 
has been shown to promote gastric ulcer healing by mediating the effects of HGF 
and gastrin (Brzozowski et al., 2000). Thus, COX-2-derived prostaglandins appear to 
have an important role in gastric mucosal defence and repair and their involvement 
in the modulation of epithelial cell migration and spreading may contribute to this. 
 
Non-selective and COX-2 selective antagonism was also shown to inhibit the 
protrusive activity of spreading primary gastric epithelial cells, as indicated through 
the measurement of fringe area. In agreement with these findings, aspirin treatment 
has previously been associated with poorly formed lamellipodia at the wound edge 
(Yoshizawa et al., 2000). Furthermore, non-selective and COX-2 selective 
antagonism directly affects the cytoskeleton via disruption of actin stress fibre 
formation, reduction in c-Src activity and a decrease in FAK and tensin 
phosphorylation (Pai et al., 2001).  
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Thus, these findings would be consistent with COX antagonism impairing 
cytoskeletal function, leading to decreased cell protrusion and a subsequent 
inhibition of cell migration and spreading. 
 
9.1.3.Glucocorticoid receptor agonism and antagonism and epithelial cell 
migration and spreading 
 
Contrasting results were obtained when investigating the effects of GR agonism and 
antagonism on epithelial cell migration using scratch wound healing and cell 
spreading assays. GR agonism and antagonism impaired the healing of scratch 
wounded monolayers but had no significant effect on the spreading of primary 
gastric epithelial cell islands. Given that previous studies have described an 
inhibition of gastric epithelial cell migration following administration of the GR 
agonist, dexamethasone (Luo et al., 2009) and the GR antagonist, RU-38486 
(Mifepristone) (Li et al., 2004), these findings were unexpected. As the primary 
gastric epithelial cell model, described in this investigation, is a multicellular model, 
intercellular signalling networks between different epithelial cell lineages could 
explain the differences observed. Paracrine signalling appears to contribute to GR-
mediated effects on epithelial cell migration, for example, dexamethasone was 
shown to inhibit gastric epithelial cell migration through the depletion of HGF 
mRNA expression and release by gastric fibroblasts (Takahashi et al., 2003). 
However, in preparations of biopsy-derived gastric epithelial cells, as used in this 
investigation, there appears to be few gastric fibroblasts present. 
 
Furthermore, previous studies have all used cells that have either been serum-starved 
for 24 h prior to assay or cultured in serum-free media during the assay. The 
presence of serum in cell medium can profoundly influence cell behaviour, for 
example, HGF activation and secretion can be dose-dependently stimulated in 
fibroblasts cultured with FBS at concentrations of 1% to 10% (Ohshima et al., 2002), 
similarly, FBS can activate ERK-1 and -2 (Lee et al., 2001). Given that GR-mediated 
effects on cell migration involve inhibition of the ERK1/2/MAPK pathway (Piette et 
al., 2009) and suppression of HGF secretion (Takahashi et al., 2003), performing 
these experiments in serum-containing medium may significantly alter the cellular 
responses. As serum also contains relatively low levels of PGE2 that, as explained 
Chapter 9 – Final Discussion 
 
 
165 
previously, is important for the modulation of epithelial cell migration, this may also 
influence cell behaviour. GR signalling clearly has a role in epithelial cell migration 
and spreading, however, more work needs to be performed in this area.  
 
9.1.4.EP receptor expression in the canine gastric epithelium 
 
The expression and localisation of COX-2 and the prostaglandin receptors, EP3 and 
EP4 in the canine gastric epithelium were characterised in this investigation. COX-2, 
EP3 and EP4 mRNA was detected in cultured canine gastric epithelial cells. This is 
in keeping with previous observations that COX-2 mRNA is expressed in the normal 
human and rabbit gastric mucosa (Zimmerman et al., 1998) and EP3 and EP4 mRNA 
is expressed in the normal rat mucosa (Ding et al., 1997). In the normal canine 
gastric mucosa, COX-2 immunoreactivity was found to be localised in the parietal 
cells and chief cells, while EP4 was localised in the parietal cells only. The pattern of 
COX-2 expression in cultured gastric epithelial cells was predominately perinuclear, 
while EP4 staining was cytoplasmic. Perinuclear COX-2 expression has been 
reported previously in colonic epithelial cells (Singer et al., 1998) and provides 
support for the finding that COX-2 functions primarily within the nuclear envelope 
(Morita et al., 1995). In addition, EP4 expression in the parietal cells of the rat 
gastric mucosa has previously been reported (Ding et al., 1997). Different 
localisation of COX-2 expression was observed using immunohistochemistry and 
immunocytochemistry techniques, immunocytochemistry revealed COX-2 
immunoreactivity in all cells except for the parietal cells; however 
immunohistochemistry showed specific staining in the parietal cells. Given that the 
samples analysed were obtained from two individual cadaver sources, variation in 
clinical parameters may explain this difference. For instance, infection with H. pylori 
has previously been associated with marked COX-2 immunoreactivity in parietal 
cells, which is reduced following successful eradication (McCarthy et al., 1999).  
 
COX-2, EP3 and EP4 expression was shown to be induced by serum deprivation of 
primary and immortalised epithelial cells. Furthermore, cadaver-derived gastric 
epithelial cells expressed significantly more EP3 and EP4 protein than biopsy-
derived cells. Given that tissue samples obtained from a cadaver source will be 
exposed to stressors, such as ischaemia and hypoxia prior to collection, it is not 
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surprising that protein expression is affected. Retinal ischaemia, induced through 
elevation of intraocular pressure, has been shown to change EP receptor expression 
and localisation and to change the dimer/monomer ratio of all the EP receptors 
(Osborne et al., 2009). In particular, ischaemia caused the down-regulation of the 
EP3 and EP4 dimers and the up-regulation of their monomers. Furthermore, 
expression of PTGER4, the gene encoding the EP4 receptor, is induced in response 
to hypoxia, independently of the COX/PG system (Catalano et al., 2011) and 
PTGER4 signalling and hypoxia, in combination, promote cellular proliferation 
(Catalano et al., 2011). Thus, the observations presented in this thesis suggest that 
COX-2, EP3 and EP4 protein expression is readily induced in response to acute 
stressors and indicates a role for these receptors in acute stress responses in the 
physiologically challenging niche of the gastric epithelium. 
 
9.1.5.Characterisation of the EP receptor subtypes involved in the modulation 
of epithelial cell migration and spreading 
 
The findings presented in this thesis provide evidence that PGE2 signalling via the 
EP3 and EP4 receptors plays an important role in modulating epithelial cell 
migration and spreading. EP3 and EP4 activation produced markedly different 
functional responses in two distinct models of cell migration. Using sub-type 
specific agonists and antagonists, EP3 activation was shown to positively regulate 
MDCK cell migration, while EP4 acted as a negative regulator. In contrast, EP4 
activation inhibited cell protrusion, an indicator of spreading activity, in primary 
gastric epithelial cells. These findings suggest that the EP receptor profile of a cell 
may be an important determinant for the outcome of PGE2 signalling, thus changes 
to EP receptor expression induced via acute stressors, as described previously, may 
alter the outcome of PGE2 signalling. 
 
9.1.6.Relationship between clinical parameters and EP receptor 
expression in the canine gastric epithelium 
 
Up-regulation of COX-2 expression in the gastric mucosa of H. pylori-infected 
humans has previously been reported (Chan et al., 2001; McCarthy et al., 1999). In 
addition, in vitro studies have shown that COX-2 expression is up-regulated in cell 
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lines incubated with H. pylori (Romano et al., 1998; Shen et al., 2006). Given the 
role that COX-2-derived prostaglandins have in the promotion of epithelial cell 
migration and spreading, this up-regulation of COX-2 and subsequent increase in 
PGE2 production, could be important for maintaining the gastric mucosal integrity. 
In this investigation, COX-2 expression was shown to be significantly increased in 
the gastric mucosal tissue of dogs infected with spiral bacteria. To the best of our 
knowledge this is the first study to report this finding. Given the role of PGE2 in 
regulating epithelial cell migration and spreading, Helicobacter status should be 
taken into account when evaluating the effects of PGE2
 
in the canine stomach and 
may be expected to impact on the effects associated with NSAID treatment. 
 
9.2 Strengths and limitations of the research 
 
Primary cell models utilising intact gastric glands, such as that used in this 
investigation, have been widely used to study cell migration and spreading. The 
major difference between this primary cell culture model and in vivo experiments is 
the absence of complex systemic factors, such as blood supply and neural inputs that 
can influence cell migration, thus eliminating these factors allows analysis of a 
simpler system. When using this model, results need to be cautiously extrapolated to 
the whole tissue, preferably by evaluating in vivo effects and correlating the findings. 
However, using the in vitro model described in this project, gastric cell spreading 
can be studied using a minimally invasive approach and, as the cultured gastric 
glands should comprise all epithelial cell types found in vivo and normal cell-cell 
contacts are maintained, intercellular signalling can be investigated. The use of a 
model incorporating clinical samples was considered advantageous to the sponsors 
of this investigation as it enables the influence of clinical variables to be considered. 
Additionally, using an in vitro model enables the quantification of data to be quickly 
and accurately performed, hence, this model provides a valuable scientific tool for 
studying the mechanisms involved in gastric cell spreading.  
 
There were some limitations to the use of this model, including a scarcity of 
sufficient endoscopic mucosal tissue samples. To overcome this limitation, 
additional mucosal tissue samples were collected from cadaver sources. These, in-
turn displayed altered properties which themselves provided valuable insights into 
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the mechanisms of PGE2 signalling in the gastric mucosa. Scratch wound assays 
using immortalised cell lines were also performed to support the primary cell 
experiments. Scratch wound assays can be quickly and reproducibly performed and 
have been used previously to study the effects of gastric epithelial cell migration in 
vitro (Pai et al., 2001; Giap et al., 2002). In addition, using clinical samples 
introduces biological variation as natural heterogeneity exists between individual 
samples and the sample collection conditions may vary.  While clinical data was 
collected for all endoscopic biopsy samples, this data was not available for tissue 
samples derived from cadaver sources. Thus, a large amount of the protein 
expression data could not be compared against clinical findings and as such no 
meaningful evaluations could be made for the effects of breed and the presence of 
gastric cancer on protein expression. This investigation was therefore limited by a 
relatively small sample size, however sampling can continue and the study has 
highlighted analyses to plan on-going work.  
 
9.3 Future perspectives 
 
This thesis has highlighted key areas where further work is needed. While 
performing in vitro work provides a simplified model for studying the effects of 
COX antagonism on cell migration and spreading, systemic factors, such as gastric 
mucosal blood flow may influence these effects. Thus, in order to obtain more 
clinically relevant information, it would be useful to perform complimentary in vivo 
studies. 
 
Expression of EP3 and EP4 has been partially characterised in this investigation, 
however, further work is required in this area. Expression of COX-2, EP3 and EP4 in 
whole gastric mucosal tissue samples was localised to specific cell types using 
immunohistochemistry techniques, however, while immunocytochemical analysis 
demonstrated COX-2 and EP4 expression in cadaver-derived cultured gastric 
epithelial cells, due to time constraints, characterisation of the expressing cells was 
not performed. As discussed in previous chapters, double immunofluorescence 
labelling could be utilised in order to identify cell types exhibiting specific 
immunostaining and identifying cell-type specific protein expression would provide 
valuable insight into the cell types involved in PGE2-mediated EP3 and EP4 
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signalling. Furthermore, expression of EP3 in cultured gastric epithelial cells was not 
elucidated as immunocytochemical analysis of EP3 expression provided non-
specific, diffuse cytoplasmic staining. Given the findings presented in this thesis, 
demonstrating that EP3 expression is induced through serum-starvation, further 
studies to investigate EP3 expression in this model may be performed using serum-
starved gastric epithelial cells.  
 
In order to better understand the conflicting findings presented regarding GR-
mediated effects on epithelial cell migration and spreading, it would be useful to 
characterise GR expression and localisation in the canine gastric epithelium and in 
cultured gastric epithelial cells. In addition, given the marked effects of serum-
starvation on cellular protein expression presented in this thesis and the effects of 
serum exposure on GR expression reported previously (Yang et al., 2008), it would 
be interesting to investigate the effects of GR agonism and antagonism on cell 
spreading using serum-starved gastric epithelial cell islands.  
 
While COX-2 derived prostaglandins have been shown to be important for 
regulating epithelial cell migration and spreading, it would be useful to better 
understand the role of COX-1 through the use of a COX-1 selective antagonist, of 
which there are many available, including P6, P10 and SC-560 (Calvello et al., 
2012). Furthermore, it would be interesting to investigate the influence of gastric 
fibroblasts on canine gastric epithelial cell spreading using either an in vitro co-
culture model or in vitro culture with gastric fibroblast-conditioned medium. 
Previous studies have demonstrated, using a co-culture model that prostaglandins 
target gastric fibroblasts and induce HGF mRNA expression and protein production, 
which may occur via EP2/EP4-mediated cAMP signalling and that HGF may 
modulate prostaglandin-induced restitution (Takahashi et al., 1996). In the course of 
this investigation, putative primary gastric fibroblasts were successfully isolated 
from mucosal tissue samples in addition to gastric glands; however, communication 
between mesenchymal and epithelial cells was not studied. 
 
The importance of PGE2-mediated EP3 and EP4 signalling in the modulation of 
epithelial cell migration and spreading has been discussed in this thesis. Given that 
COX-2 derived PGE2 is known to regulate cell migration via transactivation and 
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phosphorylation of the EGF receptor (Buchanan, 2003), it would be interesting to 
determine EP receptor-dependent activation of the EGF receptor. This could be 
performed using an immunoprecipitation assay followed by Western blot analysis. 
Blockade of the EGF receptor using EGF receptor-specific tyrosine kinase inhibitors 
could be used to confirm its role. As EP3 and EP4 are known to signal via inhibition 
and stimulation of cAMP respectively (Narumiya et al., 1999), a FRET-based cAMP 
reporter system, such as that used in previous studies (Bagorda et al., 2009), could be 
used to assess EP receptor-mediated changes in intracellular cAMP levels. 
Additionally, a gene reporter assay could be performed to evaluate changes in the 
transcriptional activity of the COX-2 promoter in response to COX antagonism. The 
canine COX-2 promoter sequence could be cloned from cultured gastric epithelial 
cells into a luciferase or GFP reporter construct. NF-κB-dependent activation of the 
canine COX-2 promoter could be assessed through deletion or mutation of the NF-
κB binding sites. 
 
The role of EP receptor activation in the modulation of epithelial cell migration and 
spreading could be confirmed using siRNA transfection experiments to silence the 
appropriate genes. In the course of this investigation, suitable siRNAs were designed 
and shown to successfully diminish EP3 and EP4 protein expression in cultured 
MDCK cells. Future investigation would involve transfection of cultured gastric 
epithelial cells, in order to determine whether these siRNAs can also silence genes in 
primary cell cultures. The effect of gene silencing on epithelial cell migration could 
be assessed using scratch wound assays and analysis of cell spreading in cultured 
gastric epithelial cell islands.  
 
Finally, the association between specific clinical parameters and COX-2 and EP 
receptor expression in dogs could have an important clinical relevance. While, this 
association was investigated in this thesis, a small sample size limited this study and 
thus these results should be regarded as preliminary findings. Completing this 
investigation using a larger sample size could provide valuable information. 
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9.4 Conclusions 
 
In conclusion, this investigation has highlighted an important role for COX-2-
derived PGE2 in the modulation of epithelial cell migration and spreading, which 
may be related to the formation and maintenance of cellular protrusions. Thus, 
reduced PGE2 production in the gastric mucosa may inhibit gastric epithelial 
migration and spreading and contribute to the ulcerogenic effects associated with 
COX antagonist therapy. Furthermore, the migratory effects of PGE2 are mediated 
through EP3 and EP4 receptor signalling, and given that EP3 and EP4 activation 
produces different functional responses in two models of cell migration, the EP 
receptor profile of a cell may be an important determinant of the outcome of PGE2 
signalling. The inhibitory effect of EP4 activation on canine gastric epithelial cell 
protrusion, an indicator of spreading activity, is a novel finding. Increased expression 
of EP3, EP4 and COX-2 was found in serum-starved cells, while EP3 and EP4 
expression was increased in cadaver-derived cells and COX-2 expression was up-
regulated in the gastric mucosal tissue of canines infected with spiral bacteria. Thus, 
the expression of COX-2, EP3 and EP4 appears to be readily influenced by acute 
stressors. Further investigation is required in this area in order to determine the 
clinical relevance of these findings. 
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